<!DOCTYPE html><html  lang="en" data-capo=""><head><meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1">
<title>Frontiers | Prevalence estimation of ATTRv in China based on genetic databases</title>
<link rel="stylesheet" href="/ap-2024/_nuxt/entry.CWBB-NGm.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/vue-core.B-WA3Vg5.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/explainer.CMppEa5M.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleDetails.B93eTAmx.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleLayoutHeader.CKWUz2Al.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/AnnouncementCard.Db7nmstV.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/FloatingButtons.xuP8gC33.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleEvent.D0PaxIW7.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/SimilarArticles.BMee4Fk4.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleTemplateBanner.CXmOJ7NH.css">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/v1IBIWh4.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/B674Mi_H.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BXedFy5e.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/eQMj-Fph.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Y8NTh2i4.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BUyL5Z_3.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/m8mdd2tc.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DHv8pTSw.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BHPWSuhB.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/x5HZk7Le.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CNJXQ6ZR.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Dss5ciUI.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Do5q9QoL.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BhVAcJSK.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/y69VltF1.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Bw-bWKkJ.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/sQBxgu5L.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/D5YKKJGW.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CSLdjdGS.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BUN89Jk2.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CCeQzihV.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DVDwh0-U.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Dw4ta0fP.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CYv-CzHi.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/U-mJlaMn.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/NhyIC1F3.js">
<link rel="prefetch" as="style" crossorigin href="/ap-2024/_nuxt/ArticleHubLayout.q6CU8_bN.css">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/CKQJuUlk.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/D3plh7Cs.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/GWtHKqLR.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/DS3EY-DL.js">
<meta name="theme-color" content="#0C4DED">
<meta name="mobile-web-app-capable" content="yes">
<meta name="apple-mobile-web-app-capable" content="yes">
<script type="text/javascript" data-hid="4cd079c">window.NREUM||(NREUM={});NREUM.info = {"agent":"","beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"598a124f17","applicationID":"586843029","agentToken":null,"applicationTime":4.386577,"transactionName":"MQcDMkECCkNSW0YMWghNLwlBDgVcWkJXAWAUC04MXBYWXlJUQUpSAwwEEloAFx9SSkYMVgoHEkkZTAJXVlZXSwdWUFJIAlJWBgsLBEpTEw4N","queueTime":0,"ttGuid":"c448ed405cfed937"}; (window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},feature_flags:["soft_nav"],distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"594460232",accountID:"230385",trustKey:"230385",xpid:"VgUHUl5WGwYIUllWBAEFXw==",licenseKey:"598a124f17",applicationID:"586843029",browserID:"594460232"};;/*! For license information please see nr-loader-spa-1.303.0.min.js.LICENSE.txt */
(()=>{var e,t,r={384:(e,t,r)=>{"use strict";r.d(t,{NT:()=>s,US:()=>d,Zm:()=>a,bQ:()=>u,dV:()=>c,pV:()=>l});var n=r(6154),i=r(1863),o=r(1910);const s={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return n.gm.NREUM||(n.gm.NREUM={}),void 0===n.gm.newrelic&&(n.gm.newrelic=n.gm.NREUM),n.gm.NREUM}function c(){let e=a();return e.o||(e.o={ST:n.gm.setTimeout,SI:n.gm.setImmediate||n.gm.setInterval,CT:n.gm.clearTimeout,XHR:n.gm.XMLHttpRequest,REQ:n.gm.Request,EV:n.gm.Event,PR:n.gm.Promise,MO:n.gm.MutationObserver,FETCH:n.gm.fetch,WS:n.gm.WebSocket},(0,o.i)(...Object.values(e.o))),e}function u(e,t){let r=a();r.initializedAgents??={},t.initializedAt={ms:(0,i.t)(),date:new Date},r.initializedAgents[e]=t}function d(e,t){a()[e]=t}function l(){return function(){let e=a();const t=e.info||{};e.info={beacon:s.beacon,errorBeacon:s.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),c(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},782:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewTiming},860:(e,t,r)=>{"use strict";r.d(t,{$J:()=>d,K7:()=>c,P3:()=>u,XX:()=>i,Yy:()=>a,df:()=>o,qY:()=>n,v4:()=>s});const n="events",i="jserrors",o="browser/blobs",s="rum",a="browser/logs",c={ajax:"ajax",genericEvents:"generic_events",jserrors:i,logging:"logging",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",softNav:"soft_navigations",spa:"spa"},u={[c.pageViewEvent]:1,[c.pageViewTiming]:2,[c.metrics]:3,[c.jserrors]:4,[c.spa]:5,[c.ajax]:6,[c.sessionTrace]:7,[c.softNav]:8,[c.sessionReplay]:9,[c.logging]:10,[c.genericEvents]:11},d={[c.pageViewEvent]:s,[c.pageViewTiming]:n,[c.ajax]:n,[c.spa]:n,[c.softNav]:n,[c.metrics]:i,[c.jserrors]:i,[c.sessionTrace]:o,[c.sessionReplay]:o,[c.logging]:a,[c.genericEvents]:"ins"}},944:(e,t,r)=>{"use strict";r.d(t,{R:()=>i});var n=r(3241);function i(e,t){"function"==typeof console.debug&&(console.debug("New Relic Warning: https://github.com/newrelic/newrelic-browser-agent/blob/main/docs/warning-codes.md#".concat(e),t),(0,n.W)({agentIdentifier:null,drained:null,type:"data",name:"warn",feature:"warn",data:{code:e,secondary:t}}))}},993:(e,t,r)=>{"use strict";r.d(t,{A$:()=>o,ET:()=>s,TZ:()=>a,p_:()=>i});var n=r(860);const i={ERROR:"ERROR",WARN:"WARN",INFO:"INFO",DEBUG:"DEBUG",TRACE:"TRACE"},o={OFF:0,ERROR:1,WARN:2,INFO:3,DEBUG:4,TRACE:5},s="log",a=n.K7.logging},1687:(e,t,r)=>{"use strict";r.d(t,{Ak:()=>u,Ze:()=>f,x3:()=>d});var n=r(3241),i=r(7836),o=r(3606),s=r(860),a=r(2646);const c={};function u(e,t){const r={staged:!1,priority:s.P3[t]||0};l(e),c[e].get(t)||c[e].set(t,r)}function d(e,t){e&&c[e]&&(c[e].get(t)&&c[e].delete(t),p(e,t,!1),c[e].size&&h(e))}function l(e){if(!e)throw new Error("agentIdentifier required");c[e]||(c[e]=new Map)}function f(e="",t="feature",r=!1){if(l(e),!e||!c[e].get(t)||r)return p(e,t);c[e].get(t).staged=!0,h(e)}function h(e){const t=Array.from(c[e]);t.every(([e,t])=>t.staged)&&(t.sort((e,t)=>e[1].priority-t[1].priority),t.forEach(([t])=>{c[e].delete(t),p(e,t)}))}function p(e,t,r=!0){const s=e?i.ee.get(e):i.ee,c=o.i.handlers;if(!s.aborted&&s.backlog&&c){if((0,n.W)({agentIdentifier:e,type:"lifecycle",name:"drain",feature:t}),r){const e=s.backlog[t],r=c[t];if(r){for(let t=0;e&&t<e.length;++t)g(e[t],r);Object.entries(r).forEach(([e,t])=>{Object.values(t||{}).forEach(t=>{t[0]?.on&&t[0]?.context()instanceof a.y&&t[0].on(e,t[1])})})}}s.isolatedBacklog||delete c[t],s.backlog[t]=null,s.emit("drain-"+t,[])}}function g(e,t){var r=e[1];Object.values(t[r]||{}).forEach(t=>{var r=e[0];if(t[0]===r){var n=t[1],i=e[3],o=e[2];n.apply(i,o)}})}},1741:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(944),i=r(4261);class o{#e(e,...t){if(this[e]!==o.prototype[e])return this[e](...t);(0,n.R)(35,e)}addPageAction(e,t){return this.#e(i.hG,e,t)}register(e){return this.#e(i.eY,e)}recordCustomEvent(e,t){return this.#e(i.fF,e,t)}setPageViewName(e,t){return this.#e(i.Fw,e,t)}setCustomAttribute(e,t,r){return this.#e(i.cD,e,t,r)}noticeError(e,t){return this.#e(i.o5,e,t)}setUserId(e){return this.#e(i.Dl,e)}setApplicationVersion(e){return this.#e(i.nb,e)}setErrorHandler(e){return this.#e(i.bt,e)}addRelease(e,t){return this.#e(i.k6,e,t)}log(e,t){return this.#e(i.$9,e,t)}start(){return this.#e(i.d3)}finished(e){return this.#e(i.BL,e)}recordReplay(){return this.#e(i.CH)}pauseReplay(){return this.#e(i.Tb)}addToTrace(e){return this.#e(i.U2,e)}setCurrentRouteName(e){return this.#e(i.PA,e)}interaction(e){return this.#e(i.dT,e)}wrapLogger(e,t,r){return this.#e(i.Wb,e,t,r)}measure(e,t){return this.#e(i.V1,e,t)}consent(e){return this.#e(i.Pv,e)}}},1863:(e,t,r)=>{"use strict";function n(){return Math.floor(performance.now())}r.d(t,{t:()=>n})},1910:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(944);const i=new Map;function o(...e){return e.every(e=>{if(i.has(e))return i.get(e);const t="function"==typeof e&&e.toString().includes("[native code]");return t||(0,n.R)(64,e?.name||e?.toString()),i.set(e,t),t})}},2555:(e,t,r)=>{"use strict";r.d(t,{D:()=>a,f:()=>s});var n=r(384),i=r(8122);const o={beacon:n.NT.beacon,errorBeacon:n.NT.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0};function s(e){try{return!!e.licenseKey&&!!e.errorBeacon&&!!e.applicationID}catch(e){return!1}}const a=e=>(0,i.a)(e,o)},2614:(e,t,r)=>{"use strict";r.d(t,{BB:()=>s,H3:()=>n,g:()=>u,iL:()=>c,tS:()=>a,uh:()=>i,wk:()=>o});const n="NRBA",i="SESSION",o=144e5,s=18e5,a={STARTED:"session-started",PAUSE:"session-pause",RESET:"session-reset",RESUME:"session-resume",UPDATE:"session-update"},c={SAME_TAB:"same-tab",CROSS_TAB:"cross-tab"},u={OFF:0,FULL:1,ERROR:2}},2646:(e,t,r)=>{"use strict";r.d(t,{y:()=>n});class n{constructor(e){this.contextId=e}}},2843:(e,t,r)=>{"use strict";r.d(t,{u:()=>i});var n=r(3878);function i(e,t=!1,r,i){(0,n.DD)("visibilitychange",function(){if(t)return void("hidden"===document.visibilityState&&e());e(document.visibilityState)},r,i)}},3241:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(6154);const i="newrelic";function o(e={}){try{n.gm.dispatchEvent(new CustomEvent(i,{detail:e}))}catch(e){}}},3304:(e,t,r)=>{"use strict";r.d(t,{A:()=>o});var n=r(7836);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())??""}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}return""}}},3333:(e,t,r)=>{"use strict";r.d(t,{$v:()=>d,TZ:()=>n,Xh:()=>c,Zp:()=>i,kd:()=>u,mq:()=>a,nf:()=>s,qN:()=>o});const n=r(860).K7.genericEvents,i=["auxclick","click","copy","keydown","paste","scrollend"],o=["focus","blur"],s=4,a=1e3,c=2e3,u=["PageAction","UserAction","BrowserPerformance"],d={RESOURCES:"experimental.resources",REGISTER:"register"}},3434:(e,t,r)=>{"use strict";r.d(t,{Jt:()=>o,YM:()=>u});var n=r(7836),i=r(5607);const o="nr@original:".concat(i.W),s=50;var a=Object.prototype.hasOwnProperty,c=!1;function u(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");const s="-"===n.charAt(0);for(let a=0;a<t.length;a++){const c=t[a],u=e[c];l(u)||(e[c]=r(u,s?c+n:n,i,c,o))}},r.flag=o,r;function r(t,r,n,c,u){return l(t)?t:(r||(r=""),nrWrapper[o]=t,function(e,t,r){if(Object.defineProperty&&Object.keys)try{return Object.keys(e).forEach(function(r){Object.defineProperty(t,r,{get:function(){return e[r]},set:function(t){return e[r]=t,t}})}),t}catch(e){d([e],r)}for(var n in e)a.call(e,n)&&(t[n]=e[n])}(t,nrWrapper,e),nrWrapper);function nrWrapper(){var o,a,l,f;let h;try{a=this,o=[...arguments],l="function"==typeof n?n(o,a):n||{}}catch(t){d([t,"",[o,a,c],l],e)}i(r+"start",[o,a,c],l,u);const p=performance.now();let g;try{return f=t.apply(a,o),g=performance.now(),f}catch(e){throw g=performance.now(),i(r+"err",[o,a,e],l,u),h=e,h}finally{const e=g-p,t={start:p,end:g,duration:e,isLongTask:e>=s,methodName:c,thrownError:h};t.isLongTask&&i("long-task",[t,a],l,u),i(r+"end",[o,a,f],l,u)}}}function i(r,n,i,o){if(!c||t){var s=c;c=!0;try{e.emit(r,n,i,t,o)}catch(t){d([t,r,n,i],e)}c=s}}}function d(e,t){t||(t=n.ee);try{t.emit("internal-error",e)}catch(e){}}function l(e){return!(e&&"function"==typeof e&&e.apply&&!e[o])}},3606:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(9908);o.on=s;var i=o.handlers={};function o(e,t,r,o){s(o||n.d,i,e,t,r)}function s(e,t,r,i,o){o||(o="feature"),e||(e=n.d);var s=t[o]=t[o]||{};(s[r]=s[r]||[]).push([e,i])}},3738:(e,t,r)=>{"use strict";r.d(t,{He:()=>i,Kp:()=>a,Lc:()=>u,Rz:()=>d,TZ:()=>n,bD:()=>o,d3:()=>s,jx:()=>l,sl:()=>f,uP:()=>c});const n=r(860).K7.sessionTrace,i="bstResource",o="resource",s="-start",a="-end",c="fn"+s,u="fn"+a,d="pushState",l=1e3,f=3e4},3785:(e,t,r)=>{"use strict";r.d(t,{R:()=>c,b:()=>u});var n=r(9908),i=r(1863),o=r(860),s=r(8154),a=r(993);function c(e,t,r={},c=a.p_.INFO,u,d=(0,i.t)()){(0,n.p)(s.xV,["API/logging/".concat(c.toLowerCase(),"/called")],void 0,o.K7.metrics,e),(0,n.p)(a.ET,[d,t,r,c,u],void 0,o.K7.logging,e)}function u(e){return"string"==typeof e&&Object.values(a.p_).some(t=>t===e.toUpperCase().trim())}},3878:(e,t,r)=>{"use strict";function n(e,t){return{capture:e,passive:!1,signal:t}}function i(e,t,r=!1,i){window.addEventListener(e,t,n(r,i))}function o(e,t,r=!1,i){document.addEventListener(e,t,n(r,i))}r.d(t,{DD:()=>o,jT:()=>n,sp:()=>i})},3962:(e,t,r)=>{"use strict";r.d(t,{AM:()=>s,O2:()=>l,OV:()=>o,Qu:()=>f,TZ:()=>c,ih:()=>h,pP:()=>a,t1:()=>d,tC:()=>i,wD:()=>u});var n=r(860);const i=["click","keydown","submit"],o="popstate",s="api",a="initialPageLoad",c=n.K7.softNav,u=5e3,d=500,l={INITIAL_PAGE_LOAD:"",ROUTE_CHANGE:1,UNSPECIFIED:2},f={INTERACTION:1,AJAX:2,CUSTOM_END:3,CUSTOM_TRACER:4},h={IP:"in progress",PF:"pending finish",FIN:"finished",CAN:"cancelled"}},4234:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(7836),i=r(1687);class o{constructor(e,t){this.agentIdentifier=e,this.ee=n.ee.get(e),this.featureName=t,this.blocked=!1}deregisterDrain(){(0,i.x3)(this.agentIdentifier,this.featureName)}}},4261:(e,t,r)=>{"use strict";r.d(t,{$9:()=>d,BL:()=>c,CH:()=>p,Dl:()=>R,Fw:()=>w,PA:()=>v,Pl:()=>n,Pv:()=>A,Tb:()=>f,U2:()=>s,V1:()=>E,Wb:()=>T,bt:()=>y,cD:()=>b,d3:()=>x,dT:()=>u,eY:()=>g,fF:()=>h,hG:()=>o,hw:()=>i,k6:()=>a,nb:()=>m,o5:()=>l});const n="api-",i=n+"ixn-",o="addPageAction",s="addToTrace",a="addRelease",c="finished",u="interaction",d="log",l="noticeError",f="pauseReplay",h="recordCustomEvent",p="recordReplay",g="register",m="setApplicationVersion",v="setCurrentRouteName",b="setCustomAttribute",y="setErrorHandler",w="setPageViewName",R="setUserId",x="start",T="wrapLogger",E="measure",A="consent"},4387:(e,t,r)=>{"use strict";function n(e={}){return!(!e.id||!e.name)}function i(e){return"string"==typeof e&&e.trim().length<501||"number"==typeof e}function o(e,t){if(2!==t?.harvestEndpointVersion)return{};const r=t.agentRef.runtime.appMetadata.agents[0].entityGuid;return n(e)?{"mfe.id":e.id,"mfe.name":e.name,eventSource:e.eventSource,"parent.id":e.parent?.id||r}:{"entity.guid":r,appId:t.agentRef.info.applicationID}}r.d(t,{Ux:()=>o,c7:()=>n,yo:()=>i})},5205:(e,t,r)=>{"use strict";r.d(t,{j:()=>_});var n=r(384),i=r(1741);var o=r(2555),s=r(3333);const a=e=>{if(!e||"string"!=typeof e)return!1;try{document.createDocumentFragment().querySelector(e)}catch{return!1}return!0};var c=r(2614),u=r(944),d=r(8122);const l="[data-nr-mask]",f=e=>(0,d.a)(e,(()=>{const e={feature_flags:[],experimental:{allow_registered_children:!1,resources:!1},mask_selector:"*",block_selector:"[data-nr-block]",mask_input_options:{color:!1,date:!1,"datetime-local":!1,email:!1,month:!1,number:!1,range:!1,search:!1,tel:!1,text:!1,time:!1,url:!1,week:!1,textarea:!1,select:!1,password:!0}};return{ajax:{deny_list:void 0,block_internal:!0,enabled:!0,autoStart:!0},api:{get allow_registered_children(){return e.feature_flags.includes(s.$v.REGISTER)||e.experimental.allow_registered_children},set allow_registered_children(t){e.experimental.allow_registered_children=t},duplicate_registered_data:!1},browser_consent_mode:{enabled:!1},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},get feature_flags(){return e.feature_flags},set feature_flags(t){e.feature_flags=t},generic_events:{enabled:!0,autoStart:!0},harvest:{interval:30},jserrors:{enabled:!0,autoStart:!0},logging:{enabled:!0,autoStart:!0},metrics:{enabled:!0,autoStart:!0},obfuscate:void 0,page_action:{enabled:!0},page_view_event:{enabled:!0,autoStart:!0},page_view_timing:{enabled:!0,autoStart:!0},performance:{capture_marks:!1,capture_measures:!1,capture_detail:!0,resources:{get enabled(){return e.feature_flags.includes(s.$v.RESOURCES)||e.experimental.resources},set enabled(t){e.experimental.resources=t},asset_types:[],first_party_domains:[],ignore_newrelic:!0}},privacy:{cookies_enabled:!0},proxy:{assets:void 0,beacon:void 0},session:{expiresMs:c.wk,inactiveMs:c.BB},session_replay:{autoStart:!0,enabled:!1,preload:!1,sampling_rate:10,error_sampling_rate:100,collect_fonts:!1,inline_images:!1,fix_stylesheets:!0,mask_all_inputs:!0,get mask_text_selector(){return e.mask_selector},set mask_text_selector(t){a(t)?e.mask_selector="".concat(t,",").concat(l):""===t||null===t?e.mask_selector=l:(0,u.R)(5,t)},get block_class(){return"nr-block"},get ignore_class(){return"nr-ignore"},get mask_text_class(){return"nr-mask"},get block_selector(){return e.block_selector},set block_selector(t){a(t)?e.block_selector+=",".concat(t):""!==t&&(0,u.R)(6,t)},get mask_input_options(){return e.mask_input_options},set mask_input_options(t){t&&"object"==typeof t?e.mask_input_options={...t,password:!0}:(0,u.R)(7,t)}},session_trace:{enabled:!0,autoStart:!0},soft_navigations:{enabled:!0,autoStart:!0},spa:{enabled:!0,autoStart:!0},ssl:void 0,user_actions:{enabled:!0,elementAttributes:["id","className","tagName","type"]}}})());var h=r(6154),p=r(9324);let g=0;const m={buildEnv:p.F3,distMethod:p.Xs,version:p.xv,originTime:h.WN},v={consented:!1},b={appMetadata:{},get consented(){return this.session?.state?.consent||v.consented},set consented(e){v.consented=e},customTransaction:void 0,denyList:void 0,disabled:!1,harvester:void 0,isolatedBacklog:!1,isRecording:!1,loaderType:void 0,maxBytes:3e4,obfuscator:void 0,onerror:void 0,ptid:void 0,releaseIds:{},session:void 0,timeKeeper:void 0,registeredEntities:[],jsAttributesMetadata:{bytes:0},get harvestCount(){return++g}},y=e=>{const t=(0,d.a)(e,b),r=Object.keys(m).reduce((e,t)=>(e[t]={value:m[t],writable:!1,configurable:!0,enumerable:!0},e),{});return Object.defineProperties(t,r)};var w=r(5701);const R=e=>{const t=e.startsWith("http");e+="/",r.p=t?e:"https://"+e};var x=r(7836),T=r(3241);const E={accountID:void 0,trustKey:void 0,agentID:void 0,licenseKey:void 0,applicationID:void 0,xpid:void 0},A=e=>(0,d.a)(e,E),S=new Set;function _(e,t={},r,s){let{init:a,info:c,loader_config:u,runtime:d={},exposed:l=!0}=t;if(!c){const e=(0,n.pV)();a=e.init,c=e.info,u=e.loader_config}e.init=f(a||{}),e.loader_config=A(u||{}),c.jsAttributes??={},h.bv&&(c.jsAttributes.isWorker=!0),e.info=(0,o.D)(c);const p=e.init,g=[c.beacon,c.errorBeacon];S.has(e.agentIdentifier)||(p.proxy.assets&&(R(p.proxy.assets),g.push(p.proxy.assets)),p.proxy.beacon&&g.push(p.proxy.beacon),e.beacons=[...g],function(e){const t=(0,n.pV)();Object.getOwnPropertyNames(i.W.prototype).forEach(r=>{const n=i.W.prototype[r];if("function"!=typeof n||"constructor"===n)return;let o=t[r];e[r]&&!1!==e.exposed&&"micro-agent"!==e.runtime?.loaderType&&(t[r]=(...t)=>{const n=e[r](...t);return o?o(...t):n})})}(e),(0,n.US)("activatedFeatures",w.B),e.runSoftNavOverSpa&&=!0===p.soft_navigations.enabled&&p.feature_flags.includes("soft_nav")),d.denyList=[...p.ajax.deny_list||[],...p.ajax.block_internal?g:[]],d.ptid=e.agentIdentifier,d.loaderType=r,e.runtime=y(d),S.has(e.agentIdentifier)||(e.ee=x.ee.get(e.agentIdentifier),e.exposed=l,(0,T.W)({agentIdentifier:e.agentIdentifier,drained:!!w.B?.[e.agentIdentifier],type:"lifecycle",name:"initialize",feature:void 0,data:e.config})),S.add(e.agentIdentifier)}},5270:(e,t,r)=>{"use strict";r.d(t,{Aw:()=>s,SR:()=>o,rF:()=>a});var n=r(384),i=r(7767);function o(e){return!!(0,n.dV)().o.MO&&(0,i.V)(e)&&!0===e?.session_trace.enabled}function s(e){return!0===e?.session_replay.preload&&o(e)}function a(e,t){try{if("string"==typeof t?.type){if("password"===t.type.toLowerCase())return"*".repeat(e?.length||0);if(void 0!==t?.dataset?.nrUnmask||t?.classList?.contains("nr-unmask"))return e}}catch(e){}return"string"==typeof e?e.replace(/[\S]/g,"*"):"*".repeat(e?.length||0)}},5289:(e,t,r)=>{"use strict";r.d(t,{GG:()=>o,Qr:()=>a,sB:()=>s});var n=r(3878);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.sp)("load",e,t)}function s(e){if(i())return e();(0,n.DD)("DOMContentLoaded",e)}function a(e){if(i())return e();(0,n.sp)("popstate",e)}},5607:(e,t,r)=>{"use strict";r.d(t,{W:()=>n});const n=(0,r(9566).bz)()},5701:(e,t,r)=>{"use strict";r.d(t,{B:()=>o,t:()=>s});var n=r(3241);const i=new Set,o={};function s(e,t){const r=t.agentIdentifier;o[r]??={},e&&"object"==typeof e&&(i.has(r)||(t.ee.emit("rumresp",[e]),o[r]=e,i.add(r),(0,n.W)({agentIdentifier:r,loaded:!0,drained:!0,type:"lifecycle",name:"load",feature:void 0,data:e})))}},6154:(e,t,r)=>{"use strict";r.d(t,{A4:()=>a,OF:()=>d,RI:()=>i,WN:()=>h,bv:()=>o,gm:()=>s,lR:()=>f,m:()=>u,mw:()=>c,sb:()=>l});var n=r(1863);const i="undefined"!=typeof window&&!!window.document,o="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),s=i?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a="complete"===s?.document?.readyState,c=Boolean("hidden"===s?.document?.visibilityState),u=""+s?.location,d=/iPad|iPhone|iPod/.test(s.navigator?.userAgent),l=d&&"undefined"==typeof SharedWorker,f=(()=>{const e=s.navigator?.userAgent?.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),h=Date.now()-(0,n.t)()},6344:(e,t,r)=>{"use strict";r.d(t,{BB:()=>d,Qb:()=>l,TZ:()=>i,Ug:()=>s,Vh:()=>o,_s:()=>a,bc:()=>u,yP:()=>c});var n=r(2614);const i=r(860).K7.sessionReplay,o="errorDuringReplay",s=.12,a={DomContentLoaded:0,Load:1,FullSnapshot:2,IncrementalSnapshot:3,Meta:4,Custom:5},c={[n.g.ERROR]:15e3,[n.g.FULL]:3e5,[n.g.OFF]:0},u={RESET:{message:"Session was reset",sm:"Reset"},IMPORT:{message:"Recorder failed to import",sm:"Import"},TOO_MANY:{message:"429: Too Many Requests",sm:"Too-Many"},TOO_BIG:{message:"Payload was too large",sm:"Too-Big"},CROSS_TAB:{message:"Session Entity was set to OFF on another tab",sm:"Cross-Tab"},ENTITLEMENTS:{message:"Session Replay is not allowed and will not be started",sm:"Entitlement"}},d=5e3,l={API:"api",RESUME:"resume",SWITCH_TO_FULL:"switchToFull",INITIALIZE:"initialize",PRELOAD:"preload"}},6389:(e,t,r)=>{"use strict";function n(e,t=500,r={}){const n=r?.leading||!1;let i;return(...r)=>{n&&void 0===i&&(e.apply(this,r),i=setTimeout(()=>{i=clearTimeout(i)},t)),n||(clearTimeout(i),i=setTimeout(()=>{e.apply(this,r)},t))}}function i(e){let t=!1;return(...r)=>{t||(t=!0,e.apply(this,r))}}r.d(t,{J:()=>i,s:()=>n})},6630:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewEvent},6774:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.jserrors},7295:(e,t,r)=>{"use strict";r.d(t,{Xv:()=>s,gX:()=>i,iW:()=>o});var n=[];function i(e){if(!e||o(e))return!1;if(0===n.length)return!0;for(var t=0;t<n.length;t++){var r=n[t];if("*"===r.hostname)return!1;if(a(r.hostname,e.hostname)&&c(r.pathname,e.pathname))return!1}return!0}function o(e){return void 0===e.hostname}function s(e){if(n=[],e&&e.length)for(var t=0;t<e.length;t++){let r=e[t];if(!r)continue;0===r.indexOf("http://")?r=r.substring(7):0===r.indexOf("https://")&&(r=r.substring(8));const i=r.indexOf("/");let o,s;i>0?(o=r.substring(0,i),s=r.substring(i)):(o=r,s="");let[a]=o.split(":");n.push({hostname:a,pathname:s})}}function a(e,t){return!(e.length>t.length)&&t.indexOf(e)===t.length-e.length}function c(e,t){return 0===e.indexOf("/")&&(e=e.substring(1)),0===t.indexOf("/")&&(t=t.substring(1)),""===e||e===t}},7378:(e,t,r)=>{"use strict";r.d(t,{$p:()=>x,BR:()=>b,Kp:()=>R,L3:()=>y,Lc:()=>c,NC:()=>o,SG:()=>d,TZ:()=>i,U6:()=>p,UT:()=>m,d3:()=>w,dT:()=>f,e5:()=>E,gx:()=>v,l9:()=>l,oW:()=>h,op:()=>g,rw:()=>u,tH:()=>A,uP:()=>a,wW:()=>T,xq:()=>s});var n=r(384);const i=r(860).K7.spa,o=["click","submit","keypress","keydown","keyup","change"],s=999,a="fn-start",c="fn-end",u="cb-start",d="api-ixn-",l="remaining",f="interaction",h="spaNode",p="jsonpNode",g="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=(0,n.dV)().o.ST,w="-start",R="-end",x="-body",T="cb"+R,E="jsTime",A="fetch"},7485:(e,t,r)=>{"use strict";r.d(t,{D:()=>i});var n=r(6154);function i(e){if(0===(e||"").indexOf("data:"))return{protocol:"data"};try{const t=new URL(e,location.href),r={port:t.port,hostname:t.hostname,pathname:t.pathname,search:t.search,protocol:t.protocol.slice(0,t.protocol.indexOf(":")),sameOrigin:t.protocol===n.gm?.location?.protocol&&t.host===n.gm?.location?.host};return r.port&&""!==r.port||("http:"===t.protocol&&(r.port="80"),"https:"===t.protocol&&(r.port="443")),r.pathname&&""!==r.pathname?r.pathname.startsWith("/")||(r.pathname="/".concat(r.pathname)):r.pathname="/",r}catch(e){return{}}}},7699:(e,t,r)=>{"use strict";r.d(t,{It:()=>o,KC:()=>a,No:()=>i,qh:()=>s});var n=r(860);const i=16e3,o=1e6,s="SESSION_ERROR",a={[n.K7.logging]:!0,[n.K7.genericEvents]:!1,[n.K7.jserrors]:!1,[n.K7.ajax]:!1}},7767:(e,t,r)=>{"use strict";r.d(t,{V:()=>i});var n=r(6154);const i=e=>n.RI&&!0===e?.privacy.cookies_enabled},7836:(e,t,r)=>{"use strict";r.d(t,{P:()=>a,ee:()=>c});var n=r(384),i=r(8990),o=r(2646),s=r(5607);const a="nr@context:".concat(s.W),c=function e(t,r){var n={},s={},d={},l=!1;try{l=16===r.length&&u.initializedAgents?.[r]?.runtime.isolatedBacklog}catch(e){}var f={on:p,addEventListener:p,removeEventListener:function(e,t){var r=n[e];if(!r)return;for(var i=0;i<r.length;i++)r[i]===t&&r.splice(i,1)},emit:function(e,r,n,i,o){!1!==o&&(o=!0);if(c.aborted&&!i)return;t&&o&&t.emit(e,r,n);var a=h(n);g(e).forEach(e=>{e.apply(a,r)});var u=v()[s[e]];u&&u.push([f,e,r,a]);return a},get:m,listeners:g,context:h,buffer:function(e,t){const r=v();if(t=t||"feature",f.aborted)return;Object.entries(e||{}).forEach(([e,n])=>{s[n]=t,t in r||(r[t]=[])})},abort:function(){f._aborted=!0,Object.keys(f.backlog).forEach(e=>{delete f.backlog[e]})},isBuffering:function(e){return!!v()[s[e]]},debugId:r,backlog:l?{}:t&&"object"==typeof t.backlog?t.backlog:{},isolatedBacklog:l};return Object.defineProperty(f,"aborted",{get:()=>{let e=f._aborted||!1;return e||(t&&(e=t.aborted),e)}}),f;function h(e){return e&&e instanceof o.y?e:e?(0,i.I)(e,a,()=>new o.y(a)):new o.y(a)}function p(e,t){n[e]=g(e).concat(t)}function g(e){return n[e]||[]}function m(t){return d[t]=d[t]||e(f,t)}function v(){return f.backlog}}(void 0,"globalEE"),u=(0,n.Zm)();u.ee||(u.ee=c)},8122:(e,t,r)=>{"use strict";r.d(t,{a:()=>i});var n=r(944);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.R)(3);if(!t||"object"!=typeof t)return(0,n.R)(4);const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let s in o)if(void 0!==e[s])try{if(null===e[s]){r[s]=null;continue}Array.isArray(e[s])&&Array.isArray(t[s])?r[s]=Array.from(new Set([...e[s],...t[s]])):"object"==typeof e[s]&&"object"==typeof t[s]?r[s]=i(e[s],t[s]):r[s]=e[s]}catch(e){r[s]||(0,n.R)(1,e)}return r}catch(e){(0,n.R)(2,e)}}},8139:(e,t,r)=>{"use strict";r.d(t,{u:()=>f});var n=r(7836),i=r(3434),o=r(8990),s=r(6154);const a={},c=s.gm.XMLHttpRequest,u="addEventListener",d="removeEventListener",l="nr@wrapped:".concat(n.P);function f(e){var t=function(e){return(e||n.ee).get("events")}(e);if(a[t.debugId]++)return t;a[t.debugId]=1;var r=(0,i.YM)(t,!0);function f(e){r.inPlace(e,[u,d],"-",p)}function p(e,t){return e[1]}return"getPrototypeOf"in Object&&(s.RI&&h(document,f),c&&h(c.prototype,f),h(s.gm,f)),t.on(u+"-start",function(e,t){var n=e[1];if(null!==n&&("function"==typeof n||"object"==typeof n)&&"newrelic"!==e[0]){var i=(0,o.I)(n,l,function(){var e={object:function(){if("function"!=typeof n.handleEvent)return;return n.handleEvent.apply(n,arguments)},function:n}[typeof n];return e?r(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=e[1]=i}}),t.on(d+"-start",function(e){e[1]=this.wrapped||e[1]}),t}function h(e,t,...r){let n=e;for(;"object"==typeof n&&!Object.prototype.hasOwnProperty.call(n,u);)n=Object.getPrototypeOf(n);n&&t(n,...r)}},8154:(e,t,r)=>{"use strict";r.d(t,{z_:()=>o,XG:()=>a,TZ:()=>n,rs:()=>i,xV:()=>s});r(6154),r(9566),r(384);const n=r(860).K7.metrics,i="sm",o="cm",s="storeSupportabilityMetrics",a="storeEventMetrics"},8374:(e,t,r)=>{r.nc=(()=>{try{return document?.currentScript?.nonce}catch(e){}return""})()},8990:(e,t,r)=>{"use strict";r.d(t,{I:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},9300:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.ajax},9324:(e,t,r)=>{"use strict";r.d(t,{AJ:()=>s,F3:()=>i,Xs:()=>o,Yq:()=>a,xv:()=>n});const n="1.303.0",i="PROD",o="CDN",s="@newrelic/rrweb",a="1.0.1"},9566:(e,t,r)=>{"use strict";r.d(t,{LA:()=>a,ZF:()=>c,bz:()=>s,el:()=>u});var n=r(6154);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function s(){const e=n.gm?.crypto||n.gm?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(30))),i.split("").map(e=>"x"===e?o(t,r++).toString(16):"y"===e?(3&o()|8).toString(16):e).join("")}function a(e){const t=n.gm?.crypto||n.gm?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(e)));const s=[];for(var a=0;a<e;a++)s.push(o(r,i++).toString(16));return s.join("")}function c(){return a(16)}function u(){return a(32)}},9908:(e,t,r)=>{"use strict";r.d(t,{d:()=>n,p:()=>i});var n=r(7836).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce((t,r)=>(i.f[r](e,t),t),[])),i.u=e=>({212:"nr-spa-compressor",249:"nr-spa-recorder",478:"nr-spa"}[e]+"-1.303.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA-1.303.0.PROD:",i.l=(r,n,o,s)=>{if(e[r])e[r].push(n);else{var a,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d<u.length;d++){var l=u[d];if(l.getAttribute("src")==r||l.getAttribute("data-webpack")==t+o){a=l;break}}if(!a){c=!0;var f={478:"sha512-Q1pLqcoiNmLHv0rtq3wFkJBA3kofBdRJl0ExDl0mTuAoCBd0qe/1J0XWrDlQKuNlUryL6aZfVkAMPLmoikWIoQ==",249:"sha512-695ZzudsxlMtHKnpDNvkMlJd3tdMtY03IQKVCw9SX12tjUC+f7Nrx5tnWO72Vg9RFf6DSY6wVmM3cEkRM12kkQ==",212:"sha512-18Gx1wIBsppcn0AnKFhwgw4IciNgFxiw3J74W393Ape+wtg4hlg7t6SBKsIE/Dk/tfl2yltgcgBFvYRs283AFg=="};(a=document.createElement("script")).charset="utf-8",i.nc&&a.setAttribute("nonce",i.nc),a.setAttribute("data-webpack",t+o),a.src=r,0!==a.src.indexOf(window.location.origin+"/")&&(a.crossOrigin="anonymous"),f[s]&&(a.integrity=f[s])}e[r]=[n];var h=(t,n)=>{a.onerror=a.onload=null,clearTimeout(p);var i=e[r];if(delete e[r],a.parentNode&&a.parentNode.removeChild(a),i&&i.forEach(e=>e(n)),t)return t(n)},p=setTimeout(h.bind(null,void 0,{type:"timeout",target:a}),12e4);a.onerror=h.bind(null,a.onerror),a.onload=h.bind(null,a.onload),c&&document.head.appendChild(a)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.p="https://js-agent.newrelic.com/",(()=>{var e={38:0,788:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise((r,i)=>n=e[t]=[r,i]);r.push(n[2]=o);var s=i.p+i.u(t),a=new Error;i.l(s,r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),s=r&&r.target&&r.target.src;a.message="Loading chunk "+t+" failed.\n("+o+": "+s+")",a.name="ChunkLoadError",a.type=o,a.request=s,n[1](a)}},"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[s,a,c]=r,u=0;if(s.some(t=>0!==e[t])){for(n in a)i.o(a,n)&&(i.m[n]=a[n]);if(c)c(i)}for(t&&t(r);u<s.length;u++)o=s[u],i.o(e,o)&&e[o]&&e[o][0](),e[o]=0},r=self["webpackChunk:NRBA-1.303.0.PROD"]=self["webpackChunk:NRBA-1.303.0.PROD"]||[];r.forEach(t.bind(null,0)),r.push=t.bind(null,r.push.bind(r))})(),(()=>{"use strict";i(8374);var e=i(9566),t=i(1741);class r extends t.W{agentIdentifier=(0,e.LA)(16)}var n=i(860);const o=Object.values(n.K7);var s=i(5205);var a=i(9908),c=i(1863),u=i(4261),d=i(3241),l=i(944),f=i(5701),h=i(8154);function p(e,t,i,o){const s=o||i;!s||s[e]&&s[e]!==r.prototype[e]||(s[e]=function(){(0,a.p)(h.xV,["API/"+e+"/called"],void 0,n.K7.metrics,i.ee),(0,d.W)({agentIdentifier:i.agentIdentifier,drained:!!f.B?.[i.agentIdentifier],type:"data",name:"api",feature:u.Pl+e,data:{}});try{return t.apply(this,arguments)}catch(e){(0,l.R)(23,e)}})}function g(e,t,r,n,i){const o=e.info;null===r?delete o.jsAttributes[t]:o.jsAttributes[t]=r,(i||null===r)&&(0,a.p)(u.Pl+n,[(0,c.t)(),t,r],void 0,"session",e.ee)}var m=i(1687),v=i(4234),b=i(5289),y=i(6154),w=i(5270),R=i(7767),x=i(6389),T=i(7699);class E extends v.W{constructor(e,t){super(e.agentIdentifier,t),this.agentRef=e,this.abortHandler=void 0,this.featAggregate=void 0,this.loadedSuccessfully=void 0,this.onAggregateImported=new Promise(e=>{this.loadedSuccessfully=e}),this.deferred=Promise.resolve(),!1===e.init[this.featureName].autoStart?this.deferred=new Promise((t,r)=>{this.ee.on("manual-start-all",(0,x.J)(()=>{(0,m.Ak)(e.agentIdentifier,this.featureName),t()}))}):(0,m.Ak)(e.agentIdentifier,t)}importAggregator(e,t,r={}){if(this.featAggregate)return;const n=async()=>{let n;await this.deferred;try{if((0,R.V)(e.init)){const{setupAgentSession:t}=await i.e(478).then(i.bind(i,8766));n=t(e)}}catch(e){(0,l.R)(20,e),this.ee.emit("internal-error",[e]),(0,a.p)(T.qh,[e],void 0,this.featureName,this.ee)}try{if(!this.#t(this.featureName,n,e.init))return(0,m.Ze)(this.agentIdentifier,this.featureName),void this.loadedSuccessfully(!1);const{Aggregate:i}=await t();this.featAggregate=new i(e,r),e.runtime.harvester.initializedAggregates.push(this.featAggregate),this.loadedSuccessfully(!0)}catch(e){(0,l.R)(34,e),this.abortHandler?.(),(0,m.Ze)(this.agentIdentifier,this.featureName,!0),this.loadedSuccessfully(!1),this.ee&&this.ee.abort()}};y.RI?(0,b.GG)(()=>n(),!0):n()}#t(e,t,r){if(this.blocked)return!1;switch(e){case n.K7.sessionReplay:return(0,w.SR)(r)&&!!t;case n.K7.sessionTrace:return!!t;default:return!0}}}var A=i(6630),S=i(2614);class _ extends E{static featureName=A.T;constructor(e){var t;super(e,A.T),this.setupInspectionEvents(e.agentIdentifier),t=e,p(u.Fw,function(e,r){"string"==typeof e&&("/"!==e.charAt(0)&&(e="/"+e),t.runtime.customTransaction=(r||"http://custom.transaction")+e,(0,a.p)(u.Pl+u.Fw,[(0,c.t)()],void 0,void 0,t.ee))},t),this.importAggregator(e,()=>i.e(478).then(i.bind(i,1983)))}setupInspectionEvents(e){const t=(t,r)=>{t&&(0,d.W)({agentIdentifier:e,timeStamp:t.timeStamp,loaded:"complete"===t.target.readyState,type:"window",name:r,data:t.target.location+""})};(0,b.sB)(e=>{t(e,"DOMContentLoaded")}),(0,b.GG)(e=>{t(e,"load")}),(0,b.Qr)(e=>{t(e,"navigate")}),this.ee.on(S.tS.UPDATE,(t,r)=>{(0,d.W)({agentIdentifier:e,type:"lifecycle",name:"session",data:r})})}}var O=i(384);var N=i(2843),I=i(3878),P=i(782);class j extends E{static featureName=P.T;constructor(e){super(e,P.T),y.RI&&((0,N.u)(()=>(0,a.p)("docHidden",[(0,c.t)()],void 0,P.T,this.ee),!0),(0,I.sp)("pagehide",()=>(0,a.p)("winPagehide",[(0,c.t)()],void 0,P.T,this.ee)),this.importAggregator(e,()=>i.e(478).then(i.bind(i,9917))))}}class k extends E{static featureName=h.TZ;constructor(e){super(e,h.TZ),y.RI&&document.addEventListener("securitypolicyviolation",e=>{(0,a.p)(h.xV,["Generic/CSPViolation/Detected"],void 0,this.featureName,this.ee)}),this.importAggregator(e,()=>i.e(478).then(i.bind(i,6555)))}}var C=i(6774),L=i(3304);class H{constructor(e,t,r,n,i){this.name="UncaughtError",this.message="string"==typeof e?e:(0,L.A)(e),this.sourceURL=t,this.line=r,this.column=n,this.__newrelic=i}}function M(e){return U(e)?e:new H(void 0!==e?.message?e.message:e,e?.filename||e?.sourceURL,e?.lineno||e?.line,e?.colno||e?.col,e?.__newrelic,e?.cause)}function K(e){const t="Unhandled Promise Rejection: ";if(!e?.reason)return;if(U(e.reason)){try{e.reason.message.startsWith(t)||(e.reason.message=t+e.reason.message)}catch(e){}return M(e.reason)}const r=M(e.reason);return(r.message||"").startsWith(t)||(r.message=t+r.message),r}function D(e){if(e.error instanceof SyntaxError&&!/:\d+$/.test(e.error.stack?.trim())){const t=new H(e.message,e.filename,e.lineno,e.colno,e.error.__newrelic,e.cause);return t.name=SyntaxError.name,t}return U(e.error)?e.error:M(e)}function U(e){return e instanceof Error&&!!e.stack}function F(e,t,r,i,o=(0,c.t)()){"string"==typeof e&&(e=new Error(e)),(0,a.p)("err",[e,o,!1,t,r.runtime.isRecording,void 0,i],void 0,n.K7.jserrors,r.ee),(0,a.p)("uaErr",[],void 0,n.K7.genericEvents,r.ee)}var W=i(4387),B=i(993),V=i(3785);function G(e,{customAttributes:t={},level:r=B.p_.INFO}={},n,i,o=(0,c.t)()){(0,V.R)(n.ee,e,t,r,i,o)}function z(e,t,r,i,o=(0,c.t)()){(0,a.p)(u.Pl+u.hG,[o,e,t,i],void 0,n.K7.genericEvents,r.ee)}function Z(e,t,r,i,o=(0,c.t)()){const{start:s,end:d,customAttributes:f}=t||{},h={customAttributes:f||{}};if("object"!=typeof h.customAttributes||"string"!=typeof e||0===e.length)return void(0,l.R)(57);const p=(e,t)=>null==e?t:"number"==typeof e?e:e instanceof PerformanceMark?e.startTime:Number.NaN;if(h.start=p(s,0),h.end=p(d,o),Number.isNaN(h.start)||Number.isNaN(h.end))(0,l.R)(57);else{if(h.duration=h.end-h.start,!(h.duration<0))return(0,a.p)(u.Pl+u.V1,[h,e,i],void 0,n.K7.genericEvents,r.ee),h;(0,l.R)(58)}}function q(e,t={},r,i,o=(0,c.t)()){(0,a.p)(u.Pl+u.fF,[o,e,t,i],void 0,n.K7.genericEvents,r.ee)}function X(e){p(u.eY,function(t){return Y(e,t)},e)}function Y(e,t,r){const i={};(0,l.R)(54,"newrelic.register"),t||={},t.eventSource="MicroFrontendBrowserAgent",t.licenseKey||=e.info.licenseKey,t.blocked=!1,t.parent=r||{};let o=()=>{};const s=e.runtime.registeredEntities,u=s.find(({metadata:{target:{id:e,name:r}}})=>e===t.id);if(u)return u.metadata.target.name!==t.name&&(u.metadata.target.name=t.name),u;const d=e=>{t.blocked=!0,o=e};e.init.api.allow_registered_children||d((0,x.J)(()=>(0,l.R)(55))),(0,W.c7)(t)||d((0,x.J)(()=>(0,l.R)(48,t))),(0,W.yo)(t.id)&&(0,W.yo)(t.name)||d((0,x.J)(()=>(0,l.R)(48,t)));const f={addPageAction:(r,n={})=>m(z,[r,{...i,...n},e],t),log:(r,n={})=>m(G,[r,{...n,customAttributes:{...i,...n.customAttributes||{}}},e],t),measure:(r,n={})=>m(Z,[r,{...n,customAttributes:{...i,...n.customAttributes||{}}},e],t),noticeError:(r,n={})=>m(F,[r,{...i,...n},e],t),register:(t={})=>m(Y,[e,t],f.metadata.target),recordCustomEvent:(r,n={})=>m(q,[r,{...i,...n},e],t),setApplicationVersion:e=>g("application.version",e),setCustomAttribute:(e,t)=>g(e,t),setUserId:e=>g("enduser.id",e),metadata:{customAttributes:i,target:t}},p=()=>(t.blocked&&o(),t.blocked);p()||s.push(f);const g=(e,t)=>{p()||(i[e]=t)},m=(t,r,i)=>{if(p())return;const o=(0,c.t)();(0,a.p)(h.xV,["API/register/".concat(t.name,"/called")],void 0,n.K7.metrics,e.ee);try{return e.init.api.duplicate_registered_data&&"register"!==t.name&&t(...r,void 0,o),t(...r,i,o)}catch(e){(0,l.R)(50,e)}};return f}class J extends E{static featureName=C.T;constructor(e){var t;super(e,C.T),t=e,p(u.o5,(e,r)=>F(e,r,t),t),function(e){p(u.bt,function(t){e.runtime.onerror=t},e)}(e),function(e){let t=0;p(u.k6,function(e,r){++t>10||(this.runtime.releaseIds[e.slice(-200)]=(""+r).slice(-200))},e)}(e),X(e);try{this.removeOnAbort=new AbortController}catch(e){}this.ee.on("internal-error",(t,r)=>{this.abortHandler&&(0,a.p)("ierr",[M(t),(0,c.t)(),!0,{},e.runtime.isRecording,r],void 0,this.featureName,this.ee)}),y.gm.addEventListener("unhandledrejection",t=>{this.abortHandler&&(0,a.p)("err",[K(t),(0,c.t)(),!1,{unhandledPromiseRejection:1},e.runtime.isRecording],void 0,this.featureName,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),y.gm.addEventListener("error",t=>{this.abortHandler&&(0,a.p)("err",[D(t),(0,c.t)(),!1,{},e.runtime.isRecording],void 0,this.featureName,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),this.abortHandler=this.#r,this.importAggregator(e,()=>i.e(478).then(i.bind(i,2176)))}#r(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}var Q=i(8990);let ee=1;function te(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===y.gm?0:(0,Q.I)(e,"nr@id",function(){return ee++})}function re(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,L.A)(e).length}catch(e){return}}}var ne=i(8139),ie=i(7836),oe=i(3434);const se={},ae=["open","send"];function ce(e){var t=e||ie.ee;const r=function(e){return(e||ie.ee).get("xhr")}(t);if(void 0===y.gm.XMLHttpRequest)return r;if(se[r.debugId]++)return r;se[r.debugId]=1,(0,ne.u)(t);var n=(0,oe.YM)(r),i=y.gm.XMLHttpRequest,o=y.gm.MutationObserver,s=y.gm.Promise,a=y.gm.setInterval,c="readystatechange",u=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],d=[],f=y.gm.XMLHttpRequest=function(e){const t=new i(e),o=r.context(t);try{r.emit("new-xhr",[t],o),t.addEventListener(c,(s=o,function(){var e=this;e.readyState>3&&!s.resolved&&(s.resolved=!0,r.emit("xhr-resolved",[],e)),n.inPlace(e,u,"fn-",b)}),(0,I.jT)(!1))}catch(e){(0,l.R)(15,e);try{r.emit("internal-error",[e])}catch(e){}}var s;return t};function h(e,t){n.inPlace(t,["onreadystatechange"],"fn-",b)}if(function(e,t){for(var r in e)t[r]=e[r]}(i,f),f.prototype=i.prototype,n.inPlace(f.prototype,ae,"-xhr-",b),r.on("send-xhr-start",function(e,t){h(e,t),function(e){d.push(e),o&&(p?p.then(v):a?a(v):(g=-g,m.data=g))}(t)}),r.on("open-xhr-start",h),o){var p=s&&s.resolve();if(!a&&!s){var g=1,m=document.createTextNode(g);new o(v).observe(m,{characterData:!0})}}else t.on("fn-end",function(e){e[0]&&e[0].type===c||v()});function v(){for(var e=0;e<d.length;e++)h(0,d[e]);d.length&&(d=[])}function b(e,t){return t}return r}var ue="fetch-",de=ue+"body-",le=["arrayBuffer","blob","json","text","formData"],fe=y.gm.Request,he=y.gm.Response,pe="prototype";const ge={};function me(e){const t=function(e){return(e||ie.ee).get("fetch")}(e);if(!(fe&&he&&y.gm.fetch))return t;if(ge[t.debugId]++)return t;function r(e,r,n){var i=e[r];"function"==typeof i&&(e[r]=function(){var e,r=[...arguments],o={};t.emit(n+"before-start",[r],o),o[ie.P]&&o[ie.P].dt&&(e=o[ie.P].dt);var s=i.apply(this,r);return t.emit(n+"start",[r,e],s),s.then(function(e){return t.emit(n+"end",[null,e],s),e},function(e){throw t.emit(n+"end",[e],s),e})})}return ge[t.debugId]=1,le.forEach(e=>{r(fe[pe],e,de),r(he[pe],e,de)}),r(y.gm,"fetch",ue),t.on(ue+"end",function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(ue+"done",[null,r],n)}else t.emit(ue+"done",[e],n)}),t}var ve=i(7485);class be{constructor(e){this.agentRef=e}generateTracePayload(t){const r=this.agentRef.loader_config;if(!this.shouldGenerateTrace(t)||!r)return null;var n=(r.accountID||"").toString()||null,i=(r.agentID||"").toString()||null,o=(r.trustKey||"").toString()||null;if(!n||!i)return null;var s=(0,e.ZF)(),a=(0,e.el)(),c=Date.now(),u={spanId:s,traceId:a,timestamp:c};return(t.sameOrigin||this.isAllowedOrigin(t)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(s,a),u.traceContextStateHeader=this.generateTraceContextStateHeader(s,c,n,i,o)),(t.sameOrigin&&!this.excludeNewrelicHeader()||!t.sameOrigin&&this.isAllowedOrigin(t)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(s,a,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof y.gm?.btoa))return null;var s={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(s.d.tk=o),btoa((0,L.A)(s))}shouldGenerateTrace(e){return this.agentRef.init?.distributed_tracing?.enabled&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var t=!1;const r=this.agentRef.init?.distributed_tracing;if(e.sameOrigin)t=!0;else if(r?.allowed_origins instanceof Array)for(var n=0;n<r.allowed_origins.length;n++){var i=(0,ve.D)(r.allowed_origins[n]);if(e.hostname===i.hostname&&e.protocol===i.protocol&&e.port===i.port){t=!0;break}}return t}excludeNewrelicHeader(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!!e.exclude_newrelic_header}useNewrelicHeaderForCors(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!1!==e.cors_use_newrelic_header}useTraceContextHeadersForCors(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!!e.cors_use_tracecontext_headers}}var ye=i(9300),we=i(7295);function Re(e){return"string"==typeof e?e:e instanceof(0,O.dV)().o.REQ?e.url:y.gm?.URL&&e instanceof URL?e.href:void 0}var xe=["load","error","abort","timeout"],Te=xe.length,Ee=(0,O.dV)().o.REQ,Ae=(0,O.dV)().o.XHR;const Se="X-NewRelic-App-Data";class _e extends E{static featureName=ye.T;constructor(e){super(e,ye.T),this.dt=new be(e),this.handler=(e,t,r,n)=>(0,a.p)(e,t,r,n,this.ee);try{const e={xmlhttprequest:"xhr",fetch:"fetch",beacon:"beacon"};y.gm?.performance?.getEntriesByType("resource").forEach(t=>{if(t.initiatorType in e&&0!==t.responseStatus){const r={status:t.responseStatus},i={rxSize:t.transferSize,duration:Math.floor(t.duration),cbTime:0};Oe(r,t.name),this.handler("xhr",[r,i,t.startTime,t.responseEnd,e[t.initiatorType]],void 0,n.K7.ajax)}})}catch(e){}me(this.ee),ce(this.ee),function(e,t,r,i){function o(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},t.latestLongtaskEnd=0,e.addEventListener("load",function(r){A(t,e)},(0,I.jT)(!1)),y.lR||e.addEventListener("progress",function(e){t.lastSize=e.loaded},(0,I.jT)(!1))}function s(e){this.params={method:e[0]},Oe(this,e[1]),this.metrics={}}function u(t,r){e.loader_config.xpid&&this.sameOrigin&&r.setRequestHeader("X-NewRelic-ID",e.loader_config.xpid);var n=i.generateTracePayload(this.parsedOrigin);if(n){var o=!1;n.newrelicHeader&&(r.setRequestHeader("newrelic",n.newrelicHeader),o=!0),n.traceContextParentHeader&&(r.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&r.setRequestHeader("tracestate",n.traceContextStateHeader),o=!0),o&&(this.dt=n)}}function d(e,r){var n=this.metrics,i=e[0],o=this;if(n&&i){var s=re(i);s&&(n.txSize=s)}this.startTime=(0,c.t)(),this.body=i,this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof r.onload)&&"function"==typeof o.end)&&o.end(r)}catch(e){try{t.emit("internal-error",[e])}catch(e){}}};for(var a=0;a<Te;a++)r.addEventListener(xe[a],this.listener,(0,I.jT)(!1))}function l(e,t,r){this.cbTime+=e,t?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof r.onload||"function"!=typeof this.end||this.end(r)}function f(e,t){var r=""+te(e)+!!t;this.xhrGuids&&!this.xhrGuids[r]&&(this.xhrGuids[r]=!0,this.totalCbs+=1)}function p(e,t){var r=""+te(e)+!!t;this.xhrGuids&&this.xhrGuids[r]&&(delete this.xhrGuids[r],this.totalCbs-=1)}function g(){this.endTime=(0,c.t)()}function m(e,r){r instanceof Ae&&"load"===e[0]&&t.emit("xhr-load-added",[e[1],e[2]],r)}function v(e,r){r instanceof Ae&&"load"===e[0]&&t.emit("xhr-load-removed",[e[1],e[2]],r)}function b(e,t,r){t instanceof Ae&&("onload"===r&&(this.onload=!0),("load"===(e[0]&&e[0].type)||this.onload)&&(this.xhrCbStart=(0,c.t)()))}function w(e,r){this.xhrCbStart&&t.emit("xhr-cb-time",[(0,c.t)()-this.xhrCbStart,this.onload,r],r)}function R(e){var t,r=e[1]||{};if("string"==typeof e[0]?0===(t=e[0]).length&&y.RI&&(t=""+y.gm.location.href):e[0]&&e[0].url?t=e[0].url:y.gm?.URL&&e[0]&&e[0]instanceof URL?t=e[0].href:"function"==typeof e[0].toString&&(t=e[0].toString()),"string"==typeof t&&0!==t.length){t&&(this.parsedOrigin=(0,ve.D)(t),this.sameOrigin=this.parsedOrigin.sameOrigin);var n=i.generateTracePayload(this.parsedOrigin);if(n&&(n.newrelicHeader||n.traceContextParentHeader))if(e[0]&&e[0].headers)a(e[0].headers,n)&&(this.dt=n);else{var o={};for(var s in r)o[s]=r[s];o.headers=new Headers(r.headers||{}),a(o.headers,n)&&(this.dt=n),e.length>1?e[1]=o:e.push(o)}}function a(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,c.t)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r=this.opts||{},n=this.target;Oe(this,Re(n));var i=(""+(n&&n instanceof Ee&&n.method||r.method||"GET")).toUpperCase();this.params.method=i,this.body=r.body,this.txSize=re(r.body)||0}function T(e,t){if(this.endTime=(0,c.t)(),this.params||(this.params={}),(0,we.iW)(this.params))return;let i;this.params.status=t?t.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(i=+this.rxSize);const o={txSize:this.txSize,rxSize:i,duration:(0,c.t)()-this.startTime};r("xhr",[this.params,o,this.startTime,this.endTime,"fetch"],this,n.K7.ajax)}function E(e){const t=this.params,i=this.metrics;if(!this.ended){this.ended=!0;for(let t=0;t<Te;t++)e.removeEventListener(xe[t],this.listener,!1);t.aborted||(0,we.iW)(t)||(i.duration=(0,c.t)()-this.startTime,this.loadCaptureCalled||4!==e.readyState?null==t.status&&(t.status=0):A(this,e),i.cbTime=this.cbTime,r("xhr",[t,i,this.startTime,this.endTime,"xhr"],this,n.K7.ajax))}}function A(e,r){e.params.status=r.status;var i=function(e,t){var r=e.responseType;return"json"===r&&null!==t?t:"arraybuffer"===r||"blob"===r||"json"===r?re(e.response):"text"===r||""===r||void 0===r?re(e.responseText):void 0}(r,e.lastSize);if(i&&(e.metrics.rxSize=i),e.sameOrigin&&r.getAllResponseHeaders().indexOf(Se)>=0){var o=r.getResponseHeader(Se);o&&((0,a.p)(h.rs,["Ajax/CrossApplicationTracing/Header/Seen"],void 0,n.K7.metrics,t),e.params.cat=o.split(", ").pop())}e.loadCaptureCalled=!0}t.on("new-xhr",o),t.on("open-xhr-start",s),t.on("open-xhr-end",u),t.on("send-xhr-start",d),t.on("xhr-cb-time",l),t.on("xhr-load-added",f),t.on("xhr-load-removed",p),t.on("xhr-resolved",g),t.on("addEventListener-end",m),t.on("removeEventListener-end",v),t.on("fn-end",w),t.on("fetch-before-start",R),t.on("fetch-start",x),t.on("fn-start",b),t.on("fetch-done",T)}(e,this.ee,this.handler,this.dt),this.importAggregator(e,()=>i.e(478).then(i.bind(i,3845)))}}function Oe(e,t){var r=(0,ve.D)(t),n=e.params||e;n.hostname=r.hostname,n.port=r.port,n.protocol=r.protocol,n.host=r.hostname+":"+r.port,n.pathname=r.pathname,e.parsedOrigin=r,e.sameOrigin=r.sameOrigin}const Ne={},Ie=["pushState","replaceState"];function Pe(e){const t=function(e){return(e||ie.ee).get("history")}(e);return!y.RI||Ne[t.debugId]++||(Ne[t.debugId]=1,(0,oe.YM)(t).inPlace(window.history,Ie,"-")),t}var je=i(3738);function ke(e){p(u.BL,function(t=Date.now()){const r=t-y.WN;r<0&&(0,l.R)(62,t),(0,a.p)(h.XG,[u.BL,{time:r}],void 0,n.K7.metrics,e.ee),e.addToTrace({name:u.BL,start:t,origin:"nr"}),(0,a.p)(u.Pl+u.hG,[r,u.BL],void 0,n.K7.genericEvents,e.ee)},e)}const{He:Ce,bD:Le,d3:He,Kp:Me,TZ:Ke,Lc:De,uP:Ue,Rz:Fe}=je;class We extends E{static featureName=Ke;constructor(e){var t;super(e,Ke),t=e,p(u.U2,function(e){if(!(e&&"object"==typeof e&&e.name&&e.start))return;const r={n:e.name,s:e.start-y.WN,e:(e.end||e.start)-y.WN,o:e.origin||"",t:"api"};r.s<0||r.e<0||r.e<r.s?(0,l.R)(61,{start:r.s,end:r.e}):(0,a.p)("bstApi",[r],void 0,n.K7.sessionTrace,t.ee)},t),ke(e);if(!(0,R.V)(e.init))return void this.deregisterDrain();const r=this.ee;let o;Pe(r),this.eventsEE=(0,ne.u)(r),this.eventsEE.on(Ue,function(e,t){this.bstStart=(0,c.t)()}),this.eventsEE.on(De,function(e,t){(0,a.p)("bst",[e[0],t,this.bstStart,(0,c.t)()],void 0,n.K7.sessionTrace,r)}),r.on(Fe+He,function(e){this.time=(0,c.t)(),this.startPath=location.pathname+location.hash}),r.on(Fe+Me,function(e){(0,a.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,n.K7.sessionTrace,r)});try{o=new PerformanceObserver(e=>{const t=e.getEntries();(0,a.p)(Ce,[t],void 0,n.K7.sessionTrace,r)}),o.observe({type:Le,buffered:!0})}catch(e){}this.importAggregator(e,()=>i.e(478).then(i.bind(i,6974)),{resourceObserver:o})}}var Be=i(6344);class Ve extends E{static featureName=Be.TZ;#n;recorder;constructor(e){var t;let r;super(e,Be.TZ),t=e,p(u.CH,function(){(0,a.p)(u.CH,[],void 0,n.K7.sessionReplay,t.ee)},t),function(e){p(u.Tb,function(){(0,a.p)(u.Tb,[],void 0,n.K7.sessionReplay,e.ee)},e)}(e);try{r=JSON.parse(localStorage.getItem("".concat(S.H3,"_").concat(S.uh)))}catch(e){}(0,w.SR)(e.init)&&this.ee.on(u.CH,()=>this.#i()),this.#o(r)&&this.importRecorder().then(e=>{e.startRecording(Be.Qb.PRELOAD,r?.sessionReplayMode)}),this.importAggregator(this.agentRef,()=>i.e(478).then(i.bind(i,6167)),this),this.ee.on("err",e=>{this.blocked||this.agentRef.runtime.isRecording&&(this.errorNoticed=!0,(0,a.p)(Be.Vh,[e],void 0,this.featureName,this.ee))})}#o(e){return e&&(e.sessionReplayMode===S.g.FULL||e.sessionReplayMode===S.g.ERROR)||(0,w.Aw)(this.agentRef.init)}importRecorder(){return this.recorder?Promise.resolve(this.recorder):(this.#n??=Promise.all([i.e(478),i.e(249)]).then(i.bind(i,4866)).then(({Recorder:e})=>(this.recorder=new e(this),this.recorder)).catch(e=>{throw this.ee.emit("internal-error",[e]),this.blocked=!0,e}),this.#n)}#i(){this.blocked||(this.featAggregate?this.featAggregate.mode!==S.g.FULL&&this.featAggregate.initializeRecording(S.g.FULL,!0,Be.Qb.API):this.importRecorder().then(()=>{this.recorder.startRecording(Be.Qb.API,S.g.FULL)}))}}var Ge=i(3962);function ze(e){const t=e.ee.get("tracer");function r(){}p(u.dT,function(e){return(new r).get("object"==typeof e?e:{})},e);const i=r.prototype={createTracer:function(r,i){var o={},s=this,d="function"==typeof i;return(0,a.p)(h.xV,["API/createTracer/called"],void 0,n.K7.metrics,e.ee),e.runSoftNavOverSpa||(0,a.p)(u.hw+"tracer",[(0,c.t)(),r,o],s,n.K7.spa,e.ee),function(){if(t.emit((d?"":"no-")+"fn-start",[(0,c.t)(),s,d],o),d)try{return i.apply(this,arguments)}catch(e){const r="string"==typeof e?new Error(e):e;throw t.emit("fn-err",[arguments,this,r],o),r}finally{t.emit("fn-end",[(0,c.t)()],o)}}}};["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach(t=>{p.apply(this,[t,function(){return(0,a.p)(u.hw+t,[(0,c.t)(),...arguments],this,e.runSoftNavOverSpa?n.K7.softNav:n.K7.spa,e.ee),this},e,i])}),p(u.PA,function(){e.runSoftNavOverSpa?(0,a.p)(u.hw+"routeName",[performance.now(),...arguments],void 0,n.K7.softNav,e.ee):(0,a.p)(u.Pl+"routeName",[(0,c.t)(),...arguments],this,n.K7.spa,e.ee)},e)}class Ze extends E{static featureName=Ge.TZ;constructor(e){if(super(e,Ge.TZ),ze(e),!y.RI||!(0,O.dV)().o.MO)return;const t=Pe(this.ee);try{this.removeOnAbort=new AbortController}catch(e){}Ge.tC.forEach(e=>{(0,I.sp)(e,e=>{s(e)},!0,this.removeOnAbort?.signal)});const r=()=>(0,a.p)("newURL",[(0,c.t)(),""+window.location],void 0,this.featureName,this.ee);t.on("pushState-end",r),t.on("replaceState-end",r),(0,I.sp)(Ge.OV,e=>{s(e),(0,a.p)("newURL",[e.timeStamp,""+window.location],void 0,this.featureName,this.ee)},!0,this.removeOnAbort?.signal);let n=!1;const o=new((0,O.dV)().o.MO)((e,t)=>{n||(n=!0,requestAnimationFrame(()=>{(0,a.p)("newDom",[(0,c.t)()],void 0,this.featureName,this.ee),n=!1}))}),s=(0,x.s)(e=>{(0,a.p)("newUIEvent",[e],void 0,this.featureName,this.ee),o.observe(document.body,{attributes:!0,childList:!0,subtree:!0,characterData:!0})},100,{leading:!0});this.abortHandler=function(){this.removeOnAbort?.abort(),o.disconnect(),this.abortHandler=void 0},this.importAggregator(e,()=>i.e(478).then(i.bind(i,4393)),{domObserver:o})}}var qe=i(7378);const Xe={},Ye=["appendChild","insertBefore","replaceChild"];function Je(e){const t=function(e){return(e||ie.ee).get("jsonp")}(e);if(!y.RI||Xe[t.debugId])return t;Xe[t.debugId]=!0;var r=(0,oe.YM)(t),n=/[?&](?:callback|cb)=([^&#]+)/,i=/(.*)\.([^.]+)/,o=/^(\w+)(\.|$)(.*)$/;function s(e,t){if(!e)return t;const r=e.match(o),n=r[1];return s(r[3],t[n])}return r.inPlace(Node.prototype,Ye,"dom-"),t.on("dom-start",function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var o=(a=e.src,c=a.match(n),c?c[1]:null);var a,c;if(!o)return;var u=function(e){var t=e.match(i);if(t&&t.length>=3)return{key:t[2],parent:s(t[1],window)};return{key:e,parent:window}}(o);if("function"!=typeof u.parent[u.key])return;var d={};function l(){t.emit("jsonp-end",[],d),e.removeEventListener("load",l,(0,I.jT)(!1)),e.removeEventListener("error",f,(0,I.jT)(!1))}function f(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",l,(0,I.jT)(!1)),e.removeEventListener("error",f,(0,I.jT)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",l,(0,I.jT)(!1)),e.addEventListener("error",f,(0,I.jT)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])}),t}const $e={};function Qe(e){const t=function(e){return(e||ie.ee).get("promise")}(e);if($e[t.debugId])return t;$e[t.debugId]=!0;var r=t.context,n=(0,oe.YM)(t),i=y.gm.Promise;return i&&function(){function e(r){var o=t.context(),s=n(r,"executor-",o,null,!1);const a=Reflect.construct(i,[s],e);return t.context(a).getCtx=function(){return o},a}y.gm.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return i.toString()},Object.setPrototypeOf(e,i),["all","race"].forEach(function(r){const n=i[r];e[r]=function(e){let i=!1;[...e||[]].forEach(e=>{this.resolve(e).then(s("all"===r),s(!1))});const o=n.apply(this,arguments);return o;function s(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}}),["resolve","reject"].forEach(function(r){const n=i[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}}),e.prototype=i.prototype;const o=i.prototype.then;i.prototype.then=function(...e){var i=this,s=r(i);s.promise=i,e[0]=n(e[0],"cb-",s,null,!1),e[1]=n(e[1],"cb-",s,null,!1);const a=o.apply(this,e);return s.nextPromise=a,t.emit("propagate",[i,!0],a,!1,!1),a},i.prototype.then[oe.Jt]=o,t.on("executor-start",function(e){e[0]=n(e[0],"resolve-",this,null,!1),e[1]=n(e[1],"resolve-",this,null,!1)}),t.on("executor-err",function(e,t,r){e[1](r)}),t.on("cb-end",function(e,r,n){t.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),t.on("propagate",function(e,r,n){if(!this.getCtx||r){const r=this,n=e instanceof Promise?t.context(e):null;let i;this.getCtx=function(){return i||(i=n&&n!==r?"function"==typeof n.getCtx?n.getCtx():n:r,i)}}})}(),t}const et={},tt="setTimeout",rt="setInterval",nt="clearTimeout",it="-start",ot=[tt,"setImmediate",rt,nt,"clearImmediate"];function st(e){const t=function(e){return(e||ie.ee).get("timer")}(e);if(et[t.debugId]++)return t;et[t.debugId]=1;var r=(0,oe.YM)(t);return r.inPlace(y.gm,ot.slice(0,2),tt+"-"),r.inPlace(y.gm,ot.slice(2,3),rt+"-"),r.inPlace(y.gm,ot.slice(3),nt+"-"),t.on(rt+it,function(e,t,n){e[0]=r(e[0],"fn-",null,n)}),t.on(tt+it,function(e,t,n){this.method=n,this.timerDuration=isNaN(e[1])?0:+e[1],e[0]=r(e[0],"fn-",this,n)}),t}const at={};function ct(e){const t=function(e){return(e||ie.ee).get("mutation")}(e);if(!y.RI||at[t.debugId])return t;at[t.debugId]=!0;var r=(0,oe.YM)(t),n=y.gm.MutationObserver;return n&&(window.MutationObserver=function(e){return this instanceof n?new n(r(e,"fn-")):n.apply(this,arguments)},MutationObserver.prototype=n.prototype),t}const{TZ:ut,d3:dt,Kp:lt,$p:ft,wW:ht,e5:pt,tH:gt,uP:mt,rw:vt,Lc:bt}=qe;class yt extends E{static featureName=ut;constructor(e){if(super(e,ut),ze(e),!y.RI)return;try{this.removeOnAbort=new AbortController}catch(e){}let t,r=0;const n=this.ee.get("tracer"),o=Je(this.ee),s=Qe(this.ee),u=st(this.ee),d=ce(this.ee),l=this.ee.get("events"),f=me(this.ee),h=Pe(this.ee),p=ct(this.ee);function g(e,t){h.emit("newURL",[""+window.location,t])}function m(){r++,t=window.location.hash,this[mt]=(0,c.t)()}function v(){r--,window.location.hash!==t&&g(0,!0);var e=(0,c.t)();this[pt]=~~this[pt]+e-this[mt],this[bt]=e}function b(e,t){e.on(t,function(){this[t]=(0,c.t)()})}this.ee.on(mt,m),s.on(vt,m),o.on(vt,m),this.ee.on(bt,v),s.on(ht,v),o.on(ht,v),this.ee.on("fn-err",(...t)=>{t[2]?.__newrelic?.[e.agentIdentifier]||(0,a.p)("function-err",[...t],void 0,this.featureName,this.ee)}),this.ee.buffer([mt,bt,"xhr-resolved"],this.featureName),l.buffer([mt],this.featureName),u.buffer(["setTimeout"+lt,"clearTimeout"+dt,mt],this.featureName),d.buffer([mt,"new-xhr","send-xhr"+dt],this.featureName),f.buffer([gt+dt,gt+"-done",gt+ft+dt,gt+ft+lt],this.featureName),h.buffer(["newURL"],this.featureName),p.buffer([mt],this.featureName),s.buffer(["propagate",vt,ht,"executor-err","resolve"+dt],this.featureName),n.buffer([mt,"no-"+mt],this.featureName),o.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),b(f,gt+dt),b(f,gt+"-done"),b(o,"new-jsonp"),b(o,"jsonp-end"),b(o,"cb-start"),h.on("pushState-end",g),h.on("replaceState-end",g),window.addEventListener("hashchange",g,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",g,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",function(){g(0,r>1)},(0,I.jT)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#r,this.importAggregator(e,()=>i.e(478).then(i.bind(i,5592)))}#r(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}var wt=i(3333);class Rt extends E{static featureName=wt.TZ;constructor(e){super(e,wt.TZ);const t=[e.init.page_action.enabled,e.init.performance.capture_marks,e.init.performance.capture_measures,e.init.user_actions.enabled,e.init.performance.resources.enabled];var r;r=e,p(u.hG,(e,t)=>z(e,t,r),r),function(e){p(u.fF,(t,r)=>q(t,r,e),e)}(e),ke(e),X(e),function(e){p(u.V1,(t,r)=>Z(t,r,e),e)}(e);const o=e.init.feature_flags.includes("user_frustrations");let s;if(y.RI&&o&&(me(this.ee),ce(this.ee),s=Pe(this.ee)),y.RI){if(e.init.user_actions.enabled&&(wt.Zp.forEach(e=>(0,I.sp)(e,e=>(0,a.p)("ua",[e],void 0,this.featureName,this.ee),!0)),wt.qN.forEach(e=>{const t=(0,x.s)(e=>{(0,a.p)("ua",[e],void 0,this.featureName,this.ee)},500,{leading:!0});(0,I.sp)(e,t)}),o)){function c(t){const r=(0,ve.D)(t);return e.beacons.includes(r.hostname+":"+r.port)}function d(){s.emit("navChange")}y.gm.addEventListener("error",()=>{(0,a.p)("uaErr",[],void 0,n.K7.genericEvents,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),this.ee.on("open-xhr-start",(e,t)=>{c(e[1])||t.addEventListener("readystatechange",()=>{2===t.readyState&&(0,a.p)("uaXhr",[],void 0,n.K7.genericEvents,this.ee)})}),this.ee.on("fetch-start",e=>{e.length>=1&&!c(Re(e[0]))&&(0,a.p)("uaXhr",[],void 0,n.K7.genericEvents,this.ee)}),s.on("pushState-end",d),s.on("replaceState-end",d),window.addEventListener("hashchange",d,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",d,(0,I.jT)(!0,this.removeOnAbort?.signal))}if(e.init.performance.resources.enabled&&y.gm.PerformanceObserver?.supportedEntryTypes.includes("resource")){new PerformanceObserver(e=>{e.getEntries().forEach(e=>{(0,a.p)("browserPerformance.resource",[e],void 0,this.featureName,this.ee)})}).observe({type:"resource",buffered:!0})}}try{this.removeOnAbort=new AbortController}catch(l){}this.abortHandler=()=>{this.removeOnAbort?.abort(),this.abortHandler=void 0},t.some(e=>e)?this.importAggregator(e,()=>i.e(478).then(i.bind(i,8019))):this.deregisterDrain()}}var xt=i(2646);const Tt=new Map;function Et(e,t,r,n){if("object"!=typeof t||!t||"string"!=typeof r||!r||"function"!=typeof t[r])return(0,l.R)(29);const i=function(e){return(e||ie.ee).get("logger")}(e),o=(0,oe.YM)(i),s=new xt.y(ie.P);s.level=n.level,s.customAttributes=n.customAttributes;const a=t[r]?.[oe.Jt]||t[r];return Tt.set(a,s),o.inPlace(t,[r],"wrap-logger-",()=>Tt.get(a)),i}var At=i(1910);class St extends E{static featureName=B.TZ;constructor(e){var t;super(e,B.TZ),t=e,p(u.$9,(e,r)=>G(e,r,t),t),function(e){p(u.Wb,(t,r,{customAttributes:n={},level:i=B.p_.INFO}={})=>{Et(e.ee,t,r,{customAttributes:n,level:i})},e)}(e),X(e);const r=this.ee;["log","error","warn","info","debug","trace"].forEach(e=>{(0,At.i)(y.gm.console[e]),Et(r,y.gm.console,e,{level:"log"===e?"info":e})}),this.ee.on("wrap-logger-end",function([e]){const{level:t,customAttributes:n}=this;(0,V.R)(r,e,n,t)}),this.importAggregator(e,()=>i.e(478).then(i.bind(i,5288)))}}new class extends r{constructor(e){var t;(super(),y.gm)?(this.features={},(0,O.bQ)(this.agentIdentifier,this),this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(_),this.runSoftNavOverSpa=[...this.desiredFeatures].some(e=>e.featureName===n.K7.softNav),(0,s.j)(this,e,e.loaderType||"agent"),t=this,p(u.cD,function(e,r,n=!1){if("string"==typeof e){if(["string","number","boolean"].includes(typeof r)||null===r)return g(t,e,r,u.cD,n);(0,l.R)(40,typeof r)}else(0,l.R)(39,typeof e)},t),function(e){p(u.Dl,function(t){if("string"==typeof t||null===t)return g(e,"enduser.id",t,u.Dl,!0);(0,l.R)(41,typeof t)},e)}(this),function(e){p(u.nb,function(t){if("string"==typeof t||null===t)return g(e,"application.version",t,u.nb,!1);(0,l.R)(42,typeof t)},e)}(this),function(e){p(u.d3,function(){e.ee.emit("manual-start-all")},e)}(this),function(e){p(u.Pv,function(t=!0){if("boolean"==typeof t){if((0,a.p)(u.Pl+u.Pv,[t],void 0,"session",e.ee),e.runtime.consented=t,t){const t=e.features.page_view_event;t.onAggregateImported.then(e=>{const r=t.featAggregate;e&&!r.sentRum&&r.sendRum()})}}else(0,l.R)(65,typeof t)},e)}(this),this.run()):(0,l.R)(21)}get config(){return{info:this.info,init:this.init,loader_config:this.loader_config,runtime:this.runtime}}get api(){return this}run(){try{const e=function(e){const t={};return o.forEach(r=>{t[r]=!!e[r]?.enabled}),t}(this.init),t=[...this.desiredFeatures];t.sort((e,t)=>n.P3[e.featureName]-n.P3[t.featureName]),t.forEach(t=>{if(!e[t.featureName]&&t.featureName!==n.K7.pageViewEvent)return;if(this.runSoftNavOverSpa&&t.featureName===n.K7.spa)return;if(!this.runSoftNavOverSpa&&t.featureName===n.K7.softNav)return;const r=function(e){switch(e){case n.K7.ajax:return[n.K7.jserrors];case n.K7.sessionTrace:return[n.K7.ajax,n.K7.pageViewEvent];case n.K7.sessionReplay:return[n.K7.sessionTrace];case n.K7.pageViewTiming:return[n.K7.pageViewEvent];default:return[]}}(t.featureName).filter(e=>!(e in this.features));r.length>0&&(0,l.R)(36,{targetFeature:t.featureName,missingDependencies:r}),this.features[t.featureName]=new t(this)})}catch(e){(0,l.R)(22,e);for(const e in this.features)this.features[e].abortHandler?.();const t=(0,O.Zm)();delete t.initializedAgents[this.agentIdentifier]?.features,delete this.sharedAggregator;return t.ee.get(this.agentIdentifier).abort(),!1}}}({features:[_e,_,j,We,Ve,k,J,Rt,St,Ze,yt],loaderType:"spa"})})()})();</script>
<link rel="icon" type="image/png" sizes="16x16" href="https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_16-tenantFavicon-Frontiers.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_32-tenantFavicon-Frontiers.png">
<meta name="apple-mobile-web-app-title" content="Frontiers | Articles">
<link rel="manifest" href="/manifest.json">
<link rel="canonical" href="https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1126836/full">
<meta property="description" name="description" content="Introduction: Amyloid transthyretin (ATTR) is divided into either hereditary (ATTRv) or sporadic (ATTRwt) and ATTRv is a rare hereditary disease transmitted ...">
<meta property="og:title" name="title" content="Frontiers | Prevalence estimation of ATTRv in China based on genetic databases">
<meta property="og:description" name="description" content="Introduction: Amyloid transthyretin (ATTR) is divided into either hereditary (ATTRv) or sporadic (ATTRwt) and ATTRv is a rare hereditary disease transmitted ...">
<meta name="keywords" content="Amyloid transthyretin (ATTR),ChinaMap,GnomAD,Prevalence,genetic database">
<meta property="og:site_name" name="site_name" content="Frontiers">
<meta property="og:image" name="image" content="https://images-provider.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-g001.jpg">
<meta property="og:type" name="type" content="article">
<meta property="og:url" name="url" content="https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1126836/full">
<meta name="twitter:card" content="summary_large_image">
<meta name="citation_volume" content="14">
<meta name="citation_journal_title" content="Frontiers in Genetics">
<meta name="citation_publisher" content="Frontiers">
<meta name="citation_journal_abbrev" content="Front. Genet.">
<meta name="citation_issn" content="1664-8021">
<meta name="citation_doi" content="10.3389/fgene.2023.1126836">
<meta name="citation_firstpage" content="1126836">
<meta name="citation_language" content="English">
<meta name="citation_title" content="Prevalence estimation of ATTRv in China based on genetic databases">
<meta name="citation_keywords" content="Amyloid transthyretin (ATTR); ChinaMap; GnomAD; Prevalence; genetic database">
<meta name="citation_abstract" content="Introduction: Amyloid transthyretin (ATTR) is divided into either hereditary (ATTRv) or sporadic (ATTRwt) and ATTRv is a rare hereditary disease transmitted as an autosomal dominant manner. Its global prevalence is traditionally estimated as 5,000 to 10,000 persons. However, it may be underestimated and the exact prevalence of ATTRv in China mainland remains unknown.Methods: The Genome Aggregation database (gnomAD) database (containing 125,748 exomes) and two genomic sequencing databases  China Metabolic Analytics Project (ChinaMAP) (containing 10588 individuals) and Amcarelab gene database (containing 45392 exomes), were integrated to estimate the prevalence of ATTRv in the world and mainland Chinese populations. Pathogenic variants allele frequency and the prevalence of ATTRv was calculated.Results: Six variants, counting 470 alleles, were defined as pathogenic variants in gnomAD. The prevalence of ATTRv in the world population was 57.4/100,000. Two variants (2 allele counts) and 15 variants (34 individuals) were defined as pathogenic variants in the ChinaMAP database and the Amcarelab exome database, respectively. Thus, the estimated prevalence interval of ATTRv in mainland China was 18.9/100,000-74,9/100,000. Conclusion: The present study demonstrated that the previous prevalence was greatly underestimated using traditional methods. Therefore, raising awareness of the disease is essential for recognizing ATTRv in its early stage.">
<meta name="citation_article_type" content="Original Research">
<meta name="citation_pdf_url" content="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1126836/pdf">
<meta name="citation_xml_url" content="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1126836/xml">
<meta name="citation_fulltext_world_readable" content="yes">
<meta name="citation_online_date" content="2023/04/04">
<meta name="citation_publication_date" content="2023/04/13">
<meta name="citation_author" content="Yongsheng, Zheng ">
<meta name="citation_author_institution" content="Department of Neurology, China">
<meta name="citation_author" content="Chong, Sun ">
<meta name="citation_author_institution" content="Department of Neurology, China">
<meta name="citation_author" content="Bingyou, Liu ">
<meta name="citation_author_institution" content="Department of Neurology, China">
<meta name="citation_author" content="Jianian, Hu ">
<meta name="citation_author_institution" content="Department of Neurology, China">
<meta name="citation_author" content="Haofeng, Chen ">
<meta name="citation_author_institution" content="Department of Neurology, China">
<meta name="citation_author" content="Chongbo, Zhao ">
<meta name="citation_author_institution" content="Department of Neurology, China">
<meta name="citation_author" content="Zhang, Victor Wei ">
<meta name="citation_author_institution" content="Amcarelab Genetic Commercial Company, China">
<meta name="citation_author" content="Jie, Lin ">
<meta name="citation_author_institution" content="Department of Neurology, China">
<meta name="dc.identifier" content="doi:10.3389/fgene.2023.1126836">
<script type="application/ld+json">{"@context":"https://schema.org","@type":"ScholarlyArticle","headline":"Prevalence estimation of ATTRv in China based on genetic databases","author":[{"@type":"Person","name":"Zheng Yongsheng","affiliation":["Department of Neurology, China"]},{"@type":"Person","name":"Sun Chong","affiliation":["Department of Neurology, China"]},{"@type":"Person","name":"Liu Bingyou","affiliation":["Department of Neurology, China"]},{"@type":"Person","name":"Hu Jianian","affiliation":["Department of Neurology, China"]},{"@type":"Person","name":"Chen Haofeng","affiliation":["Department of Neurology, China"]},{"@type":"Person","name":"Zhao Chongbo","affiliation":["Department of Neurology, China"]},{"@type":"Person","name":"Victor Wei Zhang","affiliation":["Amcarelab Genetic Commercial Company, China"]},{"@type":"Person","name":"Lin Jie","affiliation":["Department of Neurology, China"]}],"datePublished":"2023-04-13","dateModified":"2025-11-25","publisher":{"@type":"Organization","name":"Frontiers"},"isPartOf":{"@type":"PublicationIssue","datePublished":"2023","isPartOf":{"@type":"PublicationVolume","volumeNumber":"14","isPartOf":{"@type":"Periodical","name":"Frontiers in Genetics"}}},"citation":["https://doi.org/10.3389/fgene.2023.1126836"],"inLanguage":"en"}</script>
<script type="module" src="/ap-2024/_nuxt/v1IBIWh4.js" crossorigin></script>
<script id="unhead:payload" type="application/json">{"title":"Frontiers | Articles"}</script></head><body  class="body--v3"><div id="__nuxt"><!--[--><!----><div theme="purple"><nav class="Ibar"><div class="Ibar__main"><div class="Ibar__wrapper"><button class="Ibar__burger" aria-label="Open Menu" data-event="iBar-btn-openMenu"></button><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div><a href="//www.frontiersin.org/journals/genetics" class="Ibar__journalName" data-event="iBar-a-journalHome"><div class="Ibar__journalName__container" logoclass="Ibar__logo--mixed"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Genetics</span></div></div></a><div class="Ibar__dropdown--aboutUs" parent-data-event="iBar"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About us</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About us</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Who we are</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/mission" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Mission and values</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/history" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">History</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/leadership" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Leadership</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/awards" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Awards</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Impact and progress</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/impact" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Frontiers&#39; impact</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/annual-reports" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Our annual reports</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Publishing model</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">How we publish</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Open access</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/peer-review" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Peer review</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-integrity" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research integrity</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-topics" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research Topics</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fair-data-management" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">FAIR Data Management</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Fee policy</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Services</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://publishingpartnerships.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_3-a_services">Societies</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/open-access-agreements/consortia" target="_self" data-event="iBar-aboutUs_3-a_services">National consortia</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access-agreements" target="_self" data-event="iBar-aboutUs_3-a_services">Institutional partnerships</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/collaborators" target="_self" data-event="iBar-aboutUs_3-a_services">Collaborators</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">More from Frontiers</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://forum.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Forum</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Planet Prize</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://pressoffice.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Press office</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/sustainability" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Sustainability</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://careers.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Career opportunities</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Contact us</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><!--[--><a class="Ibar__link" href="https://www.frontiersin.org/journals" data-event="iBar-a-allJournals">All journals</a><a class="Ibar__link" href="https://www.frontiersin.org/articles" data-event="iBar-a-allArticles">All articles</a><!--]--><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=1&amp;fieldid=30&amp;specialtyid=0&amp;entitytype=2&amp;entityid=240" data-event="iBar-a-submit">Submit your research</a><div class="Ibar__spacer"></div><a class="Ibar__icon Ibar__icon--search" href="//www.frontiersin.org/search" aria-label="Search" target="_self" data-event="iBar-a-search"><span>Search</span></a><!----><!----><!----><div class="Ibar__userArea"></div></div></div><div><div class="Ibar__menu Ibar__menu--journal"><div class="Ibar__menu__header"><div class="Ibar__logo"><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div></div><button class="Ibar__close" aria-label="Close Menu" data-event="iBarMenu-btn-closeMenu"></button></div><div class="Ibar__menu__wrapper"><div class="Ibar__menu__journal"><a href="//www.frontiersin.org/journals/genetics" data-event="iBarMenu-a-journalHome"><div class="Ibar__journalName__container"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Genetics</span></div></div></a><div parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/applied-genetic-epidemiology" data-event="iBarJournal-sections-a_id_549">Applied Genetic Epidemiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/behavioral-and-psychiatric-genetics" data-event="iBarJournal-sections-a_id_536">Behavioral and Psychiatric Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/cancer-genetics-and-oncogenomics" data-event="iBarJournal-sections-a_id_2030">Cancer Genetics and Oncogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/computational-genomics" data-event="iBarJournal-sections-a_id_551">Computational Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/cytogenomics" data-event="iBarJournal-sections-a_id_2512">Cytogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/elsi-in-science-and-genetics" data-event="iBarJournal-sections-a_id_650">ELSI in Science and Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/epigenomics-and-epigenetics" data-event="iBarJournal-sections-a_id_455">Epigenomics and Epigenetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/evolutionary-and-population-genetics" data-event="iBarJournal-sections-a_id_535">Evolutionary and Population Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genetics-of-aging" data-event="iBarJournal-sections-a_id_596">Genetics of Aging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genetics-of-common-and-rare-diseases" data-event="iBarJournal-sections-a_id_635">Genetics of Common and Rare Diseases</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genomic-assay-technology" data-event="iBarJournal-sections-a_id_557">Genomic Assay Technology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genomics-of-plants-and-the-phytoecosystem" data-event="iBarJournal-sections-a_id_1520">Genomics of Plants and the Phytoecosystem</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/human-and-medical-genomics" data-event="iBarJournal-sections-a_id_1419">Human and Medical Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/immunogenetics" data-event="iBarJournal-sections-a_id_2237">Immunogenetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/livestock-genomics" data-event="iBarJournal-sections-a_id_241">Livestock Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/neurogenomics" data-event="iBarJournal-sections-a_id_19">Neurogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/nutritional-genomics" data-event="iBarJournal-sections-a_id_3423">Nutritional Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/pharmacogenetics-and-pharmacogenomics" data-event="iBarJournal-sections-a_id_198">Pharmacogenetics and Pharmacogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/predictive-toxicology-and-exposomics" data-event="iBarJournal-sections-a_id_556">Predictive Toxicology and Exposomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/rna" data-event="iBarJournal-sections-a_id_555">RNA</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/statistical-genetics-and-methodology" data-event="iBarJournal-sections-a_id_454">Statistical Genetics and Methodology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/stem-cell-research" data-event="iBarJournal-sections-a_id_685">Stem Cell Research</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/genetics/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/genetics/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/genetics/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div></div><div class="Ibar__dropdown--aboutUs" parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About us</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About us</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Who we are</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/mission" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Mission and values</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/history" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">History</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/leadership" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Leadership</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/awards" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Awards</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Impact and progress</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/impact" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Frontiers&#39; impact</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/annual-reports" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Our annual reports</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Publishing model</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">How we publish</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Open access</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/peer-review" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Peer review</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-integrity" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research integrity</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-topics" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research Topics</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fair-data-management" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">FAIR Data Management</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Fee policy</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Services</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://publishingpartnerships.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_3-a_services">Societies</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/open-access-agreements/consortia" target="_self" data-event="iBar-aboutUs_3-a_services">National consortia</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access-agreements" target="_self" data-event="iBar-aboutUs_3-a_services">Institutional partnerships</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/collaborators" target="_self" data-event="iBar-aboutUs_3-a_services">Collaborators</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">More from Frontiers</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://forum.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Forum</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Planet Prize</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://pressoffice.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Press office</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/sustainability" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Sustainability</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://careers.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Career opportunities</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Contact us</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><!--[--><a class="Ibar__link" href="https://www.frontiersin.org/journals" data-event="iBar-a-allJournals">All journals</a><a class="Ibar__link" href="https://www.frontiersin.org/articles" data-event="iBar-a-allArticles">All articles</a><!--]--><!----><!----><!----><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=1&amp;fieldid=30&amp;specialtyid=0&amp;entitytype=2&amp;entityid=240" data-event="iBarMenu-a-submit">Submit your research</a></div></div></div><!--[--><div class="Ibar__journal Ibar__journal--main"><div class="Ibar__wrapper Ibar__wrapper--journal"><a href="//www.frontiersin.org/journals/genetics" class="Ibar__journalName" data-event="iBarJournal-a-journalHome"><div class="Ibar__journalName__container"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Genetics</span></div></div></a><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/applied-genetic-epidemiology" data-event="iBarJournal-sections-a_id_549">Applied Genetic Epidemiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/behavioral-and-psychiatric-genetics" data-event="iBarJournal-sections-a_id_536">Behavioral and Psychiatric Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/cancer-genetics-and-oncogenomics" data-event="iBarJournal-sections-a_id_2030">Cancer Genetics and Oncogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/computational-genomics" data-event="iBarJournal-sections-a_id_551">Computational Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/cytogenomics" data-event="iBarJournal-sections-a_id_2512">Cytogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/elsi-in-science-and-genetics" data-event="iBarJournal-sections-a_id_650">ELSI in Science and Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/epigenomics-and-epigenetics" data-event="iBarJournal-sections-a_id_455">Epigenomics and Epigenetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/evolutionary-and-population-genetics" data-event="iBarJournal-sections-a_id_535">Evolutionary and Population Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genetics-of-aging" data-event="iBarJournal-sections-a_id_596">Genetics of Aging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genetics-of-common-and-rare-diseases" data-event="iBarJournal-sections-a_id_635">Genetics of Common and Rare Diseases</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genomic-assay-technology" data-event="iBarJournal-sections-a_id_557">Genomic Assay Technology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genomics-of-plants-and-the-phytoecosystem" data-event="iBarJournal-sections-a_id_1520">Genomics of Plants and the Phytoecosystem</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/human-and-medical-genomics" data-event="iBarJournal-sections-a_id_1419">Human and Medical Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/immunogenetics" data-event="iBarJournal-sections-a_id_2237">Immunogenetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/livestock-genomics" data-event="iBarJournal-sections-a_id_241">Livestock Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/neurogenomics" data-event="iBarJournal-sections-a_id_19">Neurogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/nutritional-genomics" data-event="iBarJournal-sections-a_id_3423">Nutritional Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/pharmacogenetics-and-pharmacogenomics" data-event="iBarJournal-sections-a_id_198">Pharmacogenetics and Pharmacogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/predictive-toxicology-and-exposomics" data-event="iBarJournal-sections-a_id_556">Predictive Toxicology and Exposomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/rna" data-event="iBarJournal-sections-a_id_555">RNA</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/statistical-genetics-and-methodology" data-event="iBarJournal-sections-a_id_454">Statistical Genetics and Methodology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/stem-cell-research" data-event="iBarJournal-sections-a_id_685">Stem Cell Research</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/genetics/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/genetics/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/genetics/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><div class="Ibar__spacer"></div></div></div><div class="Ibar__journal Ibar__journal--mix"><div class="Ibar__wrapper Ibar__wrapper--journal"><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div><a href="//www.frontiersin.org/journals/genetics" class="Ibar__journalName" data-event="iBarJournal-a-journalHome"><div class="Ibar__journalName__container" logoclass="Ibar__logo--mixed"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Genetics</span></div></div></a><div class="Ibar__spacer"></div><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/applied-genetic-epidemiology" data-event="iBarJournal-sections-a_id_549">Applied Genetic Epidemiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/behavioral-and-psychiatric-genetics" data-event="iBarJournal-sections-a_id_536">Behavioral and Psychiatric Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/cancer-genetics-and-oncogenomics" data-event="iBarJournal-sections-a_id_2030">Cancer Genetics and Oncogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/computational-genomics" data-event="iBarJournal-sections-a_id_551">Computational Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/cytogenomics" data-event="iBarJournal-sections-a_id_2512">Cytogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/elsi-in-science-and-genetics" data-event="iBarJournal-sections-a_id_650">ELSI in Science and Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/epigenomics-and-epigenetics" data-event="iBarJournal-sections-a_id_455">Epigenomics and Epigenetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/evolutionary-and-population-genetics" data-event="iBarJournal-sections-a_id_535">Evolutionary and Population Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genetics-of-aging" data-event="iBarJournal-sections-a_id_596">Genetics of Aging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genetics-of-common-and-rare-diseases" data-event="iBarJournal-sections-a_id_635">Genetics of Common and Rare Diseases</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genomic-assay-technology" data-event="iBarJournal-sections-a_id_557">Genomic Assay Technology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genomics-of-plants-and-the-phytoecosystem" data-event="iBarJournal-sections-a_id_1520">Genomics of Plants and the Phytoecosystem</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/human-and-medical-genomics" data-event="iBarJournal-sections-a_id_1419">Human and Medical Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/immunogenetics" data-event="iBarJournal-sections-a_id_2237">Immunogenetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/livestock-genomics" data-event="iBarJournal-sections-a_id_241">Livestock Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/neurogenomics" data-event="iBarJournal-sections-a_id_19">Neurogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/nutritional-genomics" data-event="iBarJournal-sections-a_id_3423">Nutritional Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/pharmacogenetics-and-pharmacogenomics" data-event="iBarJournal-sections-a_id_198">Pharmacogenetics and Pharmacogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/predictive-toxicology-and-exposomics" data-event="iBarJournal-sections-a_id_556">Predictive Toxicology and Exposomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/rna" data-event="iBarJournal-sections-a_id_555">RNA</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/statistical-genetics-and-methodology" data-event="iBarJournal-sections-a_id_454">Statistical Genetics and Methodology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/stem-cell-research" data-event="iBarJournal-sections-a_id_685">Stem Cell Research</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/genetics/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/genetics/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/genetics/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><div class="Ibar__spacer"></div><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=1&amp;fieldid=30&amp;specialtyid=0&amp;entitytype=2&amp;entityid=240" data-event="iBarJournal-a-submit"><span>Submit</span><span>your research</span></a><a class="Ibar__icon Ibar__icon--search" href="//www.frontiersin.org/search" aria-label="Search" target="_self" data-event="iBar-a-search"><span>Search</span></a><!----><!----><!----><div class="Ibar__userArea"></div></div></div><!--]--></nav><div class="ArticlePage"><!--[--><div class="Layout Layout--withAside Layout--withIbarMix"><div class="Alert Alert--info Alert--noInfo ArticleTemplateBanner"><div class="Alert__icon"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" width="24px" class="FeedbackIcon"><path fill="#fff" d="M10 10h28v28H10z"></path><path fill="var(--blue50)" d="M24 2.88a21.12 21.12 0 1 0 0 42.24 21.12 21.12 0 0 0 0-42.24ZM22.08 13.4a.96.96 0 0 1 .96-.96h1.92a.96.96 0 0 1 .96.96v1.92a.96.96 0 0 1-.96.96h-1.92a.96.96 0 0 1-.96-.96V13.4Zm5.76 21.2a.96.96 0 0 1-.96.97h-5.76a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h.96v-7.68h-.96a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h3.84a.96.96 0 0 1 .96.96v10.56h.96a.96.96 0 0 1 .96.96v1.92Z"></path></svg></div><div class="Alert__main"><p class="Alert__message">Your new experience awaits. Try the new design now and help us make it even better</p><!--[--><button type="button" class="Button Button--outline Button--grey80 Button--small ArticleTemplateBanner__switchButton" data-event="btn-action"><span>Switch to the new experience</span></button><!--]--><!----></div><ol class="Alert__info"><!--[--><!--]--></ol></div><!----><main class="Layout__main"><!----><div class="ArticleDetails"><div class="ArticleLayoutHeader"><div class="ArticleLayoutHeader__info"><p class="ArticleLayoutHeader__info__title">ORIGINAL RESEARCH article</p><p class="ArticleLayoutHeader__info__journalDate"><span>Front. Genet.</span><span>, 13 April 2023</span></p><p class="ArticleLayoutHeader__info__journalDate"> Sec. Neurogenomics</p><p class="ArticleLayoutHeader__info__doiVolume"><span>Volume 14 - 2023 | </span><a class="ArticleLayoutHeader__info__doi" href="https://doi.org/10.3389/fgene.2023.1126836">https://doi.org/10.3389/fgene.2023.1126836</a></p><!----></div><!----><p class="ArticleLayoutHeader__isPartOfRT"><span class="ArticleLayoutHeader__isPartOfRT__label">This article is part of the Research Topic</span><span class="ArticleLayoutHeader__isPartOfRT__title">Insights in Neurogenomics: 2022</span><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View all 5 articles" href="https://www.frontiersin.org/research-topics/35037/insights-in-neurogenomics-2022/magazine" target="_self" data-event="customLink-linkType-a_viewAll5Articles"><span>View all 5 articles</span></a></span></p></div><div class="ArticleDetails__main__content"><div class="ArticleDetails__main__content__main ArticleDetails__main__content__main--fullArticle"><div class="JournalAbstract"><div class="JournalAbstract__titleWrapper"><h1>Prevalence estimation of ATTRv in China based on genetic databases</h1><!----></div><!----></div><div class="JournalFullText"><div class="JournalAbstract"><a id="h1" name="h1"></a><div class="authors"><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/1543548" class="user-id-1543548"><img class="pr5" src="https://loop.frontiersin.org/images/profile/1543548/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Zheng Yongsheng">Zheng Yongsheng</a><sup>1</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Sun Chong" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Sun Chong<sup>1</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Liu Bingyou" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Liu Bingyou<sup>1</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/2145086" class="user-id-2145086"><img class="pr5" src="https://loop.frontiersin.org/images/profile/2145086/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Hu Jianian">Hu Jianian</a><sup>1</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/2144719" class="user-id-2144719"><img class="pr5" src="https://loop.frontiersin.org/images/profile/2144719/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Chen Haofeng">Chen Haofeng</a><sup>1</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/877927" class="user-id-877927"><img class="pr5" src="https://loop.frontiersin.org/images/profile/877927/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Zhao Chongbo">Zhao Chongbo</a><sup>1</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/960611" class="user-id-960611"><img class="pr5" src="https://loop.frontiersin.org/images/profile/960611/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Victor Wei Zhang">Victor Wei Zhang</a><sup>2</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/1413978" class="user-id-1413978"><img class="pr5" src="https://loop.frontiersin.org/images/profile/1413978/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Lin Jie&#xa;">Lin Jie</a><sup>1</sup>&#x0002a;</span></div><ul class="notes"><li><span><sup>1</sup></span>Department of Neurology, Huashan Hospital Fudan University, Shanghai, China</li><li><span><sup>2</sup></span>Amcarelab Genetic Commercial Company, Guangzhou, China</li></ul><p class="mb15"><b>Introduction:</b> Amyloid transthyretin (ATTR) is divided into either hereditary (ATTRv) or sporadic (ATTRwt) and ATTRv is a rare hereditary disease transmitted as an autosomal dominant manner. Its global prevalence is traditionally estimated as 5,000 to 10,000 persons. However, it may be underestimated and the exact prevalence of ATTRv in China mainland remains unknown.</p><p class="mb15"><b>Methods:</b> The Genome Aggregation database (gnomAD) database (containing 125,748 exomes) and two genomic sequencing databases&#x02014;&#x02014;China Metabolic Analytics Project (ChinaMAP) (containing 10588 individuals) and Amcarelab gene database (containing 45392 exomes), were integrated to estimate the prevalence of ATTRv in the world and mainland Chinese populations. Pathogenic variants allele frequency and the prevalence of ATTRv was calculated.</p><p class="mb15"><b>Results:</b> Six variants, counting 470 alleles, were defined as pathogenic variants in gnomAD. The prevalence of ATTRv in the world population was 57.4/100,000. Two variants (2 allele counts) and 15 variants (34 individuals) were defined as pathogenic variants in the ChinaMAP database and the Amcarelab exome database, respectively. Thus, the estimated prevalence interval of ATTRv in mainland China was 18.9/100,000-74,9/100,000.</p><p class="mb15"><b>Conclusion:</b> The present study demonstrated that the previous prevalence was greatly underestimated using traditional methods. Therefore, raising awareness of the disease is essential for recognizing ATTRv in its early stage.</p><div class="clear"></div></div><div class="JournalFullText"><a id="h2" name="h2"></a><h2>Introduction</h2><p class="mb15">Amyloid transthyretin (ATTR) amyloidosis is characterized by pathologic accumulation of extracellular protein arising from unstable transthyretin (TTR) tetramers, which dissociate into monomers that misfold, aggregate, and form insoluble fibrils that are resistant to proteolysis (<a href="#B13">Finsterer et al., 2019</a>). TTR misfolding can lead to two distinct forms of amyloidosis: hereditary (ATTRv) and wild-type (ATTRwt) (<a href="#B31">Yamamoto and Yokochi, 2019</a>). ATTRv is a rare hereditary disease transmitted as an autosomal dominant manner (<a href="#B4">Adams et al., 2016</a>; <a href="#B2">Adams et al., 2021a</a>). It is caused by mutations in the transthyretin gene located on chromosome 18 (18q12.1). There is considerable heterogeneity in the clinical presentation of ATTRv, ranging from primarily cardiac, primarily neuropathic, or other progressive multisystem disorders (<a href="#B24">Rapezzi et al., 2010</a>). ATTRv usually proves fatal within 7&#x02013;12 years from the onset of symptoms, causing a heavy economic burden for families and society (<a href="#B29">Takeshima et al., 2019</a>; <a href="#B14">Galan et al., 2021</a>).</p><p class="mb15">ATTRv is an underdiagnosed disease and the true incidence and prevalence are currently unknown (<a href="#B23">Obi et al., 2022</a>). Its global prevalence is traditionally and somewhat anecdotally estimated as 5,000 to 10,000 persons but only several countries in Europe and Japan have relatively exact prevalence (<a href="#B28">Sousa et al., 1995</a>; <a href="#B18">Kato-Motozaki et al., 2008</a>; <a href="#B12">Dardiotis et al., 2009</a>; <a href="#B17">Ines et al., 2018</a>; <a href="#B21">Lauppe et al., 2021</a>). In epidemic regions such as Portugal, Sweden, and Japan, the prevalence varies from 10/100,000 to 100/100,000 people. Recently, the prevalence of transthyretin familial amyloid polyneuropathy (ATTR-FAP) in China was estimated to be approximately 2000 (range 435&#x02013;10,134) [1,347.7 million persons in total] (<a href="#B27">Schmidt et al., 2018</a>). However, the prevalence estimation and information supporting prevalence calculations were extracted from records yielded by reference-databases searches, conference proceedings and published cases or case series, which certainly had it underestimated.</p><p class="mb15">Previous prevalence estimation was given using traditional methods, namely, case reports, epidemiological surveys and patient registries (<a href="#B16">Ikeda et al., 2002</a>; <a href="#B17">Ines et al., 2018</a>). These traditional methods are prone to underestimations due to diagnostic bias and small sample size. In recent years, population-based genomic sequencing projects provided a new genetic perspective on the estimation of disease-related prevalences (<a href="#B19">Lahuerta Pueyo et al., 2019</a>). To date, several studies have employed publicly available large-population databases to infer pathogenicity, penetrance or prevalence of rare diseases (<a href="#B26">Rutten et al., 2016</a>; <a href="#B19">Lahuerta Pueyo et al., 2019</a>; <a href="#B22">Liu et al., 2019</a>). Herein, we utilized an integrated world population and Chinese population genomic sequencing databases to reevaluate the ATTRv prevalence in the mainland Chinese population.</p><a id="h3" name="h3"></a><h2>Materials and methods</h2><h3 class="pt0">The Genome Aggregation database</h3><p class="mb0">GnomAD contained 125,748 exomes from unrelated individuals and from different populations, sequenced as part of various disease-specific and population genetic studies. All <em>TTR</em> (canonical transcript ENST00000237014) variants were selected from the gnomAD version 2.1.1 (<a href="http://gnomad.broadinstitute.org/">http://gnomad.broadinstitute.org/</a>). The analysis of the gnomAD data was carried out from June 2022 to August 2022. In terms of populations, all variants analyzed were classified according to the diverse ethnicities defined in the gnomAD database. The population classifications were as follows: non-Finnish European, African/African American, Latino, Finnish, Ashkenazi Jewish, East Asian, South Asian and other. Population in mainland China was not included in the gnomAD.</p><h3 class="pt0">The China metabolic analytics project database</h3><p class="mb0">The ChinaMAP was based on cohort studies across diverse regions and ethnic groups in China. ChinaMAP (beta version, 2020-03) provided allele frequencies data of variants identified in the Chinese population (<em>n</em> &#x0003d; 10588). It randomly selected participants from 8 ethnic groups (Han, Hui, Manchu, Miao, Mongolian, Yi, Tibetan and Zhuang) across 27 provinces of China without biased selection or filtration (<a href="#B8">Cao et al., 2020</a>). Therefore, the ChinaMAP database may be considered as a genetic database for the general Chinese population. All <em>TTR</em> (transcript NM_000371.3) variants were extracted from <a href="http://www.mBiobank.com">www.mBiobank.com</a> on August 2022.</p><h3 class="pt0">The Amcarelab gene database</h3><p class="mb0">The Amcarelab gene database was provided by the Amcarelab genetic commercial company. It is composed of 45392 individuals who were suspected to have gene related disorders by medical practitioners from different clinical specialties. Therefore, this database included a subpopulation with negative results from genetic testing as well as patients with definite genetic disorders. All <em>TTR</em> (transcript NM_000371.4) variants were extracted on June 2022.</p><h3 class="pt0">Data analysis and variant annotation</h3><p class="mb0">The present study is focused on missense mutations, genetic variations that result in the substitution of one amino acid with another. The disease-associated variants analyzed in this study specifically affect protein folding, which leads to the accumulation of misfolded proteins, rather than the truncation of protein function. For this reason, the study excluded splicing variants, stop codons, and frameshift changes, as these variants may lead to the production of truncated or non-functional proteins. Additionally, intronic variants, variants in non-coding regions, and synonymous variants were not considered in the study. Following the recommendations of American College of Medical Genetics and Genomics (ACMG), the variants were divided into the following categories: pathogenic, likely pathogenic, uncertain significance, likely benign, benign. In present study, pathogenic and likely pathogenic variants were further defined as disease-causing variant. The calculation of the prevalence of disease-causing variants is our main goal.</p><a id="h4" name="h4"></a><h2>Results</h2><h3 class="pt0">Allele frequency of pathogenic variants in gnomAD</h3><p class="mb0">About 66 missense variants were found in the <em>TTR</em> gene, with an average of 125,780 exomes studied. According to our definition, six disease-causing variants (including 470 alleles count) were identified and their minor allelic frequency (MAF) was described in <a href="#T1">Table 1</a>. There were 3 homozygotes identified. The disease-causing amyloidogenic variants MAF was 0.00186 and so the overall prevalence was 371.3/100,000. This is about 4-fold&#x02013;40-fold higher than what would be expected based on the current epidemic regions prevalence estimation of 10/100,000 (actually from 10/100,000 to 100/100,000) (<a href="#B16">Ikeda et al., 2002</a>; <a href="#B18">Kato-Motozaki et al., 2008</a>). This huge prevalence gap between the estimation based on gene databases and traditional methods led us to conduct a further investigation. At first, we analyzed the relationship between population ethnicities and variants. Interestingly, we found a strong relation between the African population and the variant c.424G&#x0003e;A (p. (Val142Ile)) (<a href="#F1">Figure 1</a>). Among the amyloidogenic <em>TTR</em> pathogenic variants, the point change c.424G&#x0003e;A is unusual for its overwhelmingly predominant occurrence in individuals of documented African descent. Previous studies have shown that the c.424G&#x0003e;A variant was reported in the European population with an allele frequency of 0.00004, while in the African population it was reported with an allele frequency of 0.016 (<a href="#B19">Lahuerta Pueyo et al., 2019</a>). According to more recent data, the worldwide prevalence of this variant ranges from 0.3% to 1.6% in the general population. However, studies have reported higher prevalence rates of the c.424G&#x0003e;A variant among people of African descent, ranging from 1.1% to 9.8%. It is important to note that the prevalence of the c.424G&#x0003e;A variant in a specific region is highly dependent on the percentage of people with African ancestry residing in that region (<a href="#B9">Chandrashekar et al., 2021</a>). For its predominance in African/African-American, we further classified pathogenic missense variants found in gnomAD into two groups: African/African-American population and non-African. Then, the allele counts of the African/African-American population group based on gnomAD was 402 in 12487 exomes, and the allele frequency was 0.016, which was consistent with the prevalence previously reported. At last, the allele counts of the non-African group was 65 in 113261 exomes and the allele frequency was 0.0000287 (prevalence: 57.4/100,000).</p><div class="DottedLine"></div><div class="Imageheaders">TABLE 1</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t001.jpg" name="Table1" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t001.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t001.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t001.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t001.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t001.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t001.jpg" alt="www.frontiersin.org" id="T1" loading="lazy">
  </picture>
</a><p><b>TABLE 1</b>. Variants in the <em>TTR</em> gene classified as disease-causing variants from the gnomAD database global population.</p></div><div class="clear"></div><div class="DottedLine"></div><div class="Imageheaders">FIGURE 1</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-g001.jpg" name="Figure1" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-g001.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-g001.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-g001.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-g001.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-g001.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-g001.jpg" alt="www.frontiersin.org" id="F1" loading="lazy">
  </picture>
</a><p><b>FIGURE 1</b>. Population and pathogenic variant correlation in gnomAD Abbreviations: The ethical information was achieved from gnomAD database. The line connecting represent the pathogenic variant present in the ethnic population. The thicker the line, the higher the proportion of the corresponding variant in that ethnic population.</p></div><div class="clear"></div><div class="DottedLine"></div><h3 class="pt0">Prevalence estimation based on the ChinaMAP database</h3><p class="mb0">Analysis of the 10588 Chinese individuals identified 32 <em>TTR</em> missense mutation variants (<a href="#SM1">Supplementary Material S1</a>). Importantly, 2 variants (allele counts: 2), c.148 &#x0003e; A (p.Val50Met) and c.424G&#x0003e;A (p.Val142Ile) were classified as disease-causing variants according to this study. The allele frequency of disease-causing variants in the <em>TTR</em> within the Chinese population was estimated to be 0.0000944 (prevalence: 18.9/100,000).</p><h3 class="pt0">Prevalence estimation based on the Amcarelab exome database</h3><p class="mb0">Excluding synonymous, non-sense, splice variants, intron variants and variants in non-coding regions, analysis of the 45392 exomes identified 107 missense <em>TTR</em> variants <b>(</b><a href="#SM1">Supplementary Material S2</a><b>)</b> and 15 variants were pathogenic and likely pathogenic (34 individuals) (<a href="#T2">Table 2</a>). Thus, the prevalence of disease-causing variants in Chinese population was estimated to be 34 in 45392, namely 74.9/100,000. Herein, the estimated prevalence interval of ATTRv in mainland China was 18.9&#x0223c;74.9/100,000, based on the public exome, ChinaMAP, and the commercial exome databases.</p><div class="DottedLine"></div><div class="Imageheaders">TABLE 2</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t002.jpg" name="Table2" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t002.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t002.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t002.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t002.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t002.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t002.jpg" alt="www.frontiersin.org" id="T2" loading="lazy">
  </picture>
</a><p><b>TABLE 2</b>. Variants in the <em>TTR</em> gene classified as pathogenic variants from the Amcarelab database.</p></div><div class="clear"></div><div class="DottedLine"></div><h3 class="pt0">Prevalence estimation in the previous reported studies and in present study</h3><p class="mb0"><a href="#T3">Table 3</a> showed the prevalence of ATTRv in previous reports. In epidemic regions such as Portugal, Japan, and Sweden, the prevalence ranges from 1.1/100,000 to 151/100,000 according to different estimation methods. In non-epidemic regions, the prevalence various from 0.433/100,000 to 3.72/100,000. Specially, ATTRv prevalence in Saudi was estimated to 21.5/100,000 using genome sequencing database.</p><div class="DottedLine"></div><div class="Imageheaders">TABLE 3</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t003.jpg" name="Table3" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t003.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t003.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t003.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t003.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t003.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t003.jpg" alt="www.frontiersin.org" id="T3" loading="lazy">
  </picture>
</a><p><b>TABLE 3</b>. Previous ATTRv prevalence estimations.</p></div><div class="clear"></div><div class="DottedLine"></div><a id="h5" name="h5"></a><h2>Discussion</h2><p class="mb15">This is the first study to identify and investigate the prevalence of disease-causing <em>TTR</em> variants in the Chinese mainland population. The estimated prevalence interval of ATTRv was 18.9&#x02013;74.9/100,000 based on the public exome ChinaMAP and commercial exome databases. The lower limit of the prevalence interval was as high as or near 20-fold higher than that in Japan (prevalence: 1/100,000) concluded by traditional epidemiological methods (<a href="#B18">Kato-Motozaki et al., 2008</a>). Our results suggested that ATTRv in the Chinese was observed much more prevalent than previously recognized.</p><p class="mb15">To determine whether the prevalence in China is high, we estimated the prevalence of different populations and various cohorts using gnomAD data. The gnomAD database consisted of eight ethnic groups but not all populations were equally represented, with the European population being the most represented and the Asian and Latino the least represented (<a href="#B10">Collins et al., 2020</a>). Noteworthy, these databases did not contain the Chinese population. Comparisons to other population may aid in determine the prevalence gap of a number of disorders that exist between the Chinese and world populations. Not surprisingly, the ATTRv prevalence was 57.4 per 100,000 persons estimated by the genomic sequencing projects approach. It was equal to or even higher than that in epidemic regions such as Portugal, Sweden, and Japan, whose prevalence were calculated by case reports, epidemiological surveys and patient registries. A recent study using a national population-based exome sequence database reported the prevalence of 21.5 per 100,000 persons in Saudi (<a href="#B1">Abouelhoda et al., 2021</a>), an Asian country that was not reported as an ATTRv epidemic region. This further supported that the true prevalence of ATTRv was much higher than that reported in previous studies.</p><p class="mb15">There are four plausible explanations for the unexpected high prevalence: 1) the pathogenic variants in the ChinaMAP and Amcarelab databases differ from those found in ATTRv in reality and variants were not pathogenic but were polymorphisms, 2) all of the individuals with a <em>TTR</em> pathogenic variant in the ChinaMAP and Amcarelab databases have an undiagnosed or unreported classical <em>TTR</em> variant; 3) a late onset, mild <em>TTR</em> phenotype which was less readily diagnosed, may be much more prevalent than recognized to date. However, it is highly unlikely that any of the 15 disease-causing amyloidogenic <em>TTR</em> variants found in ChinaMAP and Amcarelab databases were polymorphisms as most the 15 pathogenic variants have been previously reported in <em>TTR</em> pedigrees. Taking the results from the gnomAD and Saudi databases into consideration, low prevalence estimation from previous traditional methods may be from penetrance <em>TTR</em> variability, misdiagnosis or missed diagnosis, delayed diagnosis and/or for other reasons (<a href="#B24">Rapezzi et al., 2010</a>).</p><p class="mb15">A high prevalence highlights the importance of diagnosing ATTRv clinically at an early stage. Recent years have seen the description of a series of novel and effective therapies for ATTRv. Tafamidis, patisiran, inotersen as well as the most promising NTLA-2001 have shown great benefits for patients with ATTRv. Specifically, these benefits are better received when ATTRv is diagnosed at an early stage of disease (<a href="#B7">Benson et al., 2018</a>; <a href="#B20">Lamb and Deeks, 2019</a>; <a href="#B3">Adams et al., 2021b</a>; <a href="#B15">Gillmore et al., 2021</a>). It challenges and encourage clinical practitioners to raise awareness and have a deeper and broader understanding of ATTRv because early diagnosis of amyloidosis remains an elusive goal that requires education of both physicians and patients (<a href="#B30">Wechalekar et al., 2016</a>). Further examinations or even gene sequencing must be performed when there is any suspicion of hereditary amyloidosis with initial signs and symptoms, to enter the screening process for amyloidosis and improve early diagnosis (<a href="#B11">Conceicao et al., 2019</a>).</p><p class="mb15">Our study has several limitations. First, in the present study, only &#x0201c;pathogenic&#x0201d; and &#x0201c;likely pathogenic&#x0201d; variants were defined as disease-causing variants. In fact, some variants in the &#x0201c;uncertain significance&#x0201d; group may also be disease-causing. Thus, the prevalence of ATTRv may be even higher. Secondly, penetrance analysis of the <em>TTR</em> gene could not be determined. Lastly, the characteristics of the Chinese variants and the relationship between variants and clinical characteristics were not analyzed.</p><p class="mb15">In conclusion, we confirmed the high prevalence of ATTRv in the Chinese mainland population, demonstrating that the previous prevalence was greatly underestimated obtained using traditional methods. Therefore, raising awareness of the disease is essential for recognizing ATTRv in its early stage.</p><a id="h6" name="h6"></a><h2>Data availability statement</h2><p class="mb15">The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p><a id="h7" name="h7"></a><h2>Author contributions</h2><p class="mb0">ZY wrote, checked and revised draft manuscripts; ZY, SC, LB, HJ, CH searched data from databases and collected and analyzed data together. LJ and VZ conceptualized the manuscript. LJ and ZC reviewed the draft and revised it.</p><a id="h8" name="h8"></a><h2>Acknowledgments</h2><p class="mb03">We want to express our gratitude to the curators who help maintain the online genetic databases this study included.</p><a id="h9" name="h9"></a><h2>Conflict of interest</h2><p class="mb0">Author VZ was employed by the company Amcarelab Genetic Commercial Company.</p><p class="mb0">The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p><a id="h10" name="h10"></a><h2>Publisher&#x02019;s note</h2><p class="mb15">All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p><a id="h11" name="h11"></a><h2>Supplementary material</h2><p class="mb15" id="SM1">The Supplementary Material for this article can be found online at: <a href="https://www.frontiersin.org/articles/10.3389/fgene.2023.1126836/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fgene.2023.1126836/full&#x00023;supplementary-material</a></p><a id="h12" name="h12"></a><h2>Abbreviations</h2><p class="mb15">ACMG, American College of Medical Genetics and Genomics; ATTR, amyloid transthyretin; ATTR-FAP, transthyretin familial amyloid polyneuropathy; ATTRv, hereditary amyloid transthyretin; ATTRwt, wild-type amyloid transthyretin; ChinaMAP, China Metabolic Analytics Project; GnomAD, Genome Aggregation database; HGVS, Human Genome Variation Society; TTR, transthyretin.</p><a id="h13" name="h13"></a><h2>References</h2><div class="References"><p class="ReferencesCopy1"><a name="B1" id="B1"></a>Abouelhoda, M., Mohty, D., Alayary, I., Meyer, B. F., Arold, S. T., Fadel, B. M., et al. (2021). Established and candidate transthyretin amyloidosis variants identified in the Saudi population by data mining. <em>Hum. Genomics</em> 15, 52. doi:10.1186/s40246-021-00351-2</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/34380564/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1186/s40246-021-00351-2">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Established+and+candidate+transthyretin+amyloidosis+variants+identified+in+the+Saudi+population+by+data+mining&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B2" id="B2"></a>Adams, D., Ando, Y., Beirao, J. M., Coelho, T., Gertz, M. A., Gillmore, J. D., et al. (2021). Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy. <em>J. Neurol.</em> 268, 2109&#x02013;2122. doi:10.1007/s00415-019-09688-0</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/31907599/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1007/s00415-019-09688-0">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Expert+consensus+recommendations+to+improve+diagnosis+of+ATTR+amyloidosis+with+polyneuropathy&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B3" id="B3"></a>Adams, D., Polydefkis, M., Gonzalez-Duarte, A., Wixner, J., Kristen, A. V., Schmidt, H. H., et al. (2021). Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study. <em>Lancet Neurol.</em> 20, 49&#x02013;59. doi:10.1016/S1474-4422(20)30368-9</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/33212063/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/S1474-4422(20)30368-9">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Long-term+safety+and+efficacy+of+patisiran+for+hereditary+transthyretin-mediated+amyloidosis+with+polyneuropathy:+12-month+results+of+an+open-label+extension+study&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B4" id="B4"></a>Adams, D., Suhr, O. B., Hund, E., Obici, L., Tournev, I., Campistol, J. M., et al. (2016). First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy. <em>Curr. Opin. Neurol.</em> 29 (1), S14&#x02013;S26. doi:10.1097/WCO.0000000000000289</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/26734952/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1097/WCO.0000000000000289">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=First+European+consensus+for+diagnosis,+management,+and+treatment+of+transthyretin+familial+amyloid+polyneuropathy&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B5" id="B5"></a>Andersson, R. (1976). Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden. <em>Acta Med. Scand. Suppl.</em> 590, 1&#x02013;64.</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/1064291/">PubMed Abstract</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Familial+amyloidosis+with+polyneuropathy.+A+clinical+study+based+on+patients+living+in+northern+Sweden&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B6" id="B6"></a>Auer-Grumbach, M., Rettl, R., Ablasser, K., Agis, H., Beetz, C., Duca, F., et al. (2020). Hereditary ATTR amyloidosis in Austria: Prevalence and epidemiological hot spots. <em>J. Clin. Med.</em> 9, 2234. doi:10.3390/jcm9072234</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32674397/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.3390/jcm9072234">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Hereditary+ATTR+amyloidosis+in+Austria:+Prevalence+and+epidemiological+hot+spots&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B7" id="B7"></a>Benson, M. D., Waddington-Cruz, M., Berk, J. L., Polydefkis, M., Dyck, P. J., Wang, A. K., et al. (2018). Inotersen treatment for patients with hereditary transthyretin amyloidosis. <em>N. Engl. J. Med.</em> 379, 22&#x02013;31. doi:10.1056/NEJMoa1716793</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29972757/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1056/NEJMoa1716793">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Inotersen+treatment+for+patients+with+hereditary+transthyretin+amyloidosis&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B8" id="B8"></a>Cao, Y., Li, L., Xu, M., Feng, Z., Sun, X., Lu, J., et al. (2020). The ChinaMAP analytics of deep whole genome sequences in 10,588 individuals. <em>Cell Res.</em> 30, 717&#x02013;731. doi:10.1038/s41422-020-0322-9</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32355288/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1038/s41422-020-0322-9">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+ChinaMAP+analytics+of+deep+whole+genome+sequences+in+10,588+individuals&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B9" id="B9"></a>Chandrashekar, P., Alhuneafat, L., Mannello, M., Al-Rashdan, L., Kim, M. M., Dungu, J., et al. (2021). Prevalence and outcomes of p.Val142Ile TTR amyloidosis cardiomyopathy: A systematic review. <em>Circ. Genom Precis. Med.</em> 14, e003356. doi:10.1161/CIRCGEN.121.003356</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/34461737/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1161/CIRCGEN.121.003356">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Prevalence+and+outcomes+of+p.Val142Ile+TTR+amyloidosis+cardiomyopathy:+A+systematic+review&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B10" id="B10"></a>Collins, R. L., Brand, H., Karczewski, K. J., Zhao, X., Alf&#x000f6;ldi, J., Francioli, L. C., et al. (2020). A structural variation reference for medical and population genetics. <em>Nature</em> 581, 444&#x02013;451. doi:10.1038/s41586-020-2287-8</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32461652/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1038/s41586-020-2287-8">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=A+structural+variation+reference+for+medical+and+population+genetics&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B11" id="B11"></a>Conceicao, I., Damy, T., Romero, M., Gal&#x000e1;n, L., Attarian, S., Luigetti, M., et al. (2019). Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations. <em>Amyloid</em> 26, 3&#x02013;9. doi:10.1080/13506129.2018.1556156</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/30793974/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1080/13506129.2018.1556156">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Early+diagnosis+of+ATTR+amyloidosis+through+targeted+follow-up+of+identified+carriers+of+TTR+gene+mutations&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B12" id="B12"></a>Dardiotis, E., Koutsou, P., Papanicolaou, E. Z., Vonta, I., Kladi, A., Vassilopoulos, D., et al. (2009). Epidemiological, clinical and genetic study of familial amyloidotic polyneuropathy in Cyprus. <em>Amyloid</em> 16, 32&#x02013;37. doi:10.1080/13506120802676948</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/19291512/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1080/13506120802676948">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Epidemiological,+clinical+and+genetic+study+of+familial+amyloidotic+polyneuropathy+in+Cyprus&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B13" id="B13"></a>Finsterer, J., Iglseder, S., Wanschitz, J., Topakian, R., Loscher, W. N., and Grisold, W. (2019). Hereditary transthyretin-related amyloidosis. <em>Acta Neurol. Scand.</em> 139, 92&#x02013;105. doi:10.1111/ane.13035</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/30295933/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1111/ane.13035">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Hereditary+transthyretin-related+amyloidosis&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B14" id="B14"></a>Galan, L., Gonzalez-Moreno, J., Martinez-Sesmero, J. M., Mu&#x000f1;oz-Beamud, F., Santos-Rubio, M. D., Tran, D., et al. (2021). Estimating the annual economic burden for the management of patients with transthyretin amyloid polyneuropathy in Spain. <em>Expert Rev. Pharmacoecon Outcomes Res.</em> 21, 967&#x02013;973. doi:10.1080/14737167.2021.1900738</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/33724140/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1080/14737167.2021.1900738">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Estimating+the+annual+economic+burden+for+the+management+of+patients+with+transthyretin+amyloid+polyneuropathy+in+Spain&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B15" id="B15"></a>Gillmore, J. D., Gane, E., Taubel, J., Kao, J., Fontana, M., Maitland, M. L., et al. (2021). CRISPR-Cas9 <em>in vivo</em> gene editing for transthyretin amyloidosis. <em>N. Engl. J. Med.</em> 385, 493&#x02013;502. doi:10.1056/NEJMoa2107454</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/34215024/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1056/NEJMoa2107454">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=CRISPR-Cas9+in+vivo+gene+editing+for+transthyretin+amyloidosis&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B16" id="B16"></a>Ikeda, S., Nakazato, M., Ando, Y., and Sobue, G. (2002). Familial transthyretin-type amyloid polyneuropathy in Japan: Clinical and genetic heterogeneity. <em>Neurology</em> 58, 1001&#x02013;1007. doi:10.1212/wnl.58.7.1001</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/11940682/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1212/wnl.58.7.1001">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Familial+transthyretin-type+amyloid+polyneuropathy+in+Japan:+Clinical+and+genetic+heterogeneity&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B17" id="B17"></a>Ines, M., Coelho, T., Conceicao, I., Duarte-Ramos, F., de Carvalho, M., and Costa, J. (2018). Epidemiology of transthyretin familial amyloid polyneuropathy in Portugal: A nationwide study. <em>Neuroepidemiology</em> 51, 177&#x02013;182. doi:10.1159/000490553</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/30153683/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1159/000490553">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Epidemiology+of+transthyretin+familial+amyloid+polyneuropathy+in+Portugal:+A+nationwide+study&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B18" id="B18"></a>Kato-Motozaki, Y., Ono, K., Shima, K., Morinaga, A., Machiya, T., Nozaki, I., et al. (2008). Epidemiology of familial amyloid polyneuropathy in Japan: Identification of a novel endemic focus. <em>J. Neurol. Sci.</em> 270, 133&#x02013;140. doi:10.1016/j.jns.2008.02.019</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/18410945/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.jns.2008.02.019">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Epidemiology+of+familial+amyloid+polyneuropathy+in+Japan:+Identification+of+a+novel+endemic+focus&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B19" id="B19"></a>Lahuerta Pueyo, C., Aibar Arregui, M. A., Gracia Gutierrez, A., Bueno Juana, E., and Menao Guillen, S. (2019). Estimating the prevalence of allelic variants in the transthyretin gene by analysing large-scale sequencing data. <em>Eur. J. Hum. Genet.</em> 27, 783&#x02013;791. doi:10.1038/s41431-019-0337-1</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/30683924/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1038/s41431-019-0337-1">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Estimating+the+prevalence+of+allelic+variants+in+the+transthyretin+gene+by+analysing+large-scale+sequencing+data&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B20" id="B20"></a>Lamb, Y. N., and Deeks, E. D. (2019). Tafamidis: A review in transthyretin amyloidosis with polyneuropathy. <em>Drugs</em> 79, 863&#x02013;874. doi:10.1007/s40265-019-01129-6</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/31098895/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1007/s40265-019-01129-6">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Tafamidis:+A+review+in+transthyretin+amyloidosis+with+polyneuropathy&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B21" id="B21"></a>Lauppe, R. E., Liseth Hansen, J., Gerdeskold, C., Rozenbaum, M. H., Strand, A. M., Vakevainen, M., et al. (2021). Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden. <em>Open Heart</em> 8, e001755. doi:10.1136/openhrt-2021-001755</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/34645699/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1136/openhrt-2021-001755">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Nationwide+prevalence+and+characteristics+of+transthyretin+amyloid+cardiomyopathy+in+Sweden&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B22" id="B22"></a>Liu, W., Pajusalu, S., Lake, N. J., Zhou, G., Ioannidis, N., Mittal, P., et al. (2019). Estimating prevalence for limb-girdle muscular dystrophy based on public sequencing databases. <em>Genet. Med.</em> 21, 2512&#x02013;2520. doi:10.1038/s41436-019-0544-8</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/31105274/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1038/s41436-019-0544-8">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Estimating+prevalence+for+limb-girdle+muscular+dystrophy+based+on+public+sequencing+databases&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B23" id="B23"></a>Obi, C. A., Mostertz, W. C., Griffin, J. M., and Judge, D. P. (2022). ATTR epidemiology, genetics, and prognostic factors. <em>Methodist Debakey Cardiovasc J.</em> 18, 17&#x02013;26. doi:10.14797/mdcvj.1066</p><p class="ReferencesCopy2"><a href="https://doi.org/10.14797/mdcvj.1066">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=ATTR+epidemiology,+genetics,+and+prognostic+factors&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B24" id="B24"></a>Rapezzi, C., Quarta, C. C., Riva, L., Longhi, S., Gallelli, I., Lorenzini, M., et al. (2010). Transthyretin-related amyloidoses and the heart: A clinical overview. <em>Nat. Rev. Cardiol.</em> 7, 398&#x02013;408. doi:10.1038/nrcardio.2010.67</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/20479782/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1038/nrcardio.2010.67">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Transthyretin-related+amyloidoses+and+the+heart:+A+clinical+overview&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B25" id="B25"></a>Russo, M., Obici, L., Bartolomei, I., Cappelli, F., Luigetti, M., Fenu, S., et al. (2020). ATTRv amyloidosis Italian registry: Clinical and epidemiological data. <em>Amyloid</em> 27, 259&#x02013;265. doi:10.1080/13506129.2020.1794807</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32696671/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1080/13506129.2020.1794807">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=ATTRv+amyloidosis+Italian+registry:+Clinical+and+epidemiological+data&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B26" id="B26"></a>Rutten, J. W., Dauwerse, H. G., Gravesteijn, G., van Belzen, M. J., van der Grond, J., Polke, J. M., et al. (2016). Archetypal NOTCH3 mutations frequent in public exome: Implications for CADASIL. <em>Ann. Clin. Transl. Neurol.</em> 3, 844&#x02013;853. doi:10.1002/acn3.344</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/27844030/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1002/acn3.344">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Archetypal+NOTCH3+mutations+frequent+in+public+exome:+Implications+for+CADASIL&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B27" id="B27"></a>Schmidt, H. H., Waddington-Cruz, M., Botteman, M. F., Carter, J. A., Chopra, A. S., Hopps, M., et al. (2018). Estimating the global prevalence of transthyretin familial amyloid polyneuropathy. <em>Muscle Nerve</em> 57, 829&#x02013;837. doi:10.1002/mus.26034</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29211930/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1002/mus.26034">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Estimating+the+global+prevalence+of+transthyretin+familial+amyloid+polyneuropathy&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B28" id="B28"></a>Sousa, A., Coelho, T., Barros, J., and Sequeiros, J. (1995). Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Povoa do Varzim and Vila do Conde (north of Portugal). <em>Am. J. Med. Genet.</em> 60, 512&#x02013;521. doi:10.1002/ajmg.1320600606</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/8825887/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1002/ajmg.1320600606">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Genetic+epidemiology+of+familial+amyloidotic+polyneuropathy+(FAP)-type+I+in+Povoa+do+Varzim+and+Vila+do+Conde+(north+of+Portugal)&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B29" id="B29"></a>Takeshima, T., Wan, Q., Zhang, Y., Komori, M., Stretton, S., Rajan, N., et al. (2019). Prevalence, burden, and clinical management of migraine in China, Japan, and South Korea: A comprehensive review of the literature. <em>J. Headache Pain</em> 20, 111. doi:10.1186/s10194-019-1062-4</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/31805851/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1186/s10194-019-1062-4">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Prevalence,+burden,+and+clinical+management+of+migraine+in+China,+Japan,+and+South+Korea:+A+comprehensive+review+of+the+literature&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B30" id="B30"></a>Wechalekar, A. D., Gillmore, J. D., and Hawkins, P. N. (2016). Systemic amyloidosis. <em>Lancet</em> 387, 2641&#x02013;2654. doi:10.1016/S0140-6736(15)01274-X</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/26719234/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/S0140-6736(15)01274-X">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Systemic+amyloidosis&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B31" id="B31"></a>Yamamoto, H., and Yokochi, T. (2019). Transthyretin cardiac amyloidosis: An update on diagnosis and treatment. <em>Esc. Heart Fail</em> 6, 1128&#x02013;1139. doi:10.1002/ehf2.12518</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/31553132/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1002/ehf2.12518">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Transthyretin+cardiac+amyloidosis:+An+update+on+diagnosis+and+treatment&amp;btnG=">Google Scholar</a></p></div></div><div class="thinLineM20"></div><div class="AbstractSummary"><p><span>Keywords:</span> amyloid transthyretin (ATTR), ChinaMap, GnomAD, prevalence, genetic database</p><p><span>Citation:</span> Yongsheng Z, Chong S, Bingyou L, Jianian H, Haofeng C, Chongbo Z, Zhang VW and Jie L (2023) Prevalence estimation of ATTRv in China based on genetic databases. <em>Front. Genet.</em> 14:1126836. doi: 10.3389/fgene.2023.1126836</p><p id="timestamps"><span>Received:</span> 18 December 2022; <span>Accepted:</span> 04 April 2023;<br><span>Published:</span> 13 April 2023.</p><div><p>Edited by:</p> <a href="https://loop.frontiersin.org/people/437033/overview">Sarah H. Elsea</a>, Baylor College of Medicine, United States</div><div><p>Reviewed by:</p> <a href="https://loop.frontiersin.org/people/949480/overview">Dario Ronchi</a>, University of Milan, Italy<br><a href="https://loop.frontiersin.org/people/734185/overview">Michel Satya Naslavsky</a>, University of S&#x000e3;o Paulo, Brazil</div><p><span>Copyright</span> &#x000a9; 2023 Yongsheng, Chong, Bingyou, Jianian, Haofeng, Chongbo, Zhang and Jie. This is an open-access article distributed under the terms of the <a rel="license" href="http://creativecommons.org/licenses/by/4.0/" target="_blank">Creative Commons Attribution License (CC BY).</a> The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p><p><span>&#x0002a;Correspondence:</span> Lin Jie, <a id="encmail">bGluamllMTVAZnVkYW4uZWR1LmNu</a></p><div class="clear"></div></div></div></div><p class="AbstractSummary__disclaimer"><span>Disclaimer: </span> All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher. </p></div></div><!----></main><aside class="Layout__aside"><div class="ArticleDetails__wrapper"><div class="ArticleDetails__aside"><div class="ArticleDetails__aside__responsiveButtons"><div class="ActionsDropDown" id="FloatingButtonsEl"><button aria-label="Open dropdown" class="ActionsDropDown__button--type ActionsDropDown__button--icon ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Download article</span></button><div class="ActionsDropDown__menuWrapper"><!----><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1126836/pdf" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-pdf">Download PDF</a></li><li><a href="http://www.readcube.com/articles/10.3389/fgene.2023.1126836" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-readCube">ReadCube</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1126836/epub" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-epub">EPUB</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1126836/xml" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-nlmXml">XML</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><div class="ArticleDetails__aside__responsiveButtons__items"><span></span><div class="ArticleDetailsShare__responsive"><button class="ArticleDetailsShare__trigger" aria-label="Open share options"></button><div class="ArticleDetailsShare"><p class="ArticleDetailsShare__title">Share on</p><ul class="ArticleDetailsShare__list"><!--[--><li class="ArticleDetailsShare__item"><a href="https://www.twitter.com/share?url=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1126836/full" target="_blank" class="ArticleDetailsShare__link--x ArticleDetailsShare__link" title="Share on X" aria-label="Share on X"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.linkedin.com/share?url=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1126836/full" target="_blank" class="ArticleDetailsShare__link--linkedin ArticleDetailsShare__link" title="Share on Linkedin" aria-label="Share on Linkedin"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.facebook.com/sharer/sharer.php?u=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1126836/full" target="_blank" class="ArticleDetailsShare__link--facebook ArticleDetailsShare__link" title="Share on Facebook" aria-label="Share on Facebook"></a></li><!--]--></ul></div></div><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--typeIconButton ActionsDropDown__button--iconQuote ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><!----></button><div class="ActionsDropDown__menuWrapper"><div class="ActionsDropDown__mobileTitle">Export citation</div><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1126836/endNote" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-endNote">EndNote</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1126836/reference" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-referenceManager">Reference Manager</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1126836/text" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-simpleTextFile">Simple Text file</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1126836/bibTex" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-bibTex">BibTex</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div></div></div><div class="TotalViews"><div class="TotalViews__data"><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">3,8K</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Total views</div></div></div><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">1,4K</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Downloads</div></div></div><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">7</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Citations</div></div></div><div class="ImpactMetricsInfoPopover"><button aria-label="Open impact metrics info" class="ImpactMetricsInfoPopover__button"></button><div class="ImpactMetricsInfoPopover__tooltip"><button aria-label="Close impact metrics info" class="ImpactMetricsInfoPopover__tooltip__closeButton"></button><div class="ImpactMetricsInfoPopover__tooltip__text"> Citation numbers are available from Dimensions </div></div></div></div><div class="TotalViews__viewImpactLink"><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View article impact" href="http://loop-impact.frontiersin.org/impact/article/1126836#totalviews/views" target="_blank" data-event="customLink-link-a_viewArticleImpact"><span>View article impact</span></a></span></div><div class="TotalViews__altmetric"><div data-badge-popover="bottom" data-badge-type="donut" data-doi="10.3389/fgene.2023.1126836" data-condensed="true" data-link-target="new" class="altmetric-embed"></div><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View altmetric score" href="https://www.altmetric.com/details/doi/10.3389/fgene.2023.1126836" target="_blank" data-event="customLink-link-a_viewAltmetricScore"><span>View altmetric score</span></a></span></div></div><div class="ArticleDetailsShare"><p class="ArticleDetailsShare__title">Share on</p><ul class="ArticleDetailsShare__list"><!--[--><li class="ArticleDetailsShare__item"><a href="https://www.twitter.com/share?url=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1126836/full" target="_blank" class="ArticleDetailsShare__link--x ArticleDetailsShare__link" title="Share on X" aria-label="Share on X"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.linkedin.com/share?url=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1126836/full" target="_blank" class="ArticleDetailsShare__link--linkedin ArticleDetailsShare__link" title="Share on Linkedin" aria-label="Share on Linkedin"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.facebook.com/sharer/sharer.php?u=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1126836/full" target="_blank" class="ArticleDetailsShare__link--facebook ArticleDetailsShare__link" title="Share on Facebook" aria-label="Share on Facebook"></a></li><!--]--></ul></div><div class="ArticleDetailsEditors"><div class="ArticleDetailsEditors__editors"><div class="ArticleDetailsEditors__title">Edited by</div><!--[--><a href="https://loop.frontiersin.org/people/437033/overview" data-event="editorInfo-a-sarahHElsea" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">S</span><span class="notranslate">H</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Sarah  H Elsea</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate">Baylor College of Medicine, United States</div></div></a><!--]--></div></div><div class="ArticleDetailsEditors"><div class="ArticleDetailsEditors__editors"><div class="ArticleDetailsEditors__title">Reviewed by</div><!--[--><a href="https://loop.frontiersin.org/people/734185/overview" data-event="editorInfo-a-michelSatyaNaslavsky" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">M</span><span class="notranslate">S</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Michel  Satya Naslavsky</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate">University of So Paulo, Brazil</div></div></a><a href="https://loop.frontiersin.org/people/949480/overview" data-event="editorInfo-a-darioRonchi" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">D</span><span class="notranslate">R</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Dario  Ronchi</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate">University of Milan, Italy</div></div></a><!--]--></div></div><div class="ArticleDetailsGlossary ArticleDetailsGlossary--open"><button class="ArticleDetailsGlossary__header"><div class="ArticleDetailsGlossary__header__title">Table of contents</div><div class="ArticleDetailsGlossary__header__arrow"></div></button><div class="ArticleDetailsGlossary__content"><ul class="flyoutJournal"><li><a href="#h1">Abstract</a></li><li><a href="#h2">Introduction</a></li><li><a href="#h3">Materials and methods</a></li><li><a href="#h4">Results</a></li><li><a href="#h5">Discussion</a></li><li><a href="#h6">Data availability statement</a></li><li><a href="#h7">Author contributions</a></li><li><a href="#h8">Acknowledgments</a></li><li><a href="#h9">Conflict of interest</a></li><li><a href="#h10">Publisher&#x02019;s note</a></li><li><a href="#h11">Supplementary material</a></li><li><a href="#h12">Abbreviations</a></li><li><a href="#h13">References</a></li></ul></div></div><span></span><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--typeOutline ActionsDropDown__button--iconQuote ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Export citation</span></button><div class="ActionsDropDown__menuWrapper"><!----><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1126836/endNote" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-endNote">EndNote</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1126836/reference" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-referenceManager">Reference Manager</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1126836/text" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-simpleTextFile">Simple Text file</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1126836/bibTex" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-bibTex">BibTex</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><div class="CheckForUpdates"><button data-target="crossmark" class="CheckForUpdates__link" data-event="checkForUpdates-btn-openModal"><img class="CheckForUpdates__link__img" src="/ap-2024/images/crossmark.svg" alt="Crossmark icon"><div class="CheckForUpdates__link__text">Check for updates</div></button></div><div class="AnnouncementCard"><p class="AnnouncementCard__title">Frontiers&#39; impact</p><article class="CardA"><div class="CardA__wrapper CardA__wrapper--vertical"><figure class="FrontiersImage CardA__img"><picture class="FrontiersImage"><!--[--><source srcset="https://images-provider.frontiersin.org/api/ipx/w=440&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 563px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=320x400&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 1024px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=268x280&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 1441px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media><source srcset="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=jpg/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media><!--]--><img src="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=jpg/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" class="is-inside-mask" alt loading="eager"></picture><!----></figure><div class="CardA__info"><!--[--><h2 class="CardA__title">Articles published with Frontiers have received 12 million total citations</h2><p class="CardA__text">Your research is the real superpower - learn how we maximise its impact through our leading community journals</p><br><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--small Link--icon Link--chevronRight Link--right" aria-label="Explore our impact metrics" href="https://www.frontiersin.org/about/impact" target="_self" data-event="customLink-linkType-a_exploreOurImpactMe"><span>Explore our impact metrics</span></a></span><!--]--></div></div></article></div><!----><!----></div><div><div class="Modal Modal--noFooter"><button aria-label="Close modal" class="Modal__overlay" data-event="modal-overlay-close"></button><div class="Modal__container"><div class="Modal__header"><p class="Modal__title">Supplementary Material</p><button aria-label="Close modal" class="Modal__close" data-event="modal-button-close"></button></div><div class="Modal__body"><!--[--><div class="SupplementalData"><ul class="SupplementalData__list"><!--[--><!--]--></ul></div><!--]--><!----></div><!----><!----></div></div></div><div><div class="FloatingButtons"><!----><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--type ActionsDropDown__button--iconDownload ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Download article</span></button><div class="ActionsDropDown__menuWrapper"><div class="ActionsDropDown__mobileTitle">Download</div><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1126836/pdf" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-pdf">Download PDF</a></li><li><a href="http://www.readcube.com/articles/10.3389/fgene.2023.1126836" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-readCube">ReadCube</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1126836/epub" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-epub">EPUB</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1126836/xml" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-nlmXml">XML</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><!----></div></div></div></aside></div><div class=""><!----></div><!--]--></div><!----><footer class="Footer"><div class="Footer__wrapper"><div class="Footer__sections"><ul class="Accordion"><!--[--><!--[--><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Guidelines</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://www.frontiersin.org/guidelines/author-guidelines" target="_self" data-event="footer-block_0-a_authorGuidelines">Author guidelines</a></li><li><a href="https://www.frontiersin.org/for-authors/author-services" target="_self" data-event="footer-block_0-a_servicesForAuthors">Services for authors</a></li><li><a href="https://www.frontiersin.org/guidelines/policies-and-publication-ethics" target="_self" data-event="footer-block_0-a_policiesAndPublicationE">Policies and publication ethics</a></li><li><a href="https://www.frontiersin.org/guidelines/editor-guidelines" target="_self" data-event="footer-block_0-a_editorGuidelines">Editor guidelines</a></li><li><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="footer-block_0-a_feePolicy">Fee policy</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Explore</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://www.frontiersin.org/articles" target="_self" data-event="footer-block_1-a_articles">Articles</a></li><li><a href="https://www.frontiersin.org/research-topics" target="_self" data-event="footer-block_1-a_researchTopics">Research Topics </a></li><li><a href="https://www.frontiersin.org/journals" target="_self" data-event="footer-block_1-a_journals">Journals</a></li><li><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="footer-block_1-a_howWePublish">How we publish</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Outreach</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://forum.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersForum">Frontiers Forum </a></li><li><a href="https://policylabs.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersPolicyLabs">Frontiers Policy Labs </a></li><li><a href="https://kids.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersForYoungMinds">Frontiers for Young Minds</a></li><li><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="footer-block_2-a_frontiersPlanetPrize">Frontiers Planet Prize</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Connect</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://helpcenter.frontiersin.org" target="_blank" data-event="footer-block_3-a_helpCenter">Help center</a></li><li><a href="https://subscription-management.frontiersin.org/emails/preferences#block0" target="_blank" data-event="footer-block_3-a_emailsAndAlerts">Emails and alerts </a></li><li><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="footer-block_3-a_contactUs">Contact us </a></li><li><a href="https://www.frontiersin.org/submission/submit" target="_self" data-event="footer-block_3-a_submit">Submit</a></li><li><a href="https://careers.frontiersin.org/" target="_blank" data-event="footer-block_3-a_careerOpportunities">Career opportunities</a></li><!--]--></ul><!--]--></div></li><!--]--><!--]--></ul><div class="Footer__socialLinks"><div class="Footer__socialLinks__title">Follow us</div><!--[--><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--facebook Link--right" aria-label="Frontiers Facebook" href="https://www.facebook.com/Frontiersin" target="_blank" data-event="footer-facebook-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--twitter Link--right" aria-label="Frontiers Twitter" href="https://twitter.com/frontiersin" target="_blank" data-event="footer-twitter-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--linkedin Link--right" aria-label="Frontiers LinkedIn" href="https://www.linkedin.com/company/frontiers" target="_blank" data-event="footer-linkedIn-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--instagram Link--right" aria-label="Frontiers Instagram" href="https://www.instagram.com/frontiersin_" target="_blank" data-event="footer-instagram-a_true"><span></span></a></span><!--]--></div></div><div class="Footer__copyright"><div><span> 2025 Frontiers Media SA. All rights reserved.</span></div><div><a href="https://www.frontiersin.org/legal/privacy-policy" target="_blank">Privacy policy</a><span>|</span><a href="https://www.frontiersin.org/legal/terms-and-conditions" target="_blank">Terms and conditions</a></div></div></div></footer><div class="SnackbarWrapper"><div class="SnackbarManager"><!--[--><!--]--></div></div></div><noscript><iframe
            src="https://tag-manager.frontiersin.org/ns.html?id=GTM-M322FV2&gtm_auth=owVbWxfaJr21yQv1fe1cAQ&gtm_preview=env-1&gtm_cookies_win=x"
            height="0"
            width="0"
            style="display: none; visibility: hidden">
          </iframe></noscript><!--]--></div><div id="teleports"></div><script type="application/json" id="__NUXT_DATA__" data-ssr="true">[["ShallowReactive",1],{"data":2,"state":4,"once":10,"_errors":11,"serverRendered":13,"path":14,"pinia":15},["ShallowReactive",3],{},["Reactive",5],{"$ssite-config":6},{"env":7,"name":8,"url":9},"production","Frontiers articles","https://article-pages-2024.frontiersin.org/",["Set"],["ShallowReactive",12],{},true,"/journals/genetics/articles/10.3389/fgene.2023.1126836/full",["Reactive",16],{"main":17,"user":514,"article":515,"articleHub":815,"mainHeader":819},{"ibar":18,"footer":276,"newsletterComponent":-1,"snackbarItem":358,"toggleShowSnackbar":359,"contentfulJournal":360,"graphJournal":414,"settingsFeaturesSwitchers":418,"templateToggleBanner":419,"tenantConfig":479},{"tenantLogo":19,"journalLogo":19,"aboutUs":20,"submitUrl":113,"showSubmitButton":13,"journal":114,"sectionTerm":207,"aboutJournal":208,"mainLinks":257,"journalLinks":264,"helpCenterLink":273},"",[21,38,47,71,87],{"title":22,"links":23},"Who we are",[24,29,32,35],{"text":25,"url":26,"target":27,"ariaLabel":28},"Mission and values","https://www.frontiersin.org/about/mission","_self",null,{"text":30,"url":31,"target":27,"ariaLabel":28},"History","https://www.frontiersin.org/about/history",{"text":33,"url":34,"target":27,"ariaLabel":28},"Leadership","https://www.frontiersin.org/about/leadership",{"text":36,"url":37,"target":27,"ariaLabel":28},"Awards","https://www.frontiersin.org/about/awards",{"title":39,"links":40},"Impact and progress",[41,44],{"text":42,"url":43,"target":27,"ariaLabel":28},"Frontiers' impact","https://www.frontiersin.org/about/impact",{"text":45,"url":46,"target":27,"ariaLabel":28},"Our annual reports","https://www.frontiersin.org/about/annual-reports",{"title":48,"links":49},"Publishing model",[50,53,56,59,62,65,68],{"text":51,"url":52,"target":27,"ariaLabel":28},"How we publish","https://www.frontiersin.org/about/how-we-publish",{"text":54,"url":55,"target":27,"ariaLabel":28},"Open access","https://www.frontiersin.org/about/open-access",{"text":57,"url":58,"target":27,"ariaLabel":28},"Peer review","https://www.frontiersin.org/about/peer-review",{"text":60,"url":61,"target":27,"ariaLabel":28},"Research integrity","https://www.frontiersin.org/about/research-integrity",{"text":63,"url":64,"target":27,"ariaLabel":28},"Research Topics","https://www.frontiersin.org/about/research-topics",{"text":66,"url":67,"target":27,"ariaLabel":28},"FAIR Data Management","https://www.frontiersin.org/about/fair-data-management",{"text":69,"url":70,"target":27,"ariaLabel":28},"Fee policy","https://www.frontiersin.org/about/fee-policy",{"title":72,"links":73},"Services",[74,78,81,84],{"text":75,"url":76,"target":77,"ariaLabel":28},"Societies","https://publishingpartnerships.frontiersin.org/","_blank",{"text":79,"url":80,"target":27,"ariaLabel":28},"National consortia","https://www.frontiersin.org/open-access-agreements/consortia",{"text":82,"url":83,"target":27,"ariaLabel":28},"Institutional partnerships","https://www.frontiersin.org/about/open-access-agreements",{"text":85,"url":86,"target":27,"ariaLabel":28},"Collaborators","https://www.frontiersin.org/about/collaborators",{"title":88,"links":89},"More from Frontiers",[90,94,97,101,105,109],{"text":91,"url":92,"target":77,"ariaLabel":93},"Frontiers Forum","https://forum.frontiersin.org/","this link will take you to the Frontiers Forum website",{"text":95,"url":96,"target":27,"ariaLabel":28},"Frontiers Planet Prize","https://www.frontiersin.org/about/frontiers-planet-prize",{"text":98,"url":99,"target":77,"ariaLabel":100},"Press office","https://pressoffice.frontiersin.org/","this link will take you to the Frontiers press office website",{"text":102,"url":103,"target":27,"ariaLabel":104},"Sustainability","https://www.frontiersin.org/about/sustainability","link to information about Frontiers' sustainability",{"text":106,"url":107,"target":77,"ariaLabel":108},"Career opportunities","https://careers.frontiersin.org/","this link will take you to the Frontiers careers website",{"text":110,"url":111,"target":27,"ariaLabel":112},"Contact us","https://www.frontiersin.org/about/contact","this link will take you to the help pages to contact our support team","https://www.frontiersin.org/submission/submit?domainid=1&fieldid=30&specialtyid=0&entitytype=2&entityid=240",{"id":115,"name":116,"slug":117,"sections":118},240,"Frontiers in Genetics","genetics",[119,123,127,131,135,139,143,147,151,155,159,163,167,171,175,179,183,187,191,195,199,203],{"id":120,"name":121,"slug":122},549,"Applied Genetic Epidemiology","applied-genetic-epidemiology",{"id":124,"name":125,"slug":126},536,"Behavioral and Psychiatric Genetics","behavioral-and-psychiatric-genetics",{"id":128,"name":129,"slug":130},2030,"Cancer Genetics and Oncogenomics","cancer-genetics-and-oncogenomics",{"id":132,"name":133,"slug":134},551,"Computational Genomics","computational-genomics",{"id":136,"name":137,"slug":138},2512,"Cytogenomics","cytogenomics",{"id":140,"name":141,"slug":142},650,"ELSI in Science and Genetics","elsi-in-science-and-genetics",{"id":144,"name":145,"slug":146},455,"Epigenomics and Epigenetics","epigenomics-and-epigenetics",{"id":148,"name":149,"slug":150},535,"Evolutionary and Population Genetics","evolutionary-and-population-genetics",{"id":152,"name":153,"slug":154},596,"Genetics of Aging","genetics-of-aging",{"id":156,"name":157,"slug":158},635,"Genetics of Common and Rare Diseases","genetics-of-common-and-rare-diseases",{"id":160,"name":161,"slug":162},557,"Genomic Assay Technology","genomic-assay-technology",{"id":164,"name":165,"slug":166},1520,"Genomics of Plants and the Phytoecosystem","genomics-of-plants-and-the-phytoecosystem",{"id":168,"name":169,"slug":170},1419,"Human and Medical Genomics","human-and-medical-genomics",{"id":172,"name":173,"slug":174},2237,"Immunogenetics","immunogenetics",{"id":176,"name":177,"slug":178},241,"Livestock Genomics","livestock-genomics",{"id":180,"name":181,"slug":182},19,"Neurogenomics","neurogenomics",{"id":184,"name":185,"slug":186},3423,"Nutritional Genomics","nutritional-genomics",{"id":188,"name":189,"slug":190},198,"Pharmacogenetics and Pharmacogenomics","pharmacogenetics-and-pharmacogenomics",{"id":192,"name":193,"slug":194},556,"Predictive Toxicology and Exposomics","predictive-toxicology-and-exposomics",{"id":196,"name":197,"slug":198},555,"RNA","rna",{"id":200,"name":201,"slug":202},454,"Statistical Genetics and Methodology","statistical-genetics-and-methodology",{"id":204,"name":205,"slug":206},685,"Stem Cell Research","stem-cell-research","Sections",[209,233],{"title":210,"links":211},"Scope",[212,215,218,221,224,227,230],{"text":213,"url":214,"target":27,"ariaLabel":28},"Field chief editors","https://www.frontiersin.org/journals/genetics/about#about-editors",{"text":216,"url":217,"target":27,"ariaLabel":28},"Mission & scope","https://www.frontiersin.org/journals/genetics/about#about-scope",{"text":219,"url":220,"target":27,"ariaLabel":28},"Facts","https://www.frontiersin.org/journals/genetics/about#about-facts",{"text":222,"url":223,"target":27,"ariaLabel":28},"Journal sections","https://www.frontiersin.org/journals/genetics/about#about-submission",{"text":225,"url":226,"target":27,"ariaLabel":28},"Open access statement","https://www.frontiersin.org/journals/genetics/about#about-open",{"text":228,"url":229,"target":27,"ariaLabel":28},"Copyright statement","https://www.frontiersin.org/journals/genetics/about#copyright-statement",{"text":231,"url":232,"target":27,"ariaLabel":28},"Quality","https://www.frontiersin.org/journals/genetics/about#about-quality",{"title":234,"links":235},"For authors",[236,239,242,245,248,251,254],{"text":237,"url":238,"target":27,"ariaLabel":28},"Why submit?","https://www.frontiersin.org/journals/genetics/for-authors/why-submit",{"text":240,"url":241,"target":27,"ariaLabel":28},"Article types","https://www.frontiersin.org/journals/genetics/for-authors/article-types",{"text":243,"url":244,"target":27,"ariaLabel":28},"Author guidelines","https://www.frontiersin.org/journals/genetics/for-authors/author-guidelines",{"text":246,"url":247,"target":27,"ariaLabel":28},"Editor guidelines","https://www.frontiersin.org/journals/genetics/for-authors/editor-guidelines",{"text":249,"url":250,"target":27,"ariaLabel":28},"Publishing fees","https://www.frontiersin.org/journals/genetics/for-authors/publishing-fees",{"text":252,"url":253,"target":27,"ariaLabel":28},"Submission checklist","https://www.frontiersin.org/journals/genetics/for-authors/submission-checklist",{"text":255,"url":256,"target":27,"ariaLabel":28},"Contact editorial office","https://www.frontiersin.org/journals/genetics/for-authors/contact-editorial-office",[258,261],{"text":259,"url":260,"target":27,"ariaLabel":28},"All journals","https://www.frontiersin.org/journals",{"text":262,"url":263,"target":27,"ariaLabel":28},"All articles","https://www.frontiersin.org/articles",[265,268,270],{"text":266,"url":267,"target":27,"ariaLabel":28},"Articles","articles",{"text":63,"url":269,"target":27,"ariaLabel":28},"research-topics",{"text":271,"url":272,"target":27,"ariaLabel":28},"Editorial board","editors",{"text":274,"url":275,"target":77,"ariaLabel":274},"Help center","https://helpcenter.frontiersin.org",{"blocks":277,"socialLinks":331,"copyright":355,"termsAndConditionsUrl":356,"privacyPolicyUrl":357},[278,292,302,316],{"title":279,"links":280},"Guidelines",[281,283,286,289,291],{"text":243,"url":282,"target":27,"ariaLabel":28},"https://www.frontiersin.org/guidelines/author-guidelines",{"text":284,"url":285,"target":27,"ariaLabel":28},"Services for authors","https://www.frontiersin.org/for-authors/author-services",{"text":287,"url":288,"target":27,"ariaLabel":28},"Policies and publication ethics","https://www.frontiersin.org/guidelines/policies-and-publication-ethics",{"text":246,"url":290,"target":27,"ariaLabel":28},"https://www.frontiersin.org/guidelines/editor-guidelines",{"text":69,"url":70,"target":27,"ariaLabel":28},{"title":293,"links":294},"Explore",[295,296,299,301],{"text":266,"url":263,"target":27,"ariaLabel":28},{"text":297,"url":298,"target":27,"ariaLabel":28},"Research Topics ","https://www.frontiersin.org/research-topics",{"text":300,"url":260,"target":27,"ariaLabel":28},"Journals",{"text":51,"url":52,"target":27,"ariaLabel":28},{"title":303,"links":304},"Outreach",[305,308,311,315],{"text":306,"url":92,"target":77,"ariaLabel":307},"Frontiers Forum ","Frontiers Forum website",{"text":309,"url":310,"target":77,"ariaLabel":28},"Frontiers Policy Labs ","https://policylabs.frontiersin.org/",{"text":312,"url":313,"target":77,"ariaLabel":314},"Frontiers for Young Minds","https://kids.frontiersin.org/","Frontiers for Young Minds journal",{"text":95,"url":96,"target":27,"ariaLabel":28},{"title":317,"links":318},"Connect",[319,320,324,327,330],{"text":274,"url":275,"target":77,"ariaLabel":274},{"text":321,"url":322,"target":77,"ariaLabel":323},"Emails and alerts ","https://subscription-management.frontiersin.org/emails/preferences#block0","Subscribe to Frontiers emails",{"text":325,"url":111,"target":27,"ariaLabel":326},"Contact us ","Subscribe to newsletter",{"text":328,"url":329,"target":27,"ariaLabel":28},"Submit","https://www.frontiersin.org/submission/submit",{"text":106,"url":107,"target":77,"ariaLabel":28},[332,340,345,350],{"link":333,"type":336,"color":337,"icon":338,"size":339,"hiddenText":13},{"text":334,"url":335,"target":77,"ariaLabel":334},"Frontiers Facebook","https://www.facebook.com/Frontiersin","Link","Grey","Facebook","Medium",{"link":341,"type":336,"color":337,"icon":344,"size":339,"hiddenText":13},{"text":342,"url":343,"target":77,"ariaLabel":28},"Frontiers Twitter","https://twitter.com/frontiersin","Twitter",{"link":346,"type":336,"color":337,"icon":349,"size":339,"hiddenText":13},{"text":347,"url":348,"target":77,"ariaLabel":28},"Frontiers LinkedIn","https://www.linkedin.com/company/frontiers","LinkedIn",{"link":351,"type":336,"color":337,"icon":354,"size":339,"hiddenText":13},{"text":352,"url":353,"target":77,"ariaLabel":28},"Frontiers Instagram","https://www.instagram.com/frontiersin_","Instagram","Frontiers Media SA. All rights reserved.","https://www.frontiersin.org/legal/terms-and-conditions","https://www.frontiersin.org/legal/privacy-policy",{},false,{"__typename":361,"identifier":115,"name":116,"slug":117,"banner":362,"description":407,"mission":408,"palette":409,"impactFactor":410,"citeScore":411,"citations":412,"showTagline":28,"twitter":413},"Journal",[363],{"id":364,"src":365,"name":366,"type":367,"width":368,"height":369,"idHash":370,"archive":371,"brandId":372,"limited":371,"fileSize":373,"isPublic":374,"original":375,"copyright":19,"extension":376,"thumbnails":378,"dateCreated":386,"description":19,"orientation":387,"userCreated":388,"watermarked":371,"dateModified":386,"datePublished":389,"ecsArchiveFiles":390,"propertyOptions":391,"property_Channel":396,"property_Sub-Type":398,"property_Asset_Type":400,"activeOriginalFocusPoint":402,"property_Office_Department":405},"12AFEC62-10F2-4A9B-900C8422E4B53D54","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/12AFEC62-10F2-4A9B-900C8422E4B53D54/webimage-A09D2065-D257-435D-987C43E79D7FBDFD.png","FGENE_Main Visual_Purple_Website","image",6016,4016,"3b54103c3aad636f",0,"22C10171-81B3-4DA6-99342F272A32E8BB",10275124,1,"https://brand.frontiersin.org/m/3b54103c3aad636f/original/FGENE_Main-Visual_Purple_Website.jpg",[377],"jpg",{"mini":379,"thul":380,"webimage":365,"Guidelines":381,"WebsiteJpg_XL":382,"WebsiteWebP_L":383,"WebsiteWebP_M":384,"WebsiteWebP_XL":385},"https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/12AFEC62-10F2-4A9B-900C8422E4B53D54/mini-8741E412-02C1-4126-84DDA81B97389D5E.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/12AFEC62-10F2-4A9B-900C8422E4B53D54/thul-D176A038-2FDA-438D-B9A7E98CF3926BBE.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/12AFEC62-10F2-4A9B-900C8422E4B53D54/511D4207-6085-4D24-9E5E56EBCA9EBCD2/Guidelines-FGENE_Main Visual_Purple_Website.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/12AFEC62-10F2-4A9B-900C8422E4B53D54/511D4207-6085-4D24-9E5E56EBCA9EBCD2/WebsiteJpg_XL-FGENE_Main Visual_Purple_Website.jpg","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/12AFEC62-10F2-4A9B-900C8422E4B53D54/511D4207-6085-4D24-9E5E56EBCA9EBCD2/WebsiteWebP_L-FGENE_Main Visual_Purple_Website.webp","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/12AFEC62-10F2-4A9B-900C8422E4B53D54/511D4207-6085-4D24-9E5E56EBCA9EBCD2/WebsiteWebP_M-FGENE_Main Visual_Purple_Website.webp","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/12AFEC62-10F2-4A9B-900C8422E4B53D54/511D4207-6085-4D24-9E5E56EBCA9EBCD2/WebsiteWebP_XL-FGENE_Main Visual_Purple_Website.webp","2022-06-27T09:59:48Z","landscape","Caroline Sutter","2022-06-27T09:27:09Z",[],[392,393,394,395],"414FB2D4-2283-43FD-BE14E534ECA67928","6C18119B-14BD-4951-B437696F4357BD33","7C692885-DB25-4858-B1FB4FF47B241E9B","D88C0047-EC30-4506-A7DF28A4D765E1CF",[397],"frontiersin_org",[399],"Main_Visual",[401],"Photography",{"x":403,"y":404},3008,2008,[406],"Publishing","Explore research from the world's most cited genetics and heredity journal, advancing our understanding of genes from humans to plants and other model organisms.","\u003Cp>Frontiers in Genetics publishes research on genes and genomes relating to all the domains of life, from humans to livestock, and plants to other model organisms.\u003C/p>\n\n\u003Cp>Led by Field Chief Editor Enrico Domenici (Department of Cellular, Computational and Integrated Biology, University of Trento, Italy) Frontiers in Genetics is indexed in PubMed Central (PMC) and Scopus, among others, and explores the full spectrum of genetic and genomic research, encompassing fundamental studies and their clinical applications, while also embracing methodological advancements and exploring their applications and implications. Topics of interest include, but are not limited to:\u003C/p>\n\n\u003Cdiv> &bull; how genes or genomes relate to traits and humanpathophysiology\u003C/div>\n\u003Cdiv> &bull; advances in genomic data technology and analysis\u003C/div>\n\u003Cdiv> &bull; gene flow among species and populations\u003C/div>\n\u003Cdiv> &bull; livestock genome research Interactions between organisms, theirenvironment, and xenobiotics\u003C/div>\n\u003Cdiv> &bull; molecular and cellular genetics\u003C/div>\n\u003Cdiv> &bull; societal implicationsof genetic research.\u003C/div>\n\u003Cbr>\n\u003Cp>Submissions that emphasize advancement in the understanding of the function and variability of the genome, the use of genetic and genomic tools, and the analysis of the genetic underpinnings of biological processes are of particular interest to this journal.\u003Cp>\n\u003Cp>Furthermore, the journal actively welcomes submissions which support and advance the UNs Sustainable Development Goals (SDGs), notably SDG 3: good health and well-being.\u003C/p>\n\u003Cp>Manuscripts that focus solely on clinical outcomes, patient management, or therapeutic interventions without a clear genetic or genomic component are not suitable for publication in this journal. Studies that are purely epidemiological or observational, without a foundation in genetic or genomic mechanisms, are also not within the scope of this journal. Manuscripts consisting solely of bioinformatics, computational analyses of public data which are not accompanied by validation (independent clinical or patient cohort, or biological validation in vitro or in vivo) or are not highly innovative are not suitable for publication in this journal. Please refer to the \u003Ca href=\"https://www.frontiersin.org/guidelines/policies-and-publication-ethics#standards-for-research-methodology:~:text=complaints%20and%20allegations.-,Standards%20for%20research%20methodology,-Experiments\">Frontiers Standards for research methodology policy\u003C/a>, for more information.\u003C/p>\n\u003Cp>Frontiers in Genetics is committed to advancing developments in the field of genetics and genomics by allowing unrestricted access to articles, and communicating scientific knowledge to both researchers and the public, to enable the scientific breakthroughs of the future.\u003C/p>","purple","3.7","5.2","277710","@FrontGenetics",{"id":115,"name":116,"slug":117,"abbreviation":415,"isOnline":13,"isOpenForSubmissions":13,"citeScore":416,"impactFactor":417},"fgene",6.2,2.8,{"displayTitlePillLabels":13,"displayRelatedArticlesBox":13,"showEditors":13,"showReviewers":13,"showLoopImpactLink":13,"enableFigshare":359},{"isPublic":13,"allowCompanyUsers":359,"whiteListEmails":420,"enableAllJournals":13,"whiteListJournals":442},[421,422,423,424,425,426,427,428,429,426,430,431,432,433,434,435,436,437,438,439,440,441],"Y2FybG9zLmxvcmNhQGZyb250aWVyc2luLm9yZw==","ZGFuaWVsLmx1ekBmcm9udGllcnNpbi5vcmc=","bGF1cmEudGVuYUBmcm9udGllcnNpbi5vcmc=","cmFmYWVsLnJpYW5jaG9AZnJvbnRpZXJzaW4ub3Jn","amFtZXMuc21hbGxib25lQGZyb250aWVyc2luLm9yZw==","ZnJhbi5tb3Jlbm9AZnJvbnRpZXJzaW4ub3Jn","c2FtdWVsLmZlcm5hbmRlekBmcm9udGllcnNpbi5vcmc=","YmFyYmFyYS5jYXJjYW5naXVAZnJvbnRpZXJzaW4ub3Jn","aXZhbi5zYW50YW1hcmlhQGZyb250aWVyc2luLm9yZw==","aHVlLnRyYW5AZnJvbnRpZXJzaW4ub3Jn","Z29uY2Fsby52YXJnYXNAZnJvbnRpZXJzaW4ub3Jn","bHVjaWUuc2VubkBmcm9udGllcnNpbi5vcmc=","bG9ybi5mcmFzZXJAZnJvbnRpZXJzaW4ub3Jn","ZWxzYS5jYXJyb25AZnJvbnRpZXJzaW4ub3Jn","bWFhcnRlbi52YW5kaWpja0Bmcm9udGllcnNpbi5vcmc=","YmluZGh1LmtyaXNobmFuQGZyb250aWVyc2luLm9yZw==","bWF0dGhldy5hdHR3YXRlcnNAZnJvbnRpZXJzaW4ub3Jn","Z2l1bGlhLnZhbHNlY2NoaUBmcm9udGllcnNpbi5vcmc=","ZmFiaWFuLmRlbGxhbW9ydGVAZnJvbnRpZXJzaW4ub3Jn","dmlqYXlhbi5wcEBwaXRzb2x1dGlvbnMuY29t","Z3VpbGxhdW1lLnNldXJhdEBmcm9udGllcnNpbi5vcmc=",[443,444,445,446,447,448,374,449,450,451,452,453,454,455,456,457,458,459,460,461,462,463,464,465,466,467,468,469,470,471,472,473,474,475,476,477,478],2232,1729,2357,2456,2176,2333,1843,602,106,616,310,657,3123,1468,2137,628,1566,2726,2086,1490,451,141,1335,2655,1238,604,698,1547,176,1440,403,1239,755,2136,609,1534,{"spaceId":374,"name":374,"availableJournalPages":480,"announcement":484},[267,272,269,481,482,483],"volumes","about","community-reviewers",{"__typename":485,"sys":486,"preHeader":42,"title":488,"description":489,"image":490,"link":512},"Announcement",{"id":487},"5ITtnTtQgAzPPGH6rX0AlM","Articles published with Frontiers have received 12 million total citations","Your research is the real superpower - learn how we maximise its impact through our leading community journals",[491],{"archive":371,"brandId":372,"copyright":28,"dateCreated":492,"dateModified":493,"datePublished":494,"description":28,"extension":495,"fileSize":497,"height":498,"id":499,"isPublic":371,"limited":371,"name":500,"orientation":387,"original":28,"thumbnails":501,"type":367,"watermarked":371,"width":508,"videoPreviewURLs":509,"tags":510,"textMetaproperties":511,"src":502},"2025-06-18T12:58:01Z","2025-06-18T14:15:34Z","2025-06-18T12:57:32Z",[496],"png",1365026,920,"7C5269C4-3C83-4591-951A74D15B95DAEA","Impact metrics banner for article pages",{"webimage":502,"thul":503,"mini":504,"WebsiteWebP_L":505,"WebsiteWebP_M":506,"Guidelines":507},"https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/thul-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/mini-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/WebsiteWebP_L/Impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/WebsiteWebP_M/Impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/Guidelines/Impact-metrics-banner-for-article-pages.png",1600,[],[],[],{"text":513,"url":43,"target":27,"ariaLabel":28},"Explore our impact metrics",{"loggedUserInfo":-1},{"currentArticle":516,"isPreviewPage":359,"hasSupplementalData":359,"showCrossmarkWidget":13,"articleTemplate":676,"currentArticlePageMetaInfo":677,"xmlParsedArticleContent":-1,"xmlParsingError":-1},{"id":517,"doi":518,"title":519,"acceptanceDate":520,"receptionDate":521,"publicationDate":522,"lastModifiedDate":523,"isPublished":13,"abstract":524,"researchTopic":525,"articleType":531,"stage":534,"keywords":536,"authors":542,"editors":600,"reviewers":611,"journal":631,"section":638,"impactMetrics":640,"volume":644,"articleVolume":645,"relatedArticles":646,"isPublishedV2":359,"contents":647,"files":650},1126836,"10.3389/fgene.2023.1126836","Prevalence estimation of ATTRv in China based on genetic databases",["Date","2023-04-04T07:27:14.000Z"],["Date","2022-12-18T14:30:24.000Z"],["Date","2023-04-13T00:00:00.000Z"],["Date","2025-11-25T03:26:42.799Z"],"Introduction: Amyloid transthyretin (ATTR) is divided into either hereditary (ATTRv) or sporadic (ATTRwt) and ATTRv is a rare hereditary disease transmitted as an autosomal dominant manner. Its global prevalence is traditionally estimated as 5,000 to 10,000 persons. However, it may be underestimated and the exact prevalence of ATTRv in China mainland remains unknown.\nMethods: The Genome Aggregation database (gnomAD) database (containing 125,748 exomes) and two genomic sequencing databases  China Metabolic Analytics Project (ChinaMAP) (containing 10588 individuals) and Amcarelab gene database (containing 45392 exomes), were integrated to estimate the prevalence of ATTRv in the world and mainland Chinese populations. Pathogenic variants allele frequency and the prevalence of ATTRv was calculated.\nResults: Six variants, counting 470 alleles, were defined as pathogenic variants in gnomAD. The prevalence of ATTRv in the world population was 57.4/100,000. Two variants (2 allele counts) and 15 variants (34 individuals) were defined as pathogenic variants in the ChinaMAP database and the Amcarelab exome database, respectively. Thus, the estimated prevalence interval of ATTRv in mainland China was 18.9/100,000-74,9/100,000. \nConclusion: The present study demonstrated that the previous prevalence was greatly underestimated using traditional methods. Therefore, raising awareness of the disease is essential for recognizing ATTRv in its early stage.",{"id":526,"title":527,"articlesCount":528,"isMagazinePage":13,"slug":529,"isOpenForSubmission":359,"views":530},35037,"Insights in Neurogenomics: 2022",5,"insights-in-neurogenomics-2022",21948,{"id":532,"name":533},24,"Original Research",{"id":535,"name":19},18,[537,538,539,540,541],"Amyloid transthyretin (ATTR)","ChinaMap","GnomAD","Prevalence","genetic database",[543,552,558,564,571,578,585,593],{"id":544,"firstName":545,"middleName":19,"lastName":546,"givenNames":547,"isCorresponding":359,"isProfilePublic":13,"userId":544,"email":-1,"affiliations":548},1543548,"Zheng","Yongsheng","Zheng ",[549],{"organizationName":550,"countryName":551,"cityName":19,"stateName":19,"zipCode":19},"Department of Neurology","China",{"id":371,"firstName":553,"middleName":19,"lastName":554,"givenNames":555,"isCorresponding":359,"isProfilePublic":359,"userId":371,"email":-1,"affiliations":556},"Sun","Chong","Sun ",[557],{"organizationName":550,"countryName":551,"cityName":19,"stateName":19,"zipCode":19},{"id":371,"firstName":559,"middleName":19,"lastName":560,"givenNames":561,"isCorresponding":359,"isProfilePublic":359,"userId":371,"email":-1,"affiliations":562},"Liu","Bingyou","Liu ",[563],{"organizationName":550,"countryName":551,"cityName":19,"stateName":19,"zipCode":19},{"id":565,"firstName":566,"middleName":19,"lastName":567,"givenNames":568,"isCorresponding":359,"isProfilePublic":13,"userId":565,"email":-1,"affiliations":569},2145086,"Hu","Jianian","Hu ",[570],{"organizationName":550,"countryName":551,"cityName":19,"stateName":19,"zipCode":19},{"id":572,"firstName":573,"middleName":19,"lastName":574,"givenNames":575,"isCorresponding":359,"isProfilePublic":13,"userId":572,"email":-1,"affiliations":576},2144719,"Chen","Haofeng","Chen ",[577],{"organizationName":550,"countryName":551,"cityName":19,"stateName":19,"zipCode":19},{"id":579,"firstName":580,"middleName":19,"lastName":581,"givenNames":582,"isCorresponding":359,"isProfilePublic":13,"userId":579,"email":-1,"affiliations":583},877927,"Zhao","Chongbo","Zhao ",[584],{"organizationName":550,"countryName":551,"cityName":19,"stateName":19,"zipCode":19},{"id":586,"firstName":587,"middleName":19,"lastName":588,"givenNames":589,"isCorresponding":359,"isProfilePublic":13,"userId":586,"email":-1,"affiliations":590},960611,"Victor Wei","Zhang","Victor Wei ",[591],{"organizationName":592,"countryName":551,"cityName":19,"stateName":19,"zipCode":19},"Amcarelab Genetic Commercial Company",{"id":594,"firstName":595,"middleName":19,"lastName":596,"givenNames":597,"isCorresponding":359,"isProfilePublic":13,"userId":594,"email":-1,"affiliations":598},1413978,"Lin","Jie","Lin ",[599],{"organizationName":550,"countryName":551,"cityName":19,"stateName":19,"zipCode":19},[601],{"id":602,"firstName":603,"middleName":604,"lastName":605,"givenNames":606,"isCorresponding":359,"isProfilePublic":13,"userId":602,"email":-1,"affiliations":607},437033,"Sarah","H","Elsea","Sarah  H",[608],{"organizationName":609,"countryName":610,"cityName":19,"stateName":19,"zipCode":19},"Baylor College of Medicine","United States",[612,622],{"id":613,"firstName":614,"middleName":615,"lastName":616,"givenNames":617,"isCorresponding":359,"isProfilePublic":13,"userId":613,"email":-1,"affiliations":618},734185,"Michel","Satya","Naslavsky","Michel  Satya",[619],{"organizationName":620,"countryName":621,"cityName":19,"stateName":19,"zipCode":19},"University of So Paulo","Brazil",{"id":623,"firstName":624,"middleName":19,"lastName":625,"givenNames":626,"isCorresponding":359,"isProfilePublic":13,"userId":623,"email":-1,"affiliations":627},949480,"Dario","Ronchi","Dario ",[628],{"organizationName":629,"countryName":630,"cityName":19,"stateName":19,"zipCode":19},"University of Milan","Italy",{"id":115,"slug":117,"name":116,"shortName":632,"electronicISSN":633,"field":634,"specialtyId":28,"journalSectionPaths":636},"Front. Genet.","1664-8021",{"id":635,"domainId":374},30,[637],{"section":638},{"id":180,"name":181,"slug":182,"specialtyId":639},750,{"views":641,"downloads":642,"citations":643},3815,1421,7,14,"Volume 14 - 2023",[],{"titleHtml":519,"fullTextHtml":648,"menuHtml":649},"\u003Cdiv class=\"JournalAbstract\">\u003Ca id=\"h1\" name=\"h1\">\u003C/a>\u003Cdiv class=\"authors\">\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/1543548\" class=\"user-id-1543548\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/1543548/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Zheng Yongsheng\">Zheng Yongsheng\u003C/a>\u003Csup>1\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Sun Chong\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Sun Chong\u003Csup>1\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Liu Bingyou\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Liu Bingyou\u003Csup>1\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/2145086\" class=\"user-id-2145086\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/2145086/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Hu Jianian\">Hu Jianian\u003C/a>\u003Csup>1\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/2144719\" class=\"user-id-2144719\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/2144719/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Chen Haofeng\">Chen Haofeng\u003C/a>\u003Csup>1\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/877927\" class=\"user-id-877927\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/877927/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Zhao Chongbo\">Zhao Chongbo\u003C/a>\u003Csup>1\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/960611\" class=\"user-id-960611\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/960611/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Victor Wei Zhang\">Victor Wei Zhang\u003C/a>\u003Csup>2\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/1413978\" class=\"user-id-1413978\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/1413978/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Lin Jie&#xa;\">Lin Jie\u003C/a>\u003Csup>1\u003C/sup>&#x0002a;\u003C/span>\u003C/div>\u003Cul class=\"notes\">\u003Cli>\u003Cspan>\u003Csup>1\u003C/sup>\u003C/span>Department of Neurology, Huashan Hospital Fudan University, Shanghai, China\u003C/li>\u003Cli>\u003Cspan>\u003Csup>2\u003C/sup>\u003C/span>Amcarelab Genetic Commercial Company, Guangzhou, China\u003C/li>\u003C/ul>\u003Cp class=\"mb15\">\u003Cb>Introduction:\u003C/b> Amyloid transthyretin (ATTR) is divided into either hereditary (ATTRv) or sporadic (ATTRwt) and ATTRv is a rare hereditary disease transmitted as an autosomal dominant manner. Its global prevalence is traditionally estimated as 5,000 to 10,000 persons. However, it may be underestimated and the exact prevalence of ATTRv in China mainland remains unknown.\u003C/p>\u003Cp class=\"mb15\">\u003Cb>Methods:\u003C/b> The Genome Aggregation database (gnomAD) database (containing 125,748 exomes) and two genomic sequencing databases&#x02014;&#x02014;China Metabolic Analytics Project (ChinaMAP) (containing 10588 individuals) and Amcarelab gene database (containing 45392 exomes), were integrated to estimate the prevalence of ATTRv in the world and mainland Chinese populations. Pathogenic variants allele frequency and the prevalence of ATTRv was calculated.\u003C/p>\u003Cp class=\"mb15\">\u003Cb>Results:\u003C/b> Six variants, counting 470 alleles, were defined as pathogenic variants in gnomAD. The prevalence of ATTRv in the world population was 57.4/100,000. Two variants (2 allele counts) and 15 variants (34 individuals) were defined as pathogenic variants in the ChinaMAP database and the Amcarelab exome database, respectively. Thus, the estimated prevalence interval of ATTRv in mainland China was 18.9/100,000-74,9/100,000.\u003C/p>\u003Cp class=\"mb15\">\u003Cb>Conclusion:\u003C/b> The present study demonstrated that the previous prevalence was greatly underestimated using traditional methods. Therefore, raising awareness of the disease is essential for recognizing ATTRv in its early stage.\u003C/p>\u003Cdiv class=\"clear\">\u003C/div>\u003C/div>\u003Cdiv class=\"JournalFullText\">\u003Ca id=\"h2\" name=\"h2\">\u003C/a>\u003Ch2>Introduction\u003C/h2>\u003Cp class=\"mb15\">Amyloid transthyretin (ATTR) amyloidosis is characterized by pathologic accumulation of extracellular protein arising from unstable transthyretin (TTR) tetramers, which dissociate into monomers that misfold, aggregate, and form insoluble fibrils that are resistant to proteolysis (\u003Ca href=\"#B13\">Finsterer et al., 2019\u003C/a>). TTR misfolding can lead to two distinct forms of amyloidosis: hereditary (ATTRv) and wild-type (ATTRwt) (\u003Ca href=\"#B31\">Yamamoto and Yokochi, 2019\u003C/a>). ATTRv is a rare hereditary disease transmitted as an autosomal dominant manner (\u003Ca href=\"#B4\">Adams et al., 2016\u003C/a>; \u003Ca href=\"#B2\">Adams et al., 2021a\u003C/a>). It is caused by mutations in the transthyretin gene located on chromosome 18 (18q12.1). There is considerable heterogeneity in the clinical presentation of ATTRv, ranging from primarily cardiac, primarily neuropathic, or other progressive multisystem disorders (\u003Ca href=\"#B24\">Rapezzi et al., 2010\u003C/a>). ATTRv usually proves fatal within 7&#x02013;12 years from the onset of symptoms, causing a heavy economic burden for families and society (\u003Ca href=\"#B29\">Takeshima et al., 2019\u003C/a>; \u003Ca href=\"#B14\">Galan et al., 2021\u003C/a>).\u003C/p>\u003Cp class=\"mb15\">ATTRv is an underdiagnosed disease and the true incidence and prevalence are currently unknown (\u003Ca href=\"#B23\">Obi et al., 2022\u003C/a>). Its global prevalence is traditionally and somewhat anecdotally estimated as 5,000 to 10,000 persons but only several countries in Europe and Japan have relatively exact prevalence (\u003Ca href=\"#B28\">Sousa et al., 1995\u003C/a>; \u003Ca href=\"#B18\">Kato-Motozaki et al., 2008\u003C/a>; \u003Ca href=\"#B12\">Dardiotis et al., 2009\u003C/a>; \u003Ca href=\"#B17\">Ines et al., 2018\u003C/a>; \u003Ca href=\"#B21\">Lauppe et al., 2021\u003C/a>). In epidemic regions such as Portugal, Sweden, and Japan, the prevalence varies from 10/100,000 to 100/100,000 people. Recently, the prevalence of transthyretin familial amyloid polyneuropathy (ATTR-FAP) in China was estimated to be approximately 2000 (range 435&#x02013;10,134) [1,347.7 million persons in total] (\u003Ca href=\"#B27\">Schmidt et al., 2018\u003C/a>). However, the prevalence estimation and information supporting prevalence calculations were extracted from records yielded by reference-databases searches, conference proceedings and published cases or case series, which certainly had it underestimated.\u003C/p>\u003Cp class=\"mb15\">Previous prevalence estimation was given using traditional methods, namely, case reports, epidemiological surveys and patient registries (\u003Ca href=\"#B16\">Ikeda et al., 2002\u003C/a>; \u003Ca href=\"#B17\">Ines et al., 2018\u003C/a>). These traditional methods are prone to underestimations due to diagnostic bias and small sample size. In recent years, population-based genomic sequencing projects provided a new genetic perspective on the estimation of disease-related prevalences (\u003Ca href=\"#B19\">Lahuerta Pueyo et al., 2019\u003C/a>). To date, several studies have employed publicly available large-population databases to infer pathogenicity, penetrance or prevalence of rare diseases (\u003Ca href=\"#B26\">Rutten et al., 2016\u003C/a>; \u003Ca href=\"#B19\">Lahuerta Pueyo et al., 2019\u003C/a>; \u003Ca href=\"#B22\">Liu et al., 2019\u003C/a>). Herein, we utilized an integrated world population and Chinese population genomic sequencing databases to reevaluate the ATTRv prevalence in the mainland Chinese population.\u003C/p>\u003Ca id=\"h3\" name=\"h3\">\u003C/a>\u003Ch2>Materials and methods\u003C/h2>\u003Ch3 class=\"pt0\">The Genome Aggregation database\u003C/h3>\u003Cp class=\"mb0\">GnomAD contained 125,748 exomes from unrelated individuals and from different populations, sequenced as part of various disease-specific and population genetic studies. All \u003Cem>TTR\u003C/em> (canonical transcript ENST00000237014) variants were selected from the gnomAD version 2.1.1 (\u003Ca href=\"http://gnomad.broadinstitute.org/\">http://gnomad.broadinstitute.org/\u003C/a>). The analysis of the gnomAD data was carried out from June 2022 to August 2022. In terms of populations, all variants analyzed were classified according to the diverse ethnicities defined in the gnomAD database. The population classifications were as follows: non-Finnish European, African/African American, Latino, Finnish, Ashkenazi Jewish, East Asian, South Asian and other. Population in mainland China was not included in the gnomAD.\u003C/p>\u003Ch3 class=\"pt0\">The China metabolic analytics project database\u003C/h3>\u003Cp class=\"mb0\">The ChinaMAP was based on cohort studies across diverse regions and ethnic groups in China. ChinaMAP (beta version, 2020-03) provided allele frequencies data of variants identified in the Chinese population (\u003Cem>n\u003C/em> &#x0003d; 10588). It randomly selected participants from 8 ethnic groups (Han, Hui, Manchu, Miao, Mongolian, Yi, Tibetan and Zhuang) across 27 provinces of China without biased selection or filtration (\u003Ca href=\"#B8\">Cao et al., 2020\u003C/a>). Therefore, the ChinaMAP database may be considered as a genetic database for the general Chinese population. All \u003Cem>TTR\u003C/em> (transcript NM_000371.3) variants were extracted from \u003Ca href=\"http://www.mBiobank.com\">www.mBiobank.com\u003C/a> on August 2022.\u003C/p>\u003Ch3 class=\"pt0\">The Amcarelab gene database\u003C/h3>\u003Cp class=\"mb0\">The Amcarelab gene database was provided by the Amcarelab genetic commercial company. It is composed of 45392 individuals who were suspected to have gene related disorders by medical practitioners from different clinical specialties. Therefore, this database included a subpopulation with negative results from genetic testing as well as patients with definite genetic disorders. All \u003Cem>TTR\u003C/em> (transcript NM_000371.4) variants were extracted on June 2022.\u003C/p>\u003Ch3 class=\"pt0\">Data analysis and variant annotation\u003C/h3>\u003Cp class=\"mb0\">The present study is focused on missense mutations, genetic variations that result in the substitution of one amino acid with another. The disease-associated variants analyzed in this study specifically affect protein folding, which leads to the accumulation of misfolded proteins, rather than the truncation of protein function. For this reason, the study excluded splicing variants, stop codons, and frameshift changes, as these variants may lead to the production of truncated or non-functional proteins. Additionally, intronic variants, variants in non-coding regions, and synonymous variants were not considered in the study. Following the recommendations of American College of Medical Genetics and Genomics (ACMG), the variants were divided into the following categories: pathogenic, likely pathogenic, uncertain significance, likely benign, benign. In present study, pathogenic and likely pathogenic variants were further defined as disease-causing variant. The calculation of the prevalence of disease-causing variants is our main goal.\u003C/p>\u003Ca id=\"h4\" name=\"h4\">\u003C/a>\u003Ch2>Results\u003C/h2>\u003Ch3 class=\"pt0\">Allele frequency of pathogenic variants in gnomAD\u003C/h3>\u003Cp class=\"mb0\">About 66 missense variants were found in the \u003Cem>TTR\u003C/em> gene, with an average of 125,780 exomes studied. According to our definition, six disease-causing variants (including 470 alleles count) were identified and their minor allelic frequency (MAF) was described in \u003Ca href=\"#T1\">Table 1\u003C/a>. There were 3 homozygotes identified. The disease-causing amyloidogenic variants MAF was 0.00186 and so the overall prevalence was 371.3/100,000. This is about 4-fold&#x02013;40-fold higher than what would be expected based on the current epidemic regions prevalence estimation of 10/100,000 (actually from 10/100,000 to 100/100,000) (\u003Ca href=\"#B16\">Ikeda et al., 2002\u003C/a>; \u003Ca href=\"#B18\">Kato-Motozaki et al., 2008\u003C/a>). This huge prevalence gap between the estimation based on gene databases and traditional methods led us to conduct a further investigation. At first, we analyzed the relationship between population ethnicities and variants. Interestingly, we found a strong relation between the African population and the variant c.424G&#x0003e;A (p. (Val142Ile)) (\u003Ca href=\"#F1\">Figure 1\u003C/a>). Among the amyloidogenic \u003Cem>TTR\u003C/em> pathogenic variants, the point change c.424G&#x0003e;A is unusual for its overwhelmingly predominant occurrence in individuals of documented African descent. Previous studies have shown that the c.424G&#x0003e;A variant was reported in the European population with an allele frequency of 0.00004, while in the African population it was reported with an allele frequency of 0.016 (\u003Ca href=\"#B19\">Lahuerta Pueyo et al., 2019\u003C/a>). According to more recent data, the worldwide prevalence of this variant ranges from 0.3% to 1.6% in the general population. However, studies have reported higher prevalence rates of the c.424G&#x0003e;A variant among people of African descent, ranging from 1.1% to 9.8%. It is important to note that the prevalence of the c.424G&#x0003e;A variant in a specific region is highly dependent on the percentage of people with African ancestry residing in that region (\u003Ca href=\"#B9\">Chandrashekar et al., 2021\u003C/a>). For its predominance in African/African-American, we further classified pathogenic missense variants found in gnomAD into two groups: African/African-American population and non-African. Then, the allele counts of the African/African-American population group based on gnomAD was 402 in 12487 exomes, and the allele frequency was 0.016, which was consistent with the prevalence previously reported. At last, the allele counts of the non-African group was 65 in 113261 exomes and the allele frequency was 0.0000287 (prevalence: 57.4/100,000).\u003C/p>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cdiv class=\"Imageheaders\">TABLE 1\u003C/div>\u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t001.jpg\" name=\"Table1\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t001.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t001.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t001.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t001.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t001.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t001.jpg\" alt=\"www.frontiersin.org\" id=\"T1\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\u003Cp>\u003Cb>TABLE 1\u003C/b>. Variants in the \u003Cem>TTR\u003C/em> gene classified as disease-causing variants from the gnomAD database global population.\u003C/p>\u003C/div>\u003Cdiv class=\"clear\">\u003C/div>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cdiv class=\"Imageheaders\">FIGURE 1\u003C/div>\u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-g001.jpg\" name=\"Figure1\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-g001.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-g001.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-g001.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-g001.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-g001.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-g001.jpg\" alt=\"www.frontiersin.org\" id=\"F1\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\u003Cp>\u003Cb>FIGURE 1\u003C/b>. Population and pathogenic variant correlation in gnomAD Abbreviations: The ethical information was achieved from gnomAD database. The line connecting represent the pathogenic variant present in the ethnic population. The thicker the line, the higher the proportion of the corresponding variant in that ethnic population.\u003C/p>\u003C/div>\u003Cdiv class=\"clear\">\u003C/div>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Ch3 class=\"pt0\">Prevalence estimation based on the ChinaMAP database\u003C/h3>\u003Cp class=\"mb0\">Analysis of the 10588 Chinese individuals identified 32 \u003Cem>TTR\u003C/em> missense mutation variants (\u003Ca href=\"#SM1\">Supplementary Material S1\u003C/a>). Importantly, 2 variants (allele counts: 2), c.148 &#x0003e; A (p.Val50Met) and c.424G&#x0003e;A (p.Val142Ile) were classified as disease-causing variants according to this study. The allele frequency of disease-causing variants in the \u003Cem>TTR\u003C/em> within the Chinese population was estimated to be 0.0000944 (prevalence: 18.9/100,000).\u003C/p>\u003Ch3 class=\"pt0\">Prevalence estimation based on the Amcarelab exome database\u003C/h3>\u003Cp class=\"mb0\">Excluding synonymous, non-sense, splice variants, intron variants and variants in non-coding regions, analysis of the 45392 exomes identified 107 missense \u003Cem>TTR\u003C/em> variants \u003Cb>(\u003C/b>\u003Ca href=\"#SM1\">Supplementary Material S2\u003C/a>\u003Cb>)\u003C/b> and 15 variants were pathogenic and likely pathogenic (34 individuals) (\u003Ca href=\"#T2\">Table 2\u003C/a>). Thus, the prevalence of disease-causing variants in Chinese population was estimated to be 34 in 45392, namely 74.9/100,000. Herein, the estimated prevalence interval of ATTRv in mainland China was 18.9&#x0223c;74.9/100,000, based on the public exome, ChinaMAP, and the commercial exome databases.\u003C/p>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cdiv class=\"Imageheaders\">TABLE 2\u003C/div>\u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t002.jpg\" name=\"Table2\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t002.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t002.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t002.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t002.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t002.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t002.jpg\" alt=\"www.frontiersin.org\" id=\"T2\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\u003Cp>\u003Cb>TABLE 2\u003C/b>. Variants in the \u003Cem>TTR\u003C/em> gene classified as pathogenic variants from the Amcarelab database.\u003C/p>\u003C/div>\u003Cdiv class=\"clear\">\u003C/div>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Ch3 class=\"pt0\">Prevalence estimation in the previous reported studies and in present study\u003C/h3>\u003Cp class=\"mb0\">\u003Ca href=\"#T3\">Table 3\u003C/a> showed the prevalence of ATTRv in previous reports. In epidemic regions such as Portugal, Japan, and Sweden, the prevalence ranges from 1.1/100,000 to 151/100,000 according to different estimation methods. In non-epidemic regions, the prevalence various from 0.433/100,000 to 3.72/100,000. Specially, ATTRv prevalence in Saudi was estimated to 21.5/100,000 using genome sequencing database.\u003C/p>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cdiv class=\"Imageheaders\">TABLE 3\u003C/div>\u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t003.jpg\" name=\"Table3\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t003.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t003.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t003.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t003.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t003.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-t003.jpg\" alt=\"www.frontiersin.org\" id=\"T3\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\u003Cp>\u003Cb>TABLE 3\u003C/b>. Previous ATTRv prevalence estimations.\u003C/p>\u003C/div>\u003Cdiv class=\"clear\">\u003C/div>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Ca id=\"h5\" name=\"h5\">\u003C/a>\u003Ch2>Discussion\u003C/h2>\u003Cp class=\"mb15\">This is the first study to identify and investigate the prevalence of disease-causing \u003Cem>TTR\u003C/em> variants in the Chinese mainland population. The estimated prevalence interval of ATTRv was 18.9&#x02013;74.9/100,000 based on the public exome ChinaMAP and commercial exome databases. The lower limit of the prevalence interval was as high as or near 20-fold higher than that in Japan (prevalence: 1/100,000) concluded by traditional epidemiological methods (\u003Ca href=\"#B18\">Kato-Motozaki et al., 2008\u003C/a>). Our results suggested that ATTRv in the Chinese was observed much more prevalent than previously recognized.\u003C/p>\u003Cp class=\"mb15\">To determine whether the prevalence in China is high, we estimated the prevalence of different populations and various cohorts using gnomAD data. The gnomAD database consisted of eight ethnic groups but not all populations were equally represented, with the European population being the most represented and the Asian and Latino the least represented (\u003Ca href=\"#B10\">Collins et al., 2020\u003C/a>). Noteworthy, these databases did not contain the Chinese population. Comparisons to other population may aid in determine the prevalence gap of a number of disorders that exist between the Chinese and world populations. Not surprisingly, the ATTRv prevalence was 57.4 per 100,000 persons estimated by the genomic sequencing projects approach. It was equal to or even higher than that in epidemic regions such as Portugal, Sweden, and Japan, whose prevalence were calculated by case reports, epidemiological surveys and patient registries. A recent study using a national population-based exome sequence database reported the prevalence of 21.5 per 100,000 persons in Saudi (\u003Ca href=\"#B1\">Abouelhoda et al., 2021\u003C/a>), an Asian country that was not reported as an ATTRv epidemic region. This further supported that the true prevalence of ATTRv was much higher than that reported in previous studies.\u003C/p>\u003Cp class=\"mb15\">There are four plausible explanations for the unexpected high prevalence: 1) the pathogenic variants in the ChinaMAP and Amcarelab databases differ from those found in ATTRv in reality and variants were not pathogenic but were polymorphisms, 2) all of the individuals with a \u003Cem>TTR\u003C/em> pathogenic variant in the ChinaMAP and Amcarelab databases have an undiagnosed or unreported classical \u003Cem>TTR\u003C/em> variant; 3) a late onset, mild \u003Cem>TTR\u003C/em> phenotype which was less readily diagnosed, may be much more prevalent than recognized to date. However, it is highly unlikely that any of the 15 disease-causing amyloidogenic \u003Cem>TTR\u003C/em> variants found in ChinaMAP and Amcarelab databases were polymorphisms as most the 15 pathogenic variants have been previously reported in \u003Cem>TTR\u003C/em> pedigrees. Taking the results from the gnomAD and Saudi databases into consideration, low prevalence estimation from previous traditional methods may be from penetrance \u003Cem>TTR\u003C/em> variability, misdiagnosis or missed diagnosis, delayed diagnosis and/or for other reasons (\u003Ca href=\"#B24\">Rapezzi et al., 2010\u003C/a>).\u003C/p>\u003Cp class=\"mb15\">A high prevalence highlights the importance of diagnosing ATTRv clinically at an early stage. Recent years have seen the description of a series of novel and effective therapies for ATTRv. Tafamidis, patisiran, inotersen as well as the most promising NTLA-2001 have shown great benefits for patients with ATTRv. Specifically, these benefits are better received when ATTRv is diagnosed at an early stage of disease (\u003Ca href=\"#B7\">Benson et al., 2018\u003C/a>; \u003Ca href=\"#B20\">Lamb and Deeks, 2019\u003C/a>; \u003Ca href=\"#B3\">Adams et al., 2021b\u003C/a>; \u003Ca href=\"#B15\">Gillmore et al., 2021\u003C/a>). It challenges and encourage clinical practitioners to raise awareness and have a deeper and broader understanding of ATTRv because early diagnosis of amyloidosis remains an elusive goal that requires education of both physicians and patients (\u003Ca href=\"#B30\">Wechalekar et al., 2016\u003C/a>). Further examinations or even gene sequencing must be performed when there is any suspicion of hereditary amyloidosis with initial signs and symptoms, to enter the screening process for amyloidosis and improve early diagnosis (\u003Ca href=\"#B11\">Conceicao et al., 2019\u003C/a>).\u003C/p>\u003Cp class=\"mb15\">Our study has several limitations. First, in the present study, only &#x0201c;pathogenic&#x0201d; and &#x0201c;likely pathogenic&#x0201d; variants were defined as disease-causing variants. In fact, some variants in the &#x0201c;uncertain significance&#x0201d; group may also be disease-causing. Thus, the prevalence of ATTRv may be even higher. Secondly, penetrance analysis of the \u003Cem>TTR\u003C/em> gene could not be determined. Lastly, the characteristics of the Chinese variants and the relationship between variants and clinical characteristics were not analyzed.\u003C/p>\u003Cp class=\"mb15\">In conclusion, we confirmed the high prevalence of ATTRv in the Chinese mainland population, demonstrating that the previous prevalence was greatly underestimated obtained using traditional methods. Therefore, raising awareness of the disease is essential for recognizing ATTRv in its early stage.\u003C/p>\u003Ca id=\"h6\" name=\"h6\">\u003C/a>\u003Ch2>Data availability statement\u003C/h2>\u003Cp class=\"mb15\">The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.\u003C/p>\u003Ca id=\"h7\" name=\"h7\">\u003C/a>\u003Ch2>Author contributions\u003C/h2>\u003Cp class=\"mb0\">ZY wrote, checked and revised draft manuscripts; ZY, SC, LB, HJ, CH searched data from databases and collected and analyzed data together. LJ and VZ conceptualized the manuscript. LJ and ZC reviewed the draft and revised it.\u003C/p>\u003Ca id=\"h8\" name=\"h8\">\u003C/a>\u003Ch2>Acknowledgments\u003C/h2>\u003Cp class=\"mb03\">We want to express our gratitude to the curators who help maintain the online genetic databases this study included.\u003C/p>\u003Ca id=\"h9\" name=\"h9\">\u003C/a>\u003Ch2>Conflict of interest\u003C/h2>\u003Cp class=\"mb0\">Author VZ was employed by the company Amcarelab Genetic Commercial Company.\u003C/p>\u003Cp class=\"mb0\">The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.\u003C/p>\u003Ca id=\"h10\" name=\"h10\">\u003C/a>\u003Ch2>Publisher&#x02019;s note\u003C/h2>\u003Cp class=\"mb15\">All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.\u003C/p>\u003Ca id=\"h11\" name=\"h11\">\u003C/a>\u003Ch2>Supplementary material\u003C/h2>\u003Cp class=\"mb15\" id=\"SM1\">The Supplementary Material for this article can be found online at: \u003Ca href=\"https://www.frontiersin.org/articles/10.3389/fgene.2023.1126836/full#supplementary-material\">https://www.frontiersin.org/articles/10.3389/fgene.2023.1126836/full&#x00023;supplementary-material\u003C/a>\u003C/p>\u003Ca id=\"h12\" name=\"h12\">\u003C/a>\u003Ch2>Abbreviations\u003C/h2>\u003Cp class=\"mb15\">ACMG, American College of Medical Genetics and Genomics; ATTR, amyloid transthyretin; ATTR-FAP, transthyretin familial amyloid polyneuropathy; ATTRv, hereditary amyloid transthyretin; ATTRwt, wild-type amyloid transthyretin; ChinaMAP, China Metabolic Analytics Project; GnomAD, Genome Aggregation database; HGVS, Human Genome Variation Society; TTR, transthyretin.\u003C/p>\u003Ca id=\"h13\" name=\"h13\">\u003C/a>\u003Ch2>References\u003C/h2>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B1\" id=\"B1\">\u003C/a>Abouelhoda, M., Mohty, D., Alayary, I., Meyer, B. F., Arold, S. T., Fadel, B. M., et al. (2021). Established and candidate transthyretin amyloidosis variants identified in the Saudi population by data mining. \u003Cem>Hum. Genomics\u003C/em> 15, 52. doi:10.1186/s40246-021-00351-2\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/34380564/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1186/s40246-021-00351-2\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Established+and+candidate+transthyretin+amyloidosis+variants+identified+in+the+Saudi+population+by+data+mining&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B2\" id=\"B2\">\u003C/a>Adams, D., Ando, Y., Beirao, J. M., Coelho, T., Gertz, M. A., Gillmore, J. D., et al. (2021). Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy. \u003Cem>J. Neurol.\u003C/em> 268, 2109&#x02013;2122. doi:10.1007/s00415-019-09688-0\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31907599/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1007/s00415-019-09688-0\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Expert+consensus+recommendations+to+improve+diagnosis+of+ATTR+amyloidosis+with+polyneuropathy&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B3\" id=\"B3\">\u003C/a>Adams, D., Polydefkis, M., Gonzalez-Duarte, A., Wixner, J., Kristen, A. V., Schmidt, H. H., et al. (2021). Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study. \u003Cem>Lancet Neurol.\u003C/em> 20, 49&#x02013;59. doi:10.1016/S1474-4422(20)30368-9\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33212063/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/S1474-4422(20)30368-9\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Long-term+safety+and+efficacy+of+patisiran+for+hereditary+transthyretin-mediated+amyloidosis+with+polyneuropathy:+12-month+results+of+an+open-label+extension+study&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B4\" id=\"B4\">\u003C/a>Adams, D., Suhr, O. B., Hund, E., Obici, L., Tournev, I., Campistol, J. M., et al. (2016). First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy. \u003Cem>Curr. Opin. Neurol.\u003C/em> 29 (1), S14&#x02013;S26. doi:10.1097/WCO.0000000000000289\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/26734952/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1097/WCO.0000000000000289\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=First+European+consensus+for+diagnosis,+management,+and+treatment+of+transthyretin+familial+amyloid+polyneuropathy&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B5\" id=\"B5\">\u003C/a>Andersson, R. (1976). Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden. \u003Cem>Acta Med. Scand. Suppl.\u003C/em> 590, 1&#x02013;64.\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/1064291/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Familial+amyloidosis+with+polyneuropathy.+A+clinical+study+based+on+patients+living+in+northern+Sweden&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B6\" id=\"B6\">\u003C/a>Auer-Grumbach, M., Rettl, R., Ablasser, K., Agis, H., Beetz, C., Duca, F., et al. (2020). Hereditary ATTR amyloidosis in Austria: Prevalence and epidemiological hot spots. \u003Cem>J. Clin. Med.\u003C/em> 9, 2234. doi:10.3390/jcm9072234\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32674397/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.3390/jcm9072234\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Hereditary+ATTR+amyloidosis+in+Austria:+Prevalence+and+epidemiological+hot+spots&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B7\" id=\"B7\">\u003C/a>Benson, M. D., Waddington-Cruz, M., Berk, J. L., Polydefkis, M., Dyck, P. J., Wang, A. K., et al. (2018). Inotersen treatment for patients with hereditary transthyretin amyloidosis. \u003Cem>N. Engl. J. Med.\u003C/em> 379, 22&#x02013;31. doi:10.1056/NEJMoa1716793\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29972757/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1056/NEJMoa1716793\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Inotersen+treatment+for+patients+with+hereditary+transthyretin+amyloidosis&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B8\" id=\"B8\">\u003C/a>Cao, Y., Li, L., Xu, M., Feng, Z., Sun, X., Lu, J., et al. (2020). The ChinaMAP analytics of deep whole genome sequences in 10,588 individuals. \u003Cem>Cell Res.\u003C/em> 30, 717&#x02013;731. doi:10.1038/s41422-020-0322-9\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32355288/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1038/s41422-020-0322-9\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+ChinaMAP+analytics+of+deep+whole+genome+sequences+in+10,588+individuals&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B9\" id=\"B9\">\u003C/a>Chandrashekar, P., Alhuneafat, L., Mannello, M., Al-Rashdan, L., Kim, M. M., Dungu, J., et al. (2021). Prevalence and outcomes of p.Val142Ile TTR amyloidosis cardiomyopathy: A systematic review. \u003Cem>Circ. Genom Precis. Med.\u003C/em> 14, e003356. doi:10.1161/CIRCGEN.121.003356\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/34461737/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1161/CIRCGEN.121.003356\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Prevalence+and+outcomes+of+p.Val142Ile+TTR+amyloidosis+cardiomyopathy:+A+systematic+review&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B10\" id=\"B10\">\u003C/a>Collins, R. L., Brand, H., Karczewski, K. J., Zhao, X., Alf&#x000f6;ldi, J., Francioli, L. C., et al. (2020). A structural variation reference for medical and population genetics. \u003Cem>Nature\u003C/em> 581, 444&#x02013;451. doi:10.1038/s41586-020-2287-8\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32461652/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1038/s41586-020-2287-8\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=A+structural+variation+reference+for+medical+and+population+genetics&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B11\" id=\"B11\">\u003C/a>Conceicao, I., Damy, T., Romero, M., Gal&#x000e1;n, L., Attarian, S., Luigetti, M., et al. (2019). Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations. \u003Cem>Amyloid\u003C/em> 26, 3&#x02013;9. doi:10.1080/13506129.2018.1556156\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30793974/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1080/13506129.2018.1556156\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Early+diagnosis+of+ATTR+amyloidosis+through+targeted+follow-up+of+identified+carriers+of+TTR+gene+mutations&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B12\" id=\"B12\">\u003C/a>Dardiotis, E., Koutsou, P., Papanicolaou, E. Z., Vonta, I., Kladi, A., Vassilopoulos, D., et al. (2009). Epidemiological, clinical and genetic study of familial amyloidotic polyneuropathy in Cyprus. \u003Cem>Amyloid\u003C/em> 16, 32&#x02013;37. doi:10.1080/13506120802676948\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/19291512/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1080/13506120802676948\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Epidemiological,+clinical+and+genetic+study+of+familial+amyloidotic+polyneuropathy+in+Cyprus&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B13\" id=\"B13\">\u003C/a>Finsterer, J., Iglseder, S., Wanschitz, J., Topakian, R., Loscher, W. N., and Grisold, W. (2019). Hereditary transthyretin-related amyloidosis. \u003Cem>Acta Neurol. Scand.\u003C/em> 139, 92&#x02013;105. doi:10.1111/ane.13035\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30295933/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1111/ane.13035\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Hereditary+transthyretin-related+amyloidosis&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B14\" id=\"B14\">\u003C/a>Galan, L., Gonzalez-Moreno, J., Martinez-Sesmero, J. M., Mu&#x000f1;oz-Beamud, F., Santos-Rubio, M. D., Tran, D., et al. (2021). Estimating the annual economic burden for the management of patients with transthyretin amyloid polyneuropathy in Spain. \u003Cem>Expert Rev. Pharmacoecon Outcomes Res.\u003C/em> 21, 967&#x02013;973. doi:10.1080/14737167.2021.1900738\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33724140/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1080/14737167.2021.1900738\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Estimating+the+annual+economic+burden+for+the+management+of+patients+with+transthyretin+amyloid+polyneuropathy+in+Spain&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B15\" id=\"B15\">\u003C/a>Gillmore, J. D., Gane, E., Taubel, J., Kao, J., Fontana, M., Maitland, M. L., et al. (2021). CRISPR-Cas9 \u003Cem>in vivo\u003C/em> gene editing for transthyretin amyloidosis. \u003Cem>N. Engl. J. Med.\u003C/em> 385, 493&#x02013;502. doi:10.1056/NEJMoa2107454\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/34215024/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1056/NEJMoa2107454\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=CRISPR-Cas9+in+vivo+gene+editing+for+transthyretin+amyloidosis&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B16\" id=\"B16\">\u003C/a>Ikeda, S., Nakazato, M., Ando, Y., and Sobue, G. (2002). Familial transthyretin-type amyloid polyneuropathy in Japan: Clinical and genetic heterogeneity. \u003Cem>Neurology\u003C/em> 58, 1001&#x02013;1007. doi:10.1212/wnl.58.7.1001\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/11940682/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1212/wnl.58.7.1001\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Familial+transthyretin-type+amyloid+polyneuropathy+in+Japan:+Clinical+and+genetic+heterogeneity&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B17\" id=\"B17\">\u003C/a>Ines, M., Coelho, T., Conceicao, I., Duarte-Ramos, F., de Carvalho, M., and Costa, J. (2018). Epidemiology of transthyretin familial amyloid polyneuropathy in Portugal: A nationwide study. \u003Cem>Neuroepidemiology\u003C/em> 51, 177&#x02013;182. doi:10.1159/000490553\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30153683/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1159/000490553\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Epidemiology+of+transthyretin+familial+amyloid+polyneuropathy+in+Portugal:+A+nationwide+study&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B18\" id=\"B18\">\u003C/a>Kato-Motozaki, Y., Ono, K., Shima, K., Morinaga, A., Machiya, T., Nozaki, I., et al. (2008). Epidemiology of familial amyloid polyneuropathy in Japan: Identification of a novel endemic focus. \u003Cem>J. Neurol. Sci.\u003C/em> 270, 133&#x02013;140. doi:10.1016/j.jns.2008.02.019\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/18410945/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.jns.2008.02.019\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Epidemiology+of+familial+amyloid+polyneuropathy+in+Japan:+Identification+of+a+novel+endemic+focus&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B19\" id=\"B19\">\u003C/a>Lahuerta Pueyo, C., Aibar Arregui, M. A., Gracia Gutierrez, A., Bueno Juana, E., and Menao Guillen, S. (2019). Estimating the prevalence of allelic variants in the transthyretin gene by analysing large-scale sequencing data. \u003Cem>Eur. J. Hum. Genet.\u003C/em> 27, 783&#x02013;791. doi:10.1038/s41431-019-0337-1\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30683924/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1038/s41431-019-0337-1\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Estimating+the+prevalence+of+allelic+variants+in+the+transthyretin+gene+by+analysing+large-scale+sequencing+data&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B20\" id=\"B20\">\u003C/a>Lamb, Y. N., and Deeks, E. D. (2019). Tafamidis: A review in transthyretin amyloidosis with polyneuropathy. \u003Cem>Drugs\u003C/em> 79, 863&#x02013;874. doi:10.1007/s40265-019-01129-6\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31098895/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1007/s40265-019-01129-6\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Tafamidis:+A+review+in+transthyretin+amyloidosis+with+polyneuropathy&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B21\" id=\"B21\">\u003C/a>Lauppe, R. E., Liseth Hansen, J., Gerdeskold, C., Rozenbaum, M. H., Strand, A. M., Vakevainen, M., et al. (2021). Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden. \u003Cem>Open Heart\u003C/em> 8, e001755. doi:10.1136/openhrt-2021-001755\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/34645699/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1136/openhrt-2021-001755\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Nationwide+prevalence+and+characteristics+of+transthyretin+amyloid+cardiomyopathy+in+Sweden&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B22\" id=\"B22\">\u003C/a>Liu, W., Pajusalu, S., Lake, N. J., Zhou, G., Ioannidis, N., Mittal, P., et al. (2019). Estimating prevalence for limb-girdle muscular dystrophy based on public sequencing databases. \u003Cem>Genet. Med.\u003C/em> 21, 2512&#x02013;2520. doi:10.1038/s41436-019-0544-8\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31105274/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1038/s41436-019-0544-8\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Estimating+prevalence+for+limb-girdle+muscular+dystrophy+based+on+public+sequencing+databases&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B23\" id=\"B23\">\u003C/a>Obi, C. A., Mostertz, W. C., Griffin, J. M., and Judge, D. P. (2022). ATTR epidemiology, genetics, and prognostic factors. \u003Cem>Methodist Debakey Cardiovasc J.\u003C/em> 18, 17&#x02013;26. doi:10.14797/mdcvj.1066\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.14797/mdcvj.1066\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=ATTR+epidemiology,+genetics,+and+prognostic+factors&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B24\" id=\"B24\">\u003C/a>Rapezzi, C., Quarta, C. C., Riva, L., Longhi, S., Gallelli, I., Lorenzini, M., et al. (2010). Transthyretin-related amyloidoses and the heart: A clinical overview. \u003Cem>Nat. Rev. Cardiol.\u003C/em> 7, 398&#x02013;408. doi:10.1038/nrcardio.2010.67\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/20479782/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1038/nrcardio.2010.67\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Transthyretin-related+amyloidoses+and+the+heart:+A+clinical+overview&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B25\" id=\"B25\">\u003C/a>Russo, M., Obici, L., Bartolomei, I., Cappelli, F., Luigetti, M., Fenu, S., et al. (2020). ATTRv amyloidosis Italian registry: Clinical and epidemiological data. \u003Cem>Amyloid\u003C/em> 27, 259&#x02013;265. doi:10.1080/13506129.2020.1794807\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32696671/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1080/13506129.2020.1794807\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=ATTRv+amyloidosis+Italian+registry:+Clinical+and+epidemiological+data&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B26\" id=\"B26\">\u003C/a>Rutten, J. W., Dauwerse, H. G., Gravesteijn, G., van Belzen, M. J., van der Grond, J., Polke, J. M., et al. (2016). Archetypal NOTCH3 mutations frequent in public exome: Implications for CADASIL. \u003Cem>Ann. Clin. Transl. Neurol.\u003C/em> 3, 844&#x02013;853. doi:10.1002/acn3.344\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27844030/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1002/acn3.344\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Archetypal+NOTCH3+mutations+frequent+in+public+exome:+Implications+for+CADASIL&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B27\" id=\"B27\">\u003C/a>Schmidt, H. H., Waddington-Cruz, M., Botteman, M. F., Carter, J. A., Chopra, A. S., Hopps, M., et al. (2018). Estimating the global prevalence of transthyretin familial amyloid polyneuropathy. \u003Cem>Muscle Nerve\u003C/em> 57, 829&#x02013;837. doi:10.1002/mus.26034\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29211930/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1002/mus.26034\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Estimating+the+global+prevalence+of+transthyretin+familial+amyloid+polyneuropathy&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B28\" id=\"B28\">\u003C/a>Sousa, A., Coelho, T., Barros, J., and Sequeiros, J. (1995). Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Povoa do Varzim and Vila do Conde (north of Portugal). \u003Cem>Am. J. Med. Genet.\u003C/em> 60, 512&#x02013;521. doi:10.1002/ajmg.1320600606\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/8825887/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1002/ajmg.1320600606\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Genetic+epidemiology+of+familial+amyloidotic+polyneuropathy+(FAP)-type+I+in+Povoa+do+Varzim+and+Vila+do+Conde+(north+of+Portugal)&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B29\" id=\"B29\">\u003C/a>Takeshima, T., Wan, Q., Zhang, Y., Komori, M., Stretton, S., Rajan, N., et al. (2019). Prevalence, burden, and clinical management of migraine in China, Japan, and South Korea: A comprehensive review of the literature. \u003Cem>J. Headache Pain\u003C/em> 20, 111. doi:10.1186/s10194-019-1062-4\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31805851/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1186/s10194-019-1062-4\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Prevalence,+burden,+and+clinical+management+of+migraine+in+China,+Japan,+and+South+Korea:+A+comprehensive+review+of+the+literature&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B30\" id=\"B30\">\u003C/a>Wechalekar, A. D., Gillmore, J. D., and Hawkins, P. N. (2016). Systemic amyloidosis. \u003Cem>Lancet\u003C/em> 387, 2641&#x02013;2654. doi:10.1016/S0140-6736(15)01274-X\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/26719234/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/S0140-6736(15)01274-X\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Systemic+amyloidosis&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B31\" id=\"B31\">\u003C/a>Yamamoto, H., and Yokochi, T. (2019). Transthyretin cardiac amyloidosis: An update on diagnosis and treatment. \u003Cem>Esc. Heart Fail\u003C/em> 6, 1128&#x02013;1139. doi:10.1002/ehf2.12518\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31553132/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1002/ehf2.12518\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Transthyretin+cardiac+amyloidosis:+An+update+on+diagnosis+and+treatment&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003C/div>\u003Cdiv class=\"thinLineM20\">\u003C/div>\u003Cdiv class=\"AbstractSummary\">\u003Cp>\u003Cspan>Keywords:\u003C/span> amyloid transthyretin (ATTR), ChinaMap, GnomAD, prevalence, genetic database\u003C/p>\u003Cp>\u003Cspan>Citation:\u003C/span> Yongsheng Z, Chong S, Bingyou L, Jianian H, Haofeng C, Chongbo Z, Zhang VW and Jie L (2023) Prevalence estimation of ATTRv in China based on genetic databases. \u003Cem>Front. Genet.\u003C/em> 14:1126836. doi: 10.3389/fgene.2023.1126836\u003C/p>\u003Cp id=\"timestamps\">\u003Cspan>Received:\u003C/span> 18 December 2022; \u003Cspan>Accepted:\u003C/span> 04 April 2023;\u003Cbr>\u003Cspan>Published:\u003C/span> 13 April 2023.\u003C/p>\u003Cdiv>\u003Cp>Edited by:\u003C/p> \u003Ca href=\"https://loop.frontiersin.org/people/437033/overview\">Sarah H. Elsea\u003C/a>, Baylor College of Medicine, United States\u003C/div>\u003Cdiv>\u003Cp>Reviewed by:\u003C/p> \u003Ca href=\"https://loop.frontiersin.org/people/949480/overview\">Dario Ronchi\u003C/a>, University of Milan, Italy\u003Cbr>\u003Ca href=\"https://loop.frontiersin.org/people/734185/overview\">Michel Satya Naslavsky\u003C/a>, University of S&#x000e3;o Paulo, Brazil\u003C/div>\u003Cp>\u003Cspan>Copyright\u003C/span> &#x000a9; 2023 Yongsheng, Chong, Bingyou, Jianian, Haofeng, Chongbo, Zhang and Jie. This is an open-access article distributed under the terms of the \u003Ca rel=\"license\" href=\"http://creativecommons.org/licenses/by/4.0/\" target=\"_blank\">Creative Commons Attribution License (CC BY).\u003C/a> The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.\u003C/p>\u003Cp>\u003Cspan>&#x0002a;Correspondence:\u003C/span> Lin Jie, \u003Ca id=\"encmail\">bGluamllMTVAZnVkYW4uZWR1LmNu\u003C/a>\u003C/p>\u003Cdiv class=\"clear\">\u003C/div>\u003C/div>","\u003Cul class=\"flyoutJournal\">\u003Cli>\u003Ca href=\"#h1\">Abstract\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h2\">Introduction\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h3\">Materials and methods\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h4\">Results\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h5\">Discussion\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h6\">Data availability statement\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h7\">Author contributions\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h8\">Acknowledgments\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h9\">Conflict of interest\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h10\">Publisher&#x02019;s note\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h11\">Supplementary material\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h12\">Abbreviations\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h13\">References\u003C/a>\u003C/li>\u003C/ul>",[651,656,663,666,672],{"name":652,"fileServerPackageEntryId":19,"fileServerId":653,"fileServerVersionNumber":374,"type":654},"EPUB.epub","1126836/epub",{"code":655,"name":655},"EPUB",{"name":657,"fileServerPackageEntryId":658,"fileServerId":659,"fileServerVersionNumber":660,"type":661},"fgene-14-1126836.pdf","fgene-14-1126836-r1/fgene-14-1126836.pdf","1126836/pubmed-zip",2,{"code":662,"name":662},"PDF",{"name":657,"fileServerPackageEntryId":19,"fileServerId":664,"fileServerVersionNumber":374,"type":665},"1126836/publishers-proof/pdf",{"code":662,"name":662},{"name":667,"fileServerPackageEntryId":668,"fileServerId":659,"fileServerVersionNumber":660,"type":669},"fgene-14-1126836.xml","fgene-14-1126836-r1/fgene-14-1126836.xml",{"code":670,"name":671},"NLM_XML","XML",{"name":673,"fileServerPackageEntryId":19,"fileServerId":674,"fileServerVersionNumber":374,"type":675},"Provisional PDF.pdf","1126836/provisional-pdf",{"code":662,"name":662},"v3",{"title":678,"link":679,"meta":683,"script":803},"Frontiers | Prevalence estimation of ATTRv in China based on genetic databases",[680],{"rel":681,"href":682},"canonical","https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1126836/full",[684,687,690,692,695,699,702,706,709,712,715,717,719,721,723,725,728,731,733,736,739,741,744,747,750,753,756,760,764,767,769,772,774,777,779,782,784,787,789,792,795,798,800],{"hid":685,"property":685,"name":685,"content":686},"description","Introduction: Amyloid transthyretin (ATTR) is divided into either hereditary (ATTRv) or sporadic (ATTRwt) and ATTRv is a rare hereditary disease transmitted ...",{"hid":688,"property":688,"name":689,"content":678},"og:title","title",{"hid":691,"property":691,"name":685,"content":686},"og:description",{"hid":693,"name":693,"content":694},"keywords","Amyloid transthyretin (ATTR),ChinaMap,GnomAD,Prevalence,genetic database",{"hid":696,"property":696,"name":697,"content":698},"og:site_name","site_name","Frontiers",{"hid":700,"property":700,"name":367,"content":701},"og:image","https://images-provider.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/1126836/fgene-14-1126836-HTML/image_m/fgene-14-1126836-g001.jpg",{"hid":703,"property":703,"name":704,"content":705},"og:type","type","article",{"hid":707,"property":707,"name":708,"content":682},"og:url","url",{"hid":710,"name":710,"content":711},"twitter:card","summary_large_image",{"hid":713,"name":713,"content":714},"citation_volume","14",{"hid":716,"name":716,"content":116},"citation_journal_title",{"hid":718,"name":718,"content":698},"citation_publisher",{"hid":720,"name":720,"content":632},"citation_journal_abbrev",{"hid":722,"name":722,"content":633},"citation_issn",{"hid":724,"name":724,"content":518},"citation_doi",{"hid":726,"name":726,"content":727},"citation_firstpage","1126836",{"hid":729,"name":729,"content":730},"citation_language","English",{"hid":732,"name":732,"content":519},"citation_title",{"hid":734,"name":734,"content":735},"citation_keywords","Amyloid transthyretin (ATTR); ChinaMap; GnomAD; Prevalence; genetic database",{"hid":737,"name":737,"content":738},"citation_abstract","Introduction: Amyloid transthyretin (ATTR) is divided into either hereditary (ATTRv) or sporadic (ATTRwt) and ATTRv is a rare hereditary disease transmitted as an autosomal dominant manner. Its global prevalence is traditionally estimated as 5,000 to 10,000 persons. However, it may be underestimated and the exact prevalence of ATTRv in China mainland remains unknown.Methods: The Genome Aggregation database (gnomAD) database (containing 125,748 exomes) and two genomic sequencing databases  China Metabolic Analytics Project (ChinaMAP) (containing 10588 individuals) and Amcarelab gene database (containing 45392 exomes), were integrated to estimate the prevalence of ATTRv in the world and mainland Chinese populations. Pathogenic variants allele frequency and the prevalence of ATTRv was calculated.Results: Six variants, counting 470 alleles, were defined as pathogenic variants in gnomAD. The prevalence of ATTRv in the world population was 57.4/100,000. Two variants (2 allele counts) and 15 variants (34 individuals) were defined as pathogenic variants in the ChinaMAP database and the Amcarelab exome database, respectively. Thus, the estimated prevalence interval of ATTRv in mainland China was 18.9/100,000-74,9/100,000. Conclusion: The present study demonstrated that the previous prevalence was greatly underestimated using traditional methods. Therefore, raising awareness of the disease is essential for recognizing ATTRv in its early stage.",{"hid":740,"name":740,"content":533},"citation_article_type",{"hid":742,"name":742,"content":743},"citation_pdf_url","https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1126836/pdf",{"hid":745,"name":745,"content":746},"citation_xml_url","https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1126836/xml",{"hid":748,"name":748,"content":749},"citation_fulltext_world_readable","yes",{"hid":751,"name":751,"content":752},"citation_online_date","2023/04/04",{"hid":754,"name":754,"content":755},"citation_publication_date","2023/04/13",{"hid":757,"name":758,"content":759},"citation_author_0","citation_author","Yongsheng, Zheng ",{"hid":761,"name":762,"content":763},"citation_author_institution_0","citation_author_institution","Department of Neurology, China",{"hid":765,"name":758,"content":766},"citation_author_1","Chong, Sun ",{"hid":768,"name":762,"content":763},"citation_author_institution_1",{"hid":770,"name":758,"content":771},"citation_author_2","Bingyou, Liu ",{"hid":773,"name":762,"content":763},"citation_author_institution_2",{"hid":775,"name":758,"content":776},"citation_author_3","Jianian, Hu ",{"hid":778,"name":762,"content":763},"citation_author_institution_3",{"hid":780,"name":758,"content":781},"citation_author_4","Haofeng, Chen ",{"hid":783,"name":762,"content":763},"citation_author_institution_4",{"hid":785,"name":758,"content":786},"citation_author_5","Chongbo, Zhao ",{"hid":788,"name":762,"content":763},"citation_author_institution_5",{"hid":790,"name":758,"content":791},"citation_author_6","Zhang, Victor Wei ",{"hid":793,"name":762,"content":794},"citation_author_institution_6","Amcarelab Genetic Commercial Company, China",{"hid":796,"name":758,"content":797},"citation_author_7","Jie, Lin ",{"hid":799,"name":762,"content":763},"citation_author_institution_7",{"hid":801,"name":801,"content":802},"dc.identifier","doi:10.3389/fgene.2023.1126836",[804,807,809,811,813],{"src":805,"body":13,"type":806,"async":13},"https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6","text/javascript",{"src":808,"body":13,"type":806,"async":13},"https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML",{"src":810,"body":13,"type":806,"async":13},"https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js",{"src":812,"body":13,"type":806,"async":13},"https://api.altmetric.com/v1/doi/10.3389/fgene.2023.1126836?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15",{"src":814,"body":13,"type":806,"async":13},"https://crossmark-cdn.crossref.org/widget/v2.0/widget.js",{"articleHubSlug":19,"articleHubPage":816,"articleHubArticlesList":817,"canJournalHasArticleHub":359,"articleDoiList":818},{},[],[],{"title":19,"image":-1,"breadcrumbs":820,"linksCollection":821,"metricsCollection":823},[],{"total":371,"items":822},[],{"total":371,"items":824},[]]</script>
<script>window.__NUXT__={};window.__NUXT__.config={public:{isDevMode:false,appName:"article-pages-2024",baseUrl:"https://www.frontiersin.org",domain:"frontiersin.org",loopUrl:"https://loop.frontiersin.org",ssMainDomain:"frontiersin.org",contentfulUrl:"https://graphql.contentful.com/content/v1/spaces",spaceId:1,spaceName:"Frontiers",liveSpaceId:1,tenantLogoUrl:"",frontiersGraphUrl:"https://apollo-federation-gateway.frontiersin.org",registrationApiUrl:"https://onboarding-ui.frontiersin.org",emailDigestApiUrl:"https://api-email-digest.frontiersin.org",journalFilesApiUrl:"https://files-journal-api.frontiersin.org",publicPagesFilesUrl:"https://public-pages-files-2025.frontiersin.org",searchApiUrl:"https://search-api.frontiersin.org",productionForumApiUrl:"https://production-forum-api-v2.frontiersin.org",gtmServerUrl:"https://tag-manager.frontiersin.org",gtmId:"GTM-M322FV2",gtmAuth:"owVbWxfaJr21yQv1fe1cAQ",gtmPreview:"env-1",figsharePluginUrl:"https://widgets.figshare.com/static/figshare.js",figshareApiUrl:"https://api.figshare.com/v2/collections/search",figshareTimeout:3000,crossmarkPublishedDate:"2015/08/24",googleRecaptchaSiteKey:"6LdG3i0UAAAAAOC4qUh35ubHgJotEHp_STXHgr_v",googleRecaptchaKeyName:"FrontiersRecaptchaV2",faviconSize16:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_16-tenantFavicon-Frontiers.png",faviconSize32:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_32-tenantFavicon-Frontiers.png",faviconSize180:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_180-tenantFavicon-Frontiers.png",faviconSize192:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_192-tenantFavicon-Frontiers.png",faviconSize512:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_512-tenantFavicon-Frontiers.png",socialMediaImg:"https://brand.frontiersin.org/m/1c8bcb536c789e11/Guidelines-Frontiers_Logo_1200x628_1-91to1.png",linkedArticleCopyText:"'{\"articleTypeCopyText\":[{\"articleTypeId\":0,\"originalArticleCopyText\":\"Part of this article's content has been mentioned in:\",\"linkedArticleCopyText\":\"This article mentions parts of:\"},{\"articleTypeId\":122,\"originalArticleCopyText\":\"Parts of this article's content have been modified or rectified in:\",\"linkedArticleCopyText\":\"This article is an erratum on:\"},{\"articleTypeId\":129,\"originalArticleCopyText\":\"Parts of this article's content have been modified or rectified in:\",\"linkedArticleCopyText\":\"This article is an addendum to:\"},{\"articleTypeId\":128,\"originalArticleCopyText\":\"A correction has been applied to this article in:\",\"linkedArticleCopyText\":\"This article is a correction to:\"},{\"articleTypeId\":134,\"originalArticleCopyText\":\"A retraction of this article was approved in:\",\"linkedArticleCopyText\":\"This article is a retraction of:\"},{\"articleTypeId\":29,\"originalArticleCopyText\":\"A commentary has been posted on this article:\",\"linkedArticleCopyText\":\"This article is a commentary on:\"},{\"articleTypeId\":30,\"originalArticleCopyText\":\"A commentary has been posted on this article:\",\"linkedArticleCopyText\":\"This article is a commentary on:\"}],\"articleIdCopyText\":[]}'\n",acceptedArticleExcludedJournalIds:"'[2766,979]'\n",articleTypeConfigurableLabel:"\u003C\u003Carticle-type:uppercase>> article",settingsFeaturesSwitchers:"'{\"displayTitlePillLabels\":true,\"displayRelatedArticlesBox\":true,\"showEditors\":true,\"showReviewers\":true,\"showLoopImpactLink\":true,\"enableFigshare\":false}'\n",journalsWithArticleHub:"'{\"strings\":[\"science\"]}'\n",terminologySettings:"'{\"terms\":[{\"sequenceNumber\":1,\"key\":\"frontiers\",\"tenantTerm\":\"Frontiers\",\"frontiersDefaultTerm\":\"Frontiers\",\"category\":\"Customer\"},{\"sequenceNumber\":2,\"key\":\"submission_system\",\"tenantTerm\":\"submission system\",\"frontiersDefaultTerm\":\"submission system\",\"category\":\"Product\"},{\"sequenceNumber\":3,\"key\":\"public_pages\",\"tenantTerm\":\"public pages\",\"frontiersDefaultTerm\":\"public pages\",\"category\":\"Product\"},{\"sequenceNumber\":4,\"key\":\"my_frontiers\",\"tenantTerm\":\"my frontiers\",\"frontiersDefaultTerm\":\"my frontiers\",\"category\":\"Product\"},{\"sequenceNumber\":5,\"key\":\"digital_editorial_office\",\"tenantTerm\":\"digital editorial office\",\"frontiersDefaultTerm\":\"digital editorial office\",\"category\":\"Product\"},{\"sequenceNumber\":6,\"key\":\"deo\",\"tenantTerm\":\"DEO\",\"frontiersDefaultTerm\":\"DEO\",\"category\":\"Product\"},{\"sequenceNumber\":7,\"key\":\"digital_editorial_office_for_chiefs\",\"tenantTerm\":\"digital editorial office for chiefs\",\"frontiersDefaultTerm\":\"digital editorial office for chiefs\",\"category\":\"Product\"},{\"sequenceNumber\":8,\"key\":\"digital_editorial_office_for_eof\",\"tenantTerm\":\"digital editorial office for eof\",\"frontiersDefaultTerm\":\"digital editorial office for eof\",\"category\":\"Product\"},{\"sequenceNumber\":9,\"key\":\"editorial_office\",\"tenantTerm\":\"editorial office\",\"frontiersDefaultTerm\":\"editorial office\",\"category\":\"Product\"},{\"sequenceNumber\":10,\"key\":\"eof\",\"tenantTerm\":\"EOF\",\"frontiersDefaultTerm\":\"EOF\",\"category\":\"Product\"},{\"sequenceNumber\":11,\"key\":\"research_topic_management\",\"tenantTerm\":\"research topic management\",\"frontiersDefaultTerm\":\"research topic management\",\"category\":\"Product\"},{\"sequenceNumber\":12,\"key\":\"review_forum\",\"tenantTerm\":\"review forum\",\"frontiersDefaultTerm\":\"review forum\",\"category\":\"Product\"},{\"sequenceNumber\":13,\"key\":\"accounting_office\",\"tenantTerm\":\"accounting office\",\"frontiersDefaultTerm\":\"accounting office\",\"category\":\"Product\"},{\"sequenceNumber\":14,\"key\":\"aof\",\"tenantTerm\":\"AOF\",\"frontiersDefaultTerm\":\"AOF\",\"category\":\"Product\"},{\"sequenceNumber\":15,\"key\":\"publishing_office\",\"tenantTerm\":\"publishing office\",\"frontiersDefaultTerm\":\"publishing office\",\"category\":\"Product\"},{\"sequenceNumber\":16,\"key\":\"production_office\",\"tenantTerm\":\"production office forum\",\"frontiersDefaultTerm\":\"production office forum\",\"category\":\"Product\"},{\"sequenceNumber\":17,\"key\":\"pof\",\"tenantTerm\":\"POF\",\"frontiersDefaultTerm\":\"POF\",\"category\":\"Product\"},{\"sequenceNumber\":18,\"key\":\"book_office_forum\",\"tenantTerm\":\"book office forum\",\"frontiersDefaultTerm\":\"book office forum\",\"category\":\"Product\"},{\"sequenceNumber\":19,\"key\":\"bof\",\"tenantTerm\":\"BOF\",\"frontiersDefaultTerm\":\"BOF\",\"category\":\"Product\"},{\"sequenceNumber\":20,\"key\":\"aira\",\"tenantTerm\":\"AIRA\",\"frontiersDefaultTerm\":\"AIRA\",\"category\":\"Product\"},{\"sequenceNumber\":21,\"key\":\"editorial_board_management\",\"tenantTerm\":\"editorial board management\",\"frontiersDefaultTerm\":\"editorial board management\",\"category\":\"Product\"},{\"sequenceNumber\":22,\"key\":\"ebm\",\"tenantTerm\":\"EBM\",\"frontiersDefaultTerm\":\"EBM\",\"category\":\"Product\"},{\"sequenceNumber\":23,\"key\":\"domain\",\"tenantTerm\":\"domain\",\"frontiersDefaultTerm\":\"domain\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":24,\"key\":\"journal\",\"tenantTerm\":\"journal\",\"frontiersDefaultTerm\":\"journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":25,\"key\":\"section\",\"tenantTerm\":\"section\",\"frontiersDefaultTerm\":\"section\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":26,\"key\":\"domains\",\"tenantTerm\":\"domains\",\"frontiersDefaultTerm\":\"domains\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":27,\"key\":\"specialty_section\",\"tenantTerm\":\"specialty section\",\"frontiersDefaultTerm\":\"specialty section\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":28,\"key\":\"specialty_journal\",\"tenantTerm\":\"specialty journal\",\"frontiersDefaultTerm\":\"specialty journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":29,\"key\":\"journals\",\"tenantTerm\":\"journals\",\"frontiersDefaultTerm\":\"journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":30,\"key\":\"sections\",\"tenantTerm\":\"sections\",\"frontiersDefaultTerm\":\"sections\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":31,\"key\":\"specialty_sections\",\"tenantTerm\":\"specialty sections\",\"frontiersDefaultTerm\":\"specialty sections\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":32,\"key\":\"specialty_journals\",\"tenantTerm\":\"specialty journals\",\"frontiersDefaultTerm\":\"specialty journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":33,\"key\":\"manuscript\",\"tenantTerm\":\"manuscript\",\"frontiersDefaultTerm\":\"manuscript\",\"category\":\"Core\"},{\"sequenceNumber\":34,\"key\":\"manuscripts\",\"tenantTerm\":\"manuscripts\",\"frontiersDefaultTerm\":\"manuscripts\",\"category\":\"Core\"},{\"sequenceNumber\":35,\"key\":\"article\",\"tenantTerm\":\"article\",\"frontiersDefaultTerm\":\"article\",\"category\":\"Core\"},{\"sequenceNumber\":36,\"key\":\"articles\",\"tenantTerm\":\"articles\",\"frontiersDefaultTerm\":\"articles\",\"category\":\"Core\"},{\"sequenceNumber\":37,\"key\":\"article_type\",\"tenantTerm\":\"article type\",\"frontiersDefaultTerm\":\"article type\",\"category\":\"Core\"},{\"sequenceNumber\":38,\"key\":\"article_types\",\"tenantTerm\":\"article types\",\"frontiersDefaultTerm\":\"article types\",\"category\":\"Core\"},{\"sequenceNumber\":39,\"key\":\"author\",\"tenantTerm\":\"author\",\"frontiersDefaultTerm\":\"author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":40,\"key\":\"authors\",\"tenantTerm\":\"authors\",\"frontiersDefaultTerm\":\"authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":41,\"key\":\"authoring\",\"tenantTerm\":\"authoring\",\"frontiersDefaultTerm\":\"authoring\",\"category\":\"Core\"},{\"sequenceNumber\":42,\"key\":\"authored\",\"tenantTerm\":\"authored\",\"frontiersDefaultTerm\":\"authored\",\"category\":\"Core\"},{\"sequenceNumber\":43,\"key\":\"accept\",\"tenantTerm\":\"accept\",\"frontiersDefaultTerm\":\"accept\",\"category\":\"Process\"},{\"sequenceNumber\":44,\"key\":\"accepted\",\"tenantTerm\":\"accepted\",\"frontiersDefaultTerm\":\"accepted\",\"category\":\"Process\"},{\"sequenceNumber\":45,\"key\":\"assistant_field_chief_editor\",\"tenantTerm\":\"Assistant Field Chief Editor\",\"frontiersDefaultTerm\":\"Assistant Field Chief Editor\",\"description\":\"An editorial role on a Field Journal that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":46,\"key\":\"assistant_specialty_chief_editor\",\"tenantTerm\":\"Assistant Specialty Chief Editor\",\"frontiersDefaultTerm\":\"Assistant Specialty Chief Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":47,\"key\":\"assistant_specialty_chief_editors\",\"tenantTerm\":\"Assistant Specialty Chief Editors\",\"frontiersDefaultTerm\":\"Assistant Specialty Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":48,\"key\":\"associate_editor\",\"tenantTerm\":\"Associate Editor\",\"frontiersDefaultTerm\":\"Associate Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":49,\"key\":\"specialty_chief_editor\",\"tenantTerm\":\"Specialty Chief Editor\",\"frontiersDefaultTerm\":\"Specialty Chief Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":50,\"key\":\"specialty_chief_editors\",\"tenantTerm\":\"Specialty Chief Editors\",\"frontiersDefaultTerm\":\"Specialty Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":51,\"key\":\"chief_editor\",\"tenantTerm\":\"Chief Editor\",\"frontiersDefaultTerm\":\"Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":52,\"key\":\"chief_editors\",\"tenantTerm\":\"Chief Editors\",\"frontiersDefaultTerm\":\"Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":53,\"key\":\"call_for_participation\",\"tenantTerm\":\"call for participation\",\"frontiersDefaultTerm\":\"call for participation\",\"category\":\"Process\"},{\"sequenceNumber\":54,\"key\":\"citation\",\"tenantTerm\":\"citation\",\"frontiersDefaultTerm\":\"citation\",\"category\":\"Misc.\"},{\"sequenceNumber\":55,\"key\":\"citations\",\"tenantTerm\":\"citations\",\"frontiersDefaultTerm\":\"citations\",\"category\":\"Misc.\"},{\"sequenceNumber\":56,\"key\":\"contributor\",\"tenantTerm\":\"contributor\",\"frontiersDefaultTerm\":\"contributor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":57,\"key\":\"contributors\",\"tenantTerm\":\"contributors\",\"frontiersDefaultTerm\":\"contributors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":58,\"key\":\"corresponding_author\",\"tenantTerm\":\"corresponding author\",\"frontiersDefaultTerm\":\"corresponding author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":59,\"key\":\"corresponding_authors\",\"tenantTerm\":\"corresponding authors\",\"frontiersDefaultTerm\":\"corresponding authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":60,\"key\":\"decline\",\"tenantTerm\":\"decline\",\"frontiersDefaultTerm\":\"decline\",\"category\":\"Process\"},{\"sequenceNumber\":61,\"key\":\"declined\",\"tenantTerm\":\"declined\",\"frontiersDefaultTerm\":\"declined\",\"category\":\"Process\"},{\"sequenceNumber\":62,\"key\":\"reject\",\"tenantTerm\":\"reject\",\"frontiersDefaultTerm\":\"reject\",\"category\":\"Process\"},{\"sequenceNumber\":63,\"key\":\"rejected\",\"tenantTerm\":\"rejected\",\"frontiersDefaultTerm\":\"rejected\",\"category\":\"Process\"},{\"sequenceNumber\":64,\"key\":\"publish\",\"tenantTerm\":\"publish\",\"frontiersDefaultTerm\":\"publish\",\"category\":\"Core\"},{\"sequenceNumber\":65,\"key\":\"published\",\"tenantTerm\":\"published\",\"frontiersDefaultTerm\":\"published\",\"category\":\"Core\"},{\"sequenceNumber\":66,\"key\":\"publication\",\"tenantTerm\":\"publication\",\"frontiersDefaultTerm\":\"publication\",\"category\":\"Core\"},{\"sequenceNumber\":67,\"key\":\"peer_review\",\"tenantTerm\":\"peer review\",\"frontiersDefaultTerm\":\"peer review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":68,\"key\":\"peer_reviewed\",\"tenantTerm\":\"peer reviewed\",\"frontiersDefaultTerm\":\"peer reviewed\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":69,\"key\":\"initial_validation\",\"tenantTerm\":\"initial validation\",\"frontiersDefaultTerm\":\"initial validation\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":70,\"key\":\"editorial_assignment\",\"tenantTerm\":\"editorial assignment\",\"frontiersDefaultTerm\":\"editorial assignment\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":71,\"key\":\"independent_review\",\"tenantTerm\":\"independent review\",\"frontiersDefaultTerm\":\"independent review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":72,\"key\":\"interactive_review\",\"tenantTerm\":\"interactive review\",\"frontiersDefaultTerm\":\"interactive review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":73,\"key\":\"review\",\"tenantTerm\":\"review\",\"frontiersDefaultTerm\":\"review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":74,\"key\":\"reviewing\",\"tenantTerm\":\"reviewing\",\"frontiersDefaultTerm\":\"reviewing\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":75,\"key\":\"reviewer\",\"tenantTerm\":\"reviewer\",\"frontiersDefaultTerm\":\"reviewer\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":76,\"key\":\"reviewers\",\"tenantTerm\":\"reviewers\",\"frontiersDefaultTerm\":\"reviewers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":77,\"key\":\"review_finalized\",\"tenantTerm\":\"review finalized\",\"frontiersDefaultTerm\":\"review finalized\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":78,\"key\":\"final_decision\",\"tenantTerm\":\"final decision\",\"frontiersDefaultTerm\":\"final decision\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":79,\"key\":\"final_validation\",\"tenantTerm\":\"final validation\",\"frontiersDefaultTerm\":\"final validation\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":80,\"key\":\"ae_accept_manuscript\",\"tenantTerm\":\"recommend to accept manuscript\",\"frontiersDefaultTerm\":\"accept manuscript\",\"category\":\"Process\"},{\"sequenceNumber\":81,\"key\":\"fee\",\"tenantTerm\":\"fee\",\"frontiersDefaultTerm\":\"fee\",\"category\":\"Accounting\"},{\"sequenceNumber\":82,\"key\":\"fees\",\"tenantTerm\":\"fees\",\"frontiersDefaultTerm\":\"fees\",\"category\":\"Accounting\"},{\"sequenceNumber\":83,\"key\":\"guest_associate_editor\",\"tenantTerm\":\"Guest Associate Editor\",\"frontiersDefaultTerm\":\"Guest Associate Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":84,\"key\":\"guest_associate_editors\",\"tenantTerm\":\"Guest Associate Editors\",\"frontiersDefaultTerm\":\"Guest Associate Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":85,\"key\":\"in_review\",\"tenantTerm\":\"in review\",\"frontiersDefaultTerm\":\"in review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":86,\"key\":\"institutional_member\",\"tenantTerm\":\"institutional partner\",\"frontiersDefaultTerm\":\"institutional partner\",\"category\":\"Accounting\"},{\"sequenceNumber\":87,\"key\":\"institutional_membership\",\"tenantTerm\":\"institutional partnership\",\"frontiersDefaultTerm\":\"institutional partnership\",\"category\":\"Accounting\"},{\"sequenceNumber\":88,\"key\":\"article_processing_charge\",\"tenantTerm\":\"article processing charge\",\"frontiersDefaultTerm\":\"article processing charge\",\"category\":\"Accounting\"},{\"sequenceNumber\":89,\"key\":\"article_processing_charges\",\"tenantTerm\":\"article processing charges\",\"frontiersDefaultTerm\":\"article processing charges\",\"category\":\"Accounting\"},{\"sequenceNumber\":90,\"key\":\"apcs\",\"tenantTerm\":\"APCs\",\"frontiersDefaultTerm\":\"APCs\",\"category\":\"Accounting\"},{\"sequenceNumber\":91,\"key\":\"apc\",\"tenantTerm\":\"APC\",\"frontiersDefaultTerm\":\"APC\",\"category\":\"Accounting\"},{\"sequenceNumber\":92,\"key\":\"received\",\"tenantTerm\":\"received\",\"frontiersDefaultTerm\":\"received\",\"description\":\"Date manuscript was received on.\",\"category\":\"Core\"},{\"sequenceNumber\":93,\"key\":\"transferred\",\"tenantTerm\":\"transferred\",\"frontiersDefaultTerm\":\"transferred\",\"category\":\"Core\"},{\"sequenceNumber\":94,\"key\":\"transfer\",\"tenantTerm\":\"transfer\",\"frontiersDefaultTerm\":\"transfer\",\"category\":\"Core\"},{\"sequenceNumber\":95,\"key\":\"research_topic\",\"tenantTerm\":\"research topic\",\"frontiersDefaultTerm\":\"research topic\",\"category\":\"Core\"},{\"sequenceNumber\":96,\"key\":\"research_topics\",\"tenantTerm\":\"research topics\",\"frontiersDefaultTerm\":\"research topics\",\"category\":\"Core\"},{\"sequenceNumber\":97,\"key\":\"topic_editor\",\"tenantTerm\":\"Topic Editor\",\"frontiersDefaultTerm\":\"Topic Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":98,\"key\":\"review_editor\",\"tenantTerm\":\"Community Reviewer\",\"frontiersDefaultTerm\":\"Review Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":99,\"key\":\"title\",\"tenantTerm\":\"title\",\"frontiersDefaultTerm\":\"title\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":100,\"key\":\"running_title\",\"tenantTerm\":\"running title\",\"frontiersDefaultTerm\":\"running title\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":101,\"key\":\"submit\",\"tenantTerm\":\"submit\",\"frontiersDefaultTerm\":\"submit\",\"category\":\"Process\"},{\"sequenceNumber\":102,\"key\":\"submitted\",\"tenantTerm\":\"submitted\",\"frontiersDefaultTerm\":\"submitted\",\"category\":\"Process\"},{\"sequenceNumber\":103,\"key\":\"submitting\",\"tenantTerm\":\"submitting\",\"frontiersDefaultTerm\":\"submitting\",\"category\":\"Process\"},{\"sequenceNumber\":104,\"key\":\"t_e\",\"tenantTerm\":\"TE\",\"frontiersDefaultTerm\":\"TE\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":105,\"key\":\"topic\",\"tenantTerm\":\"topic\",\"frontiersDefaultTerm\":\"topic\",\"category\":\"Process\"},{\"sequenceNumber\":106,\"key\":\"topic_summary\",\"tenantTerm\":\"topic summary\",\"frontiersDefaultTerm\":\"topic summary\",\"category\":\"Process\"},{\"sequenceNumber\":107,\"key\":\"figure\",\"tenantTerm\":\"figure\",\"frontiersDefaultTerm\":\"figure\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":108,\"key\":\"figures\",\"tenantTerm\":\"figures\",\"frontiersDefaultTerm\":\"figures\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":109,\"key\":\"editorial_file\",\"tenantTerm\":\"editorial file\",\"frontiersDefaultTerm\":\"editorial file\",\"category\":\"Core\"},{\"sequenceNumber\":110,\"key\":\"editorial_files\",\"tenantTerm\":\"editorial files\",\"frontiersDefaultTerm\":\"editorial files\",\"category\":\"Core\"},{\"sequenceNumber\":111,\"key\":\"e_book\",\"tenantTerm\":\"e-book\",\"frontiersDefaultTerm\":\"e-book\",\"category\":\"Core\"},{\"sequenceNumber\":112,\"key\":\"organization\",\"tenantTerm\":\"organization\",\"frontiersDefaultTerm\":\"organization\",\"category\":\"Core\"},{\"sequenceNumber\":113,\"key\":\"institution\",\"tenantTerm\":\"institution\",\"frontiersDefaultTerm\":\"institution\",\"category\":\"Core\"},{\"sequenceNumber\":114,\"key\":\"reference\",\"tenantTerm\":\"reference\",\"frontiersDefaultTerm\":\"reference\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":115,\"key\":\"references\",\"tenantTerm\":\"references\",\"frontiersDefaultTerm\":\"references\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":116,\"key\":\"sce\",\"tenantTerm\":\"SCE\",\"frontiersDefaultTerm\":\"SCE\",\"description\":\"Abbreviation for Specialty Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":117,\"key\":\"submission\",\"tenantTerm\":\"submission\",\"frontiersDefaultTerm\":\"submission\",\"category\":\"Process\"},{\"sequenceNumber\":118,\"key\":\"submissions\",\"tenantTerm\":\"submissions\",\"frontiersDefaultTerm\":\"submissions\",\"category\":\"Process\"},{\"sequenceNumber\":119,\"key\":\"editing\",\"tenantTerm\":\"editing\",\"frontiersDefaultTerm\":\"editing\",\"category\":\"Process\"},{\"sequenceNumber\":120,\"key\":\"in_preparation\",\"tenantTerm\":\"in preparation\",\"frontiersDefaultTerm\":\"in preparation\",\"category\":\"Process\"},{\"sequenceNumber\":121,\"key\":\"country_region\",\"tenantTerm\":\"country/region\",\"frontiersDefaultTerm\":\"country/region\",\"description\":\"Because of political issues, some of the country listings are actually classified as `regions` and we need to include this. However other clients may not want to do this.\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":122,\"key\":\"countries_regions\",\"tenantTerm\":\"countries/regions\",\"frontiersDefaultTerm\":\"countries/regions\",\"description\":\"Because of political issues, some of the country listings are actually classified as `regions` and we need to include this. However other clients may not want to do this.\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":123,\"key\":\"specialty\",\"tenantTerm\":\"specialty\",\"frontiersDefaultTerm\":\"specialty\",\"category\":\"Core\"},{\"sequenceNumber\":124,\"key\":\"specialties\",\"tenantTerm\":\"specialties\",\"frontiersDefaultTerm\":\"specialties\",\"category\":\"Core\"},{\"sequenceNumber\":125,\"key\":\"associate_editors\",\"tenantTerm\":\"Associate Editors\",\"frontiersDefaultTerm\":\"Associate Editors\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":126,\"key\":\"reviewed\",\"tenantTerm\":\"reviewed\",\"frontiersDefaultTerm\":\"reviewed\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":127,\"key\":\"institutional_members\",\"tenantTerm\":\"institutional partners\",\"frontiersDefaultTerm\":\"institutional partners\",\"category\":\"Accounting\"},{\"sequenceNumber\":128,\"key\":\"institutional_memberships\",\"tenantTerm\":\"institutional partnerships\",\"frontiersDefaultTerm\":\"institutional partnerships\",\"category\":\"Accounting\"},{\"sequenceNumber\":129,\"key\":\"assistant_field_chief_editors\",\"tenantTerm\":\"Assistant Field Chief Editors\",\"frontiersDefaultTerm\":\"Assistant Field Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":130,\"key\":\"publications\",\"tenantTerm\":\"publications\",\"frontiersDefaultTerm\":\"publications\",\"category\":\"Process\"},{\"sequenceNumber\":131,\"key\":\"ae_accepted\",\"tenantTerm\":\"recommended acceptance\",\"frontiersDefaultTerm\":\"accepted\",\"category\":\"Process\"},{\"sequenceNumber\":132,\"key\":\"field_journal\",\"tenantTerm\":\"field journal\",\"frontiersDefaultTerm\":\"field journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":133,\"key\":\"field_journals\",\"tenantTerm\":\"field journals\",\"frontiersDefaultTerm\":\"field journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":134,\"key\":\"program_manager\",\"tenantTerm\":\"program manager\",\"frontiersDefaultTerm\":\"program manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":135,\"key\":\"journal_manager\",\"tenantTerm\":\"journal manager\",\"frontiersDefaultTerm\":\"journal manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":136,\"key\":\"journal_specialist\",\"tenantTerm\":\"journal specialist\",\"frontiersDefaultTerm\":\"journal specialist\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":137,\"key\":\"program_managers\",\"tenantTerm\":\"program managers\",\"frontiersDefaultTerm\":\"program managers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":138,\"key\":\"journal_managers\",\"tenantTerm\":\"journal managers\",\"frontiersDefaultTerm\":\"journal managers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":139,\"key\":\"journal_specialists\",\"tenantTerm\":\"journal specialists\",\"frontiersDefaultTerm\":\"journal specialists\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":140,\"key\":\"cover_letter\",\"tenantTerm\":\"manuscript contribution to the field\",\"frontiersDefaultTerm\":\"manuscript contribution to the field\",\"category\":\"Process\"},{\"sequenceNumber\":141,\"key\":\"ae_accepted_manuscript\",\"tenantTerm\":\"recommended to accept manuscript\",\"frontiersDefaultTerm\":\"accepted manuscript\",\"category\":\"Process\"},{\"sequenceNumber\":142,\"key\":\"recommend_for_rejection\",\"tenantTerm\":\"recommend for rejection\",\"frontiersDefaultTerm\":\"recommend for rejection\",\"category\":\"Process\"},{\"sequenceNumber\":143,\"key\":\"recommended_for_rejection\",\"tenantTerm\":\"recommended for rejection\",\"frontiersDefaultTerm\":\"recommended for rejection\",\"category\":\"Process\"},{\"sequenceNumber\":144,\"key\":\"ae\",\"tenantTerm\":\"AE\",\"frontiersDefaultTerm\":\"AE\",\"description\":\"Associate Editor - board member\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":145,\"key\":\"re\",\"tenantTerm\":\"RE\",\"frontiersDefaultTerm\":\"RE\",\"description\":\"Review Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":146,\"key\":\"rev\",\"tenantTerm\":\"REV\",\"frontiersDefaultTerm\":\"REV\",\"description\":\"Reviewer\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":147,\"key\":\"aut\",\"tenantTerm\":\"AUT\",\"frontiersDefaultTerm\":\"AUT\",\"description\":\"Author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":148,\"key\":\"coraut\",\"tenantTerm\":\"CORAUT\",\"frontiersDefaultTerm\":\"CORAUT\",\"description\":\"Corresponding author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":149,\"key\":\"saut\",\"tenantTerm\":\"SAUT\",\"frontiersDefaultTerm\":\"SAUT\",\"description\":\"Submitting author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":150,\"key\":\"coaut\",\"tenantTerm\":\"COAUT\",\"frontiersDefaultTerm\":\"COAUT\",\"description\":\"co-author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":151,\"key\":\"tsof\",\"tenantTerm\":\"TSOF\",\"frontiersDefaultTerm\":\"TSOF\",\"description\":\"Typesetter\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":152,\"key\":\"typesetting_office\",\"tenantTerm\":\"typesetting office\",\"frontiersDefaultTerm\":\"typesetting office\",\"category\":\"Product\"},{\"sequenceNumber\":153,\"key\":\"config\",\"tenantTerm\":\"CONFIG\",\"frontiersDefaultTerm\":\"CONFIG\",\"description\":\"Configuration office role\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":154,\"key\":\"jm\",\"tenantTerm\":\"JM\",\"frontiersDefaultTerm\":\"JM\",\"description\":\"Journal Manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":155,\"key\":\"rte\",\"tenantTerm\":\"RTE\",\"frontiersDefaultTerm\":\"RTE\",\"description\":\"Research topic editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":156,\"key\":\"organizations\",\"tenantTerm\":\"organizations\",\"frontiersDefaultTerm\":\"organizations\",\"category\":\"Core\"},{\"sequenceNumber\":157,\"key\":\"publishing\",\"tenantTerm\":\"publishing\",\"frontiersDefaultTerm\":\"publishing\",\"category\":\"Core\"},{\"sequenceNumber\":158,\"key\":\"acceptance\",\"tenantTerm\":\"acceptance\",\"frontiersDefaultTerm\":\"acceptance\",\"category\":\"Process\"},{\"sequenceNumber\":159,\"key\":\"preferred_associate_editor\",\"tenantTerm\":\"preferred associate editor\",\"frontiersDefaultTerm\":\"preferred associate editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":160,\"key\":\"topic_editors\",\"tenantTerm\":\"Topic Editors\",\"frontiersDefaultTerm\":\"Topic Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":161,\"key\":\"institutions\",\"tenantTerm\":\"institutions\",\"frontiersDefaultTerm\":\"institutions\",\"category\":\"Core\"},{\"sequenceNumber\":162,\"key\":\"author(s)\",\"tenantTerm\":\"author(s)\",\"frontiersDefaultTerm\":\"author(s)\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":163,\"key\":\"figure(s)\",\"tenantTerm\":\"figure(s)\",\"frontiersDefaultTerm\":\"figure(s)\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":164,\"key\":\"co-authors\",\"tenantTerm\":\"co-authors\",\"frontiersDefaultTerm\":\"co-authors\",\"description\":\"co-authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":165,\"key\":\"editorial_board_members\",\"tenantTerm\":\"editorial board members\",\"frontiersDefaultTerm\":\"editorial board members\",\"description\":\"editorial board members\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":166,\"key\":\"editorial_board\",\"tenantTerm\":\"editorial board\",\"frontiersDefaultTerm\":\"editorial board\",\"description\":\"editorial board\",\"category\":\"Product\"},{\"sequenceNumber\":167,\"key\":\"co-authorship\",\"tenantTerm\":\"co-authorship\",\"frontiersDefaultTerm\":\"co-authorship\",\"description\":\"co-authorship\",\"category\":\"Misc.\"},{\"sequenceNumber\":168,\"key\":\"role_id_1\",\"tenantTerm\":\"registration office\",\"frontiersDefaultTerm\":\"registration office\",\"category\":\"User Role\"},{\"sequenceNumber\":169,\"key\":\"role_id_2\",\"tenantTerm\":\"editorial office\",\"frontiersDefaultTerm\":\"editorial office\",\"category\":\"User Role\"},{\"sequenceNumber\":170,\"key\":\"role_id_7\",\"tenantTerm\":\"field chief editor\",\"frontiersDefaultTerm\":\"field chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":171,\"key\":\"role_id_8\",\"tenantTerm\":\"assistant field chief editor\",\"frontiersDefaultTerm\":\"assistant field chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":172,\"key\":\"role_id_9\",\"tenantTerm\":\"specialty chief editor\",\"frontiersDefaultTerm\":\"specialty chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":173,\"key\":\"role_id_10\",\"tenantTerm\":\"assistant specialty chief editor\",\"frontiersDefaultTerm\":\"assistant specialty chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":174,\"key\":\"role_id_11\",\"tenantTerm\":\"associate editor\",\"frontiersDefaultTerm\":\"associate editor\",\"category\":\"User Role\"},{\"sequenceNumber\":175,\"key\":\"role_id_12\",\"tenantTerm\":\"guest associate editor\",\"frontiersDefaultTerm\":\"guest associate editor\",\"category\":\"User Role\"},{\"sequenceNumber\":176,\"key\":\"role_id_13\",\"tenantTerm\":\"review editor\",\"frontiersDefaultTerm\":\"review editor\",\"category\":\"User Role\"},{\"sequenceNumber\":177,\"key\":\"role_id_14\",\"tenantTerm\":\"reviewer\",\"frontiersDefaultTerm\":\"reviewer\",\"category\":\"User Role\"},{\"sequenceNumber\":178,\"key\":\"role_id_15\",\"tenantTerm\":\"author\",\"frontiersDefaultTerm\":\"author\",\"category\":\"User Role\"},{\"sequenceNumber\":179,\"key\":\"role_id_16\",\"tenantTerm\":\"corresponding author\",\"frontiersDefaultTerm\":\"corresponding author\",\"category\":\"User Role\"},{\"sequenceNumber\":180,\"key\":\"role_id_17\",\"tenantTerm\":\"submitting author\",\"frontiersDefaultTerm\":\"submitting author\",\"category\":\"User Role\"},{\"sequenceNumber\":181,\"key\":\"role_id_18\",\"tenantTerm\":\"co-author\",\"frontiersDefaultTerm\":\"co-author\",\"category\":\"User Role\"},{\"sequenceNumber\":182,\"key\":\"role_id_20\",\"tenantTerm\":\"production office\",\"frontiersDefaultTerm\":\"production office\",\"category\":\"User Role\"},{\"sequenceNumber\":183,\"key\":\"role_id_22\",\"tenantTerm\":\"typesetting office (typesetter)\",\"frontiersDefaultTerm\":\"typesetting office (typesetter)\",\"category\":\"User Role\"},{\"sequenceNumber\":184,\"key\":\"role_id_24\",\"tenantTerm\":\"registered user\",\"frontiersDefaultTerm\":\"registered user\",\"category\":\"User Role\"},{\"sequenceNumber\":185,\"key\":\"role_id_35\",\"tenantTerm\":\"job office\",\"frontiersDefaultTerm\":\"job office\",\"category\":\"User Role\"},{\"sequenceNumber\":186,\"key\":\"role_id_41\",\"tenantTerm\":\"special event administrator\",\"frontiersDefaultTerm\":\"special event administrator\",\"category\":\"User Role\"},{\"sequenceNumber\":187,\"key\":\"role_id_42\",\"tenantTerm\":\"special event reviewer\",\"frontiersDefaultTerm\":\"special event reviewer\",\"category\":\"User Role\"},{\"sequenceNumber\":188,\"key\":\"role_id_43\",\"tenantTerm\":\"submit abstract\",\"frontiersDefaultTerm\":\"submit abstract\",\"category\":\"User Role\"},{\"sequenceNumber\":189,\"key\":\"role_id_52\",\"tenantTerm\":\"events office\",\"frontiersDefaultTerm\":\"events office\",\"category\":\"User Role\"},{\"sequenceNumber\":190,\"key\":\"role_id_53\",\"tenantTerm\":\"event administrator\",\"frontiersDefaultTerm\":\"event administrator\",\"category\":\"User Role\"},{\"sequenceNumber\":191,\"key\":\"role_id_89\",\"tenantTerm\":\"content management office\",\"frontiersDefaultTerm\":\"content management office\",\"category\":\"User Role\"},{\"sequenceNumber\":192,\"key\":\"role_id_98\",\"tenantTerm\":\"accounting office\",\"frontiersDefaultTerm\":\"accounting office\",\"category\":\"User Role\"},{\"sequenceNumber\":193,\"key\":\"role_id_99\",\"tenantTerm\":\"projects\",\"frontiersDefaultTerm\":\"projects\",\"category\":\"User Role\"},{\"sequenceNumber\":194,\"key\":\"role_id_103\",\"tenantTerm\":\"configuration office\",\"frontiersDefaultTerm\":\"configuration office\",\"category\":\"User Role\"},{\"sequenceNumber\":195,\"key\":\"role_id_104\",\"tenantTerm\":\"beta user\",\"frontiersDefaultTerm\":\"beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":196,\"key\":\"role_id_106\",\"tenantTerm\":\"wfconf\",\"frontiersDefaultTerm\":\"wfconf\",\"category\":\"User Role\"},{\"sequenceNumber\":197,\"key\":\"role_id_107\",\"tenantTerm\":\"rt management beta user\",\"frontiersDefaultTerm\":\"rt management beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":198,\"key\":\"role_id_108\",\"tenantTerm\":\"deo beta user\",\"frontiersDefaultTerm\":\"deo beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":199,\"key\":\"role_id_109\",\"tenantTerm\":\"search beta user\",\"frontiersDefaultTerm\":\"search beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":200,\"key\":\"role_id_110\",\"tenantTerm\":\"journal manager\",\"frontiersDefaultTerm\":\"journal manager\",\"category\":\"User Role\"},{\"sequenceNumber\":201,\"key\":\"role_id_111\",\"tenantTerm\":\"myfrontiers beta user\",\"frontiersDefaultTerm\":\"myfrontiers beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":202,\"key\":\"role_id_21\",\"tenantTerm\":\"copy editor\",\"frontiersDefaultTerm\":\"copy editor\",\"category\":\"User Role\"},{\"sequenceNumber\":203,\"key\":\"role_id_1_abr\",\"tenantTerm\":\"ROF\",\"frontiersDefaultTerm\":\"ROF\",\"category\":\"User Role\"},{\"sequenceNumber\":204,\"key\":\"role_id_2_abr\",\"tenantTerm\":\"EOF\",\"frontiersDefaultTerm\":\"EOF\",\"category\":\"User Role\"},{\"sequenceNumber\":205,\"key\":\"role_id_7_abr\",\"tenantTerm\":\"FCE\",\"frontiersDefaultTerm\":\"FCE\",\"category\":\"User Role\"},{\"sequenceNumber\":206,\"key\":\"role_id_8_abr\",\"tenantTerm\":\"AFCE\",\"frontiersDefaultTerm\":\"AFCE\",\"category\":\"User Role\"},{\"sequenceNumber\":207,\"key\":\"role_id_9_abr\",\"tenantTerm\":\"SCE\",\"frontiersDefaultTerm\":\"SCE\",\"category\":\"User Role\"},{\"sequenceNumber\":208,\"key\":\"role_id_10_abr\",\"tenantTerm\":\"ASCE\",\"frontiersDefaultTerm\":\"ASCE\",\"category\":\"User Role\"},{\"sequenceNumber\":209,\"key\":\"role_id_11_abr\",\"tenantTerm\":\"AE\",\"frontiersDefaultTerm\":\"AE\",\"category\":\"User Role\"},{\"sequenceNumber\":210,\"key\":\"role_id_12_abr\",\"tenantTerm\":\"GAE\",\"frontiersDefaultTerm\":\"GAE\",\"category\":\"User Role\"},{\"sequenceNumber\":211,\"key\":\"role_id_13_abr\",\"tenantTerm\":\"RE\",\"frontiersDefaultTerm\":\"RE\",\"category\":\"User Role\"},{\"sequenceNumber\":212,\"key\":\"role_id_14_abr\",\"tenantTerm\":\"REV\",\"frontiersDefaultTerm\":\"REV\",\"category\":\"User Role\"},{\"sequenceNumber\":213,\"key\":\"role_id_15_abr\",\"tenantTerm\":\"AUT\",\"frontiersDefaultTerm\":\"AUT\",\"category\":\"User Role\"},{\"sequenceNumber\":214,\"key\":\"role_id_16_abr\",\"tenantTerm\":\"CORAUT\",\"frontiersDefaultTerm\":\"CORAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":215,\"key\":\"role_id_17_abr\",\"tenantTerm\":\"SAUT\",\"frontiersDefaultTerm\":\"SAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":216,\"key\":\"role_id_18_abr\",\"tenantTerm\":\"COAUT\",\"frontiersDefaultTerm\":\"COAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":217,\"key\":\"role_id_20_abr\",\"tenantTerm\":\"POF\",\"frontiersDefaultTerm\":\"POF\",\"category\":\"User Role\"},{\"sequenceNumber\":218,\"key\":\"role_id_22_abr\",\"tenantTerm\":\"TSOF\",\"frontiersDefaultTerm\":\"TSOF\",\"category\":\"User Role\"},{\"sequenceNumber\":219,\"key\":\"role_id_24_abr\",\"tenantTerm\":\"RU\",\"frontiersDefaultTerm\":\"RU\",\"category\":\"User Role\"},{\"sequenceNumber\":220,\"key\":\"role_id_35_abr\",\"tenantTerm\":\"JOF\",\"frontiersDefaultTerm\":\"JOF\",\"category\":\"User Role\"},{\"sequenceNumber\":221,\"key\":\"role_id_41_abr\",\"tenantTerm\":\"SE-ADM\",\"frontiersDefaultTerm\":\"SE-ADM\",\"category\":\"User Role\"},{\"sequenceNumber\":222,\"key\":\"role_id_42_abr\",\"tenantTerm\":\"SE-REV\",\"frontiersDefaultTerm\":\"SE-REV\",\"category\":\"User Role\"},{\"sequenceNumber\":223,\"key\":\"role_id_43_abr\",\"tenantTerm\":\"SE-AUT\",\"frontiersDefaultTerm\":\"SE-AUT\",\"category\":\"User Role\"},{\"sequenceNumber\":224,\"key\":\"role_id_52_abr\",\"tenantTerm\":\"EVOF\",\"frontiersDefaultTerm\":\"EVOF\",\"category\":\"User Role\"},{\"sequenceNumber\":225,\"key\":\"role_id_53_abr\",\"tenantTerm\":\"EV-ADM\",\"frontiersDefaultTerm\":\"EV-ADM\",\"category\":\"User Role\"},{\"sequenceNumber\":226,\"key\":\"role_id_89_abr\",\"tenantTerm\":\"COMOF\",\"frontiersDefaultTerm\":\"COMOF\",\"category\":\"User Role\"},{\"sequenceNumber\":227,\"key\":\"role_id_98_abr\",\"tenantTerm\":\"AOF\",\"frontiersDefaultTerm\":\"AOF\",\"category\":\"User Role\"},{\"sequenceNumber\":228,\"key\":\"role_id_99_abr\",\"tenantTerm\":\"Projects\",\"frontiersDefaultTerm\":\"Projects\",\"category\":\"User Role\"},{\"sequenceNumber\":229,\"key\":\"role_id_103_abr\",\"tenantTerm\":\"CONFIG\",\"frontiersDefaultTerm\":\"CONFIG\",\"category\":\"User Role\"},{\"sequenceNumber\":230,\"key\":\"role_id_104_abr\",\"tenantTerm\":\"BETA\",\"frontiersDefaultTerm\":\"BETA\",\"category\":\"User Role\"},{\"sequenceNumber\":231,\"key\":\"role_id_106_abr\",\"tenantTerm\":\"WFCONF\",\"frontiersDefaultTerm\":\"WFCONF\",\"category\":\"User Role\"},{\"sequenceNumber\":232,\"key\":\"role_id_107_abr\",\"tenantTerm\":\"RTBETA\",\"frontiersDefaultTerm\":\"RTBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":233,\"key\":\"role_id_108_abr\",\"tenantTerm\":\"DEOBETA\",\"frontiersDefaultTerm\":\"DEOBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":234,\"key\":\"role_id_109_abr\",\"tenantTerm\":\"SEARCHBETA\",\"frontiersDefaultTerm\":\"SEARCHBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":235,\"key\":\"role_id_110_abr\",\"tenantTerm\":\"JM\",\"frontiersDefaultTerm\":\"JM\",\"category\":\"User Role\"},{\"sequenceNumber\":236,\"key\":\"role_id_111_abr\",\"tenantTerm\":\"MFBETA\",\"frontiersDefaultTerm\":\"MFBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":237,\"key\":\"role_id_21_abr\",\"tenantTerm\":\"COPED\",\"frontiersDefaultTerm\":\"COPED\",\"category\":\"User Role\"},{\"sequenceNumber\":238,\"key\":\"reviewer_editorial_board\",\"tenantTerm\":\"editorial board\",\"frontiersDefaultTerm\":\"editorial board\",\"description\":\"This is the label for the review editorial board\",\"category\":\"Label\"},{\"sequenceNumber\":239,\"key\":\"field_chief_editor\",\"tenantTerm\":\"Field Chief Editor\",\"frontiersDefaultTerm\":\"Field Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":240,\"key\":\"field_chief_editors\",\"tenantTerm\":\"Field Chief Editors\",\"frontiersDefaultTerm\":\"Field Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":241,\"key\":\"editor\",\"tenantTerm\":\"editor\",\"frontiersDefaultTerm\":\"editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":242,\"key\":\"editors\",\"tenantTerm\":\"editors\",\"frontiersDefaultTerm\":\"editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":243,\"key\":\"board\",\"tenantTerm\":\"board\",\"frontiersDefaultTerm\":\"board\",\"category\":\"Label\"},{\"sequenceNumber\":244,\"key\":\"boards\",\"tenantTerm\":\"boards\",\"frontiersDefaultTerm\":\"boards\",\"category\":\"Label\"},{\"sequenceNumber\":245,\"key\":\"article_collection\",\"tenantTerm\":\"article collection\",\"frontiersDefaultTerm\":\"article collection\",\"category\":\"Label\"},{\"sequenceNumber\":246,\"key\":\"article_collections\",\"tenantTerm\":\"article collections\",\"frontiersDefaultTerm\":\"article collections\",\"category\":\"Label\"},{\"sequenceNumber\":247,\"key\":\"handling_editor\",\"tenantTerm\":\"handling editor\",\"frontiersDefaultTerm\":\"associate editor\",\"description\":\"This terminology key is for the person assigned to edit a manuscript. It is a label for the temporary handling editor assignment.\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":248,\"key\":\"handling_editors\",\"tenantTerm\":\"handling editors\",\"frontiersDefaultTerm\":\"associate editors\",\"description\":\"This terminology key is for the person assigned to edit a manuscript. It is a label for the temporary handling editor assignment.\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":249,\"key\":\"ae_accept\",\"tenantTerm\":\"recommend acceptance\",\"frontiersDefaultTerm\":\"accept\",\"category\":\"Process\"},{\"sequenceNumber\":250,\"key\":\"rtm\",\"tenantTerm\":\"RTM\",\"frontiersDefaultTerm\":\"RTM\",\"category\":\"Product\"},{\"sequenceNumber\":251,\"key\":\"frontiers_media_sa\",\"tenantTerm\":\"Frontiers Media S.A\",\"frontiersDefaultTerm\":\"Frontiers Media S.A\",\"category\":\"Customer\"},{\"sequenceNumber\":252,\"key\":\"review_editors\",\"tenantTerm\":\"Community Reviewers\",\"frontiersDefaultTerm\":\"Review Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":253,\"key\":\"journal_card_chief_editor\",\"tenantTerm\":\"Chief Editor\",\"frontiersDefaultTerm\":\"Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":254,\"key\":\"journal_card_chief_editors\",\"tenantTerm\":\"Chief Editors\",\"frontiersDefaultTerm\":\"Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":255,\"key\":\"call_for_papers\",\"tenantTerm\":\"Call for papers\",\"frontiersDefaultTerm\":\"Call for papers\",\"category\":\"Label\"},{\"sequenceNumber\":256,\"key\":\"calls_for_papers\",\"tenantTerm\":\"Calls for papers\",\"frontiersDefaultTerm\":\"Calls for papers\",\"category\":\"Label\"},{\"sequenceNumber\":257,\"key\":\"supervising_editor\",\"tenantTerm\":\"Supervising Editor\",\"frontiersDefaultTerm\":\"Supervising Editor\",\"description\":\"A Chief or Assistant Chief editor who is assigned to a manuscript to supervise.\",\"category\":\"Role\",\"externalKey\":\"supervising_editor\"},{\"sequenceNumber\":258,\"key\":\"supervising_editors\",\"tenantTerm\":\"Supervising Editors\",\"frontiersDefaultTerm\":\"Supervising Editors\",\"description\":\"A Chief or Assistant Chief editor who is assigned to a manuscript to supervise.\",\"category\":\"Role\",\"externalKey\":\"supervising_editors\"},{\"sequenceNumber\":259,\"key\":\"reviewer_endorse\",\"tenantTerm\":\"endorse\",\"frontiersDefaultTerm\":\"endorse\",\"category\":\"Label\"},{\"sequenceNumber\":260,\"key\":\"reviewer_endorsed\",\"tenantTerm\":\"endorsed\",\"frontiersDefaultTerm\":\"endorsed\",\"category\":\"Label\"},{\"sequenceNumber\":261,\"key\":\"reviewer_endorse_publication\",\"tenantTerm\":\"endorse publication\",\"frontiersDefaultTerm\":\"endorse publication\",\"category\":\"Label\"},{\"sequenceNumber\":262,\"key\":\"reviewer_endorsed_publication\",\"tenantTerm\":\"endorsed publication\",\"frontiersDefaultTerm\":\"endorsed publication\",\"category\":\"Label\"},{\"sequenceNumber\":263,\"key\":\"editor_role\",\"tenantTerm\":\"editor role\",\"frontiersDefaultTerm\":\"Editor Role\",\"category\":\"Label\"},{\"sequenceNumber\":264,\"key\":\"editor_roles\",\"tenantTerm\":\"editor roles\",\"frontiersDefaultTerm\":\"Editor Roles\",\"category\":\"Label\"},{\"sequenceNumber\":265,\"key\":\"editorial_role\",\"tenantTerm\":\"editorial role\",\"frontiersDefaultTerm\":\"Editorial Role\",\"category\":\"Label\"},{\"sequenceNumber\":266,\"key\":\"editorial_roles\",\"tenantTerm\":\"editorial roles\",\"frontiersDefaultTerm\":\"Editorial Roles\",\"category\":\"Label\"},{\"sequenceNumber\":267,\"key\":\"call_for_paper\",\"tenantTerm\":\"Call for paper\",\"frontiersDefaultTerm\":\"Call for paper\",\"category\":\"Label\"},{\"sequenceNumber\":268,\"key\":\"research_topic_abstract\",\"tenantTerm\":\"manuscript summary\",\"frontiersDefaultTerm\":\"manuscript summary\",\"category\":\"Process\"},{\"sequenceNumber\":269,\"key\":\"research_topic_abstracts\",\"tenantTerm\":\"manuscript summaries\",\"frontiersDefaultTerm\":\"manuscript summaries\",\"category\":\"Process\"},{\"sequenceNumber\":270,\"key\":\"submissions_team_manager\",\"tenantTerm\":\"Journal Manager\",\"frontiersDefaultTerm\":\"Content Manager\",\"category\":\"Process\"},{\"sequenceNumber\":271,\"key\":\"submissions_team\",\"tenantTerm\":\"Journal Team\",\"frontiersDefaultTerm\":\"Content Team\",\"category\":\"Process\"},{\"sequenceNumber\":272,\"key\":\"topic_coordinator\",\"tenantTerm\":\"topic coordinator\",\"frontiersDefaultTerm\":\"topic coordinator\",\"category\":\"Process\"},{\"sequenceNumber\":273,\"key\":\"topic_coordinators\",\"tenantTerm\":\"topic coordinators\",\"frontiersDefaultTerm\":\"topic coordinators\",\"category\":\"Process\"},{\"sequenceNumber\":274,\"key\":\"frontiers_journal_team\",\"tenantTerm\":\"frontiers journal team\",\"frontiersDefaultTerm\":\"frontiers journal team\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":275,\"key\":\"research_topic_ic_submission\",\"tenantTerm\":\"RT:IC Submission\",\"frontiersDefaultTerm\":\"RT:IC Submission\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":276,\"key\":\"research_topic_ic_submission_participant\",\"tenantTerm\":\"RT:IC Submission participant\",\"frontiersDefaultTerm\":\"RT:IC Submission participant\",\"category\":\"Label (Role)\"}]}'\n",impactGtmId:"GTM-NJF2ML9B",impactGtmAuth:"fYo-7NoDm9w37QgFMs03SA",impactGtmPreview:"env-1",impactGoogleMapsApiKey:"AIzaSyCTEhX2EU8PWfi86GW9FI00FTcyKk6Ifr8",qualtricsV4ToV3:"'{\"enabled\":true,\"interceptId\":\"SI_er0E2ze69Oz8Yn4\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",qualtricsUmux:"'{\"enabled\":false,\"interceptId\":\"SI_89fPHY3eTxQBwtU\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",qualtricsContinuousBrand:"'{\"enabled\":true,\"interceptId\":\"SI_9ZuT94UT81FcRh4\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",defaultArticleTemplate:"v3"},app:{baseURL:"/",buildId:"ed555f16-85f7-4f41-8f2f-451827c59120",buildAssetsDir:"ap-2024/_nuxt",cdnURL:""}}</script>
<script src="https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6" type="text/javascript" async></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML" type="text/javascript" async></script>
<script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js" type="text/javascript" async></script>
<script src="https://api.altmetric.com/v1/doi/10.3389/fgene.2023.1126836?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15" type="text/javascript" async></script>
<script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript" async></script></body></html>